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A Introduction  
 
1 Introduction - Applications of aromatic heterocycles 
Aromatic heterocycles are ubiquitous in our daily life. A great number of essential biochemical 
processes rely upon systems derived from biological molecules containing heteroaromatic 
compounds as key building blocks. The side groups of DNA and RNA, the fundamental 
components of all living cells, are based on aromatic heterocycles. Furthermore, they are major 
constituents of essential amino acids, important vitamins, coenzymes, as well as plant and 
animal hormones, to name just a few. In addition to their import role in living organisms, 
heteroaromatic compounds are applied as herbicides, dyes, food additives, cosmetics, and 
perfumery ingredients among myriad other areas of modern life and industry.1 However, the 
most important contribution of aromatic heterocycles to improve the quality of human life is 
probably their utilization in medicine. A great number of biologically active natural products 
and pharmaceuticals contain heteroaromatic building blocks. Some representatives are shown 
below (figure 1).2 
 
 
Figure 1. Pharmaceuticals based on a heteroaromatic scaffold.2  
 
Sumatriptan (1), a selective serotonin 5-HT1B/1D agonist, is effective in the treatment of 
migraine, a disease that affects approximately 15% of the world's population. In the fight against 
cancer, imatinib (2) and other tyrosine kinase inhibitors are used as drugs in the therapy of 
gastrointestinal stromal tumors and chronic myeloid leukemia. Cardiovascular diseases along 
A Introduction 
2 
with cancer have become the two major causes of death in industrialized countries. Drugs like 
atorvastatin (3), an especially successful representative of the so-called statins, were developed 
to reduce the risk of myocardial infarction by lowering cholesterol and triglycerides levels in 
the blood. As a potent medication against parasitic diseases, chloroquine (4) may be 
exemplified, which is used to prevent and to treat malaria. Another widespread health problem 
are gastric ulcers, which are caused by a disorder in the production of gastric hydrochloric acid. 
Ranitidine (5) can reduce this production by blocking the histamine H2 receptors. An example 
of a drug that can act as an analgesic is articaine (6), which is usually applied as a local dental 
anesthetic.2 
Since a large number of synthetic as well as natural pharmaceuticals are constructed on an 
aromatic heterocyclic scaffold, it is not surprising, that methods to functionalize heteroaromatic 
compounds are still of continuing interest in organic chemistry. Furthermore, simple aromatic 
heterocycles are frequently used as intermediates for the synthesis of natural products and other 
high complexity targets.3,4,5 An attractive approach to utilize aromatic heterocycles for the 
generation of versatile intermediates is the [2+1] addition of carbenes.6 Applying this reaction 
to furan, pyrrole and indole derivatives gives access to valuable building blocks with the general 
substructure of 7.4 This report will focus on the transformation of cyclopropanes 7 into natural 
products, analogues, and other synthetically useful compounds. Some accessible target7–13 
compounds are shown in figure 2 and details on their synthesis will be described together with 
a variety of other applications in the following chapters. 
 
 
Figure 2. Examples of accessible compounds from cyclopropanes 7.7–13   
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2 Applications of cyclopropanated furan derivatives 
Furan and its derivatives are probably the most frequently used aromatic heterocycles for 
organic synthesis.3 A possible reason for this might be their accessibility from lignocellulose, 
being the most abundant biomass resource on earth, via furfural as an intermediate.14 
Furthermore, their versatile reactivity analogous to arenes as well as masked alkenes and dienes, 
makes them excellent starting materials for the synthesis of complex targets like natural 
products.4 
In 1983, Rokach and co-workers15,16 presented a method to utilize furan for the synthesis of 
racemic 5-HETE 18 (5-hydroxyeicosatetraenoic acid) by taking advantage of the cyclopropane 
ring unraveling strategy introduced earlier by Wenkert et al.17 Rhodium(II)-catalyzed 
cyclopropanation of furan 14 with diazo ketone 15 followed by ring opening of intermediate 16 
gave access to diene 17, which was transformed into 18 in 9 additional steps (scheme 1). In 
subsequent years, this unraveling strategy was also successfully applied by Fitzsimmons18 for 
the synthesis of racemic 12-HETE (12-hydroeicosatetraenoic acid) and by Wenkert19 for the 
synthesis of corticrocin, whereas an intramolecular variation of this strategy was utilized by 
Doyle et al.20 for the construction of macrocyclic lactones and ketones. 
 
Scheme 1. Synthesis of 5-HETE 13 by Rokach and co-workers.15,16 
 
An efficient methodology for the enantioselective construction of anti-4,5-disubstituted 
γ-butyrolactones starting from inexpensive furan 19 was developed by Reiser and co-workers.9 
One of the key steps is the Cu(I)-catalyzed cyclopropanation of 19 with diazo ester 20, which 
enables the introduction of three new stereocenters (see chapter B.1.1 for details). Ozonolysis 
of cyclopropane 21 followed by reductive workup gave rise to aldehyde 22, which was 
subjected to a nucleophilic addition in the next step. Depending on the nucleophile that is 
applied, this reaction forms the Felkin-Ahn21–23 or the Cram-Chelate24 products in high 
diastereoselectivity, respectively.25 In the next step, Felkin-Ahn product 23 was transformed to 
trans-substituted γ-butyrolactone 28 by a base induced hydrolysis that triggers a subsequent 
retroaldol/lactonization cascade (via 27), whereas the corresponding cis-substituted 
γ-butyrolactones could be formed by applying the analog Chram-Chelate products.24 These 
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versatile building blocks were utilized to construct the core structures of xanthanolides, 
guaianolides, elemanolides, as well as eudesmanolides.23 Furthermore, they were successfully 
utilized for the total synthesis of various natural products like (-)-rocellaric acid (8)9 (among 
other paraconic acids,26 see chapter B.3.2 for details), xanthatin (29)27 and arglabin™ (13).12 
For the construction of both enantiomers of arteludovicinolide A (26)28 a variation of this 
strategy was used. Protection of the free hydroxyl group in 23 with TIPS, followed by 
hydrolysis of the oxalic ester gave access to acyclic aldehyde 24, which was further transformed 
to lactones of type 25 by the addition of Grignard or organolithium reagents. The synthesis of 
arteludovicinolide A (26) was accomplished in five additional steps. 
 
Scheme 2. Synthesis of arteludovicinolide A (26), (-)-rocellaric acid (8), xanthatin (29) and arglabin™ 
(13) starting from furoate 19 by Reiser and co-workers.21–23,26–28 
 
Based on the earlier work of Chandrasekaran29 and Theodorakis,30 an elegant method to 
convert cyclopropane 30 to the unnatural enantiomer 10 of paeonilide was developed by Harrar 
and Reiser.31 Cyclopropane 30, which was synthesized analogous to 21 (see chapter B.1.1 for 
details) from methyl furan-3-carboxylate, was transformed to acid 31 by ester hydrolysis and 
subsequent hydrogenation of the double bond occurring exclusively at the convex side of the 
bicycle. An acid-catalyzed ring opening and subsequent treatment with pyridine causing 
epimerization of the bridge-head centers, followed by an intramolecular lactonization, giving 
access to bicyclic lactone 32, which was further converted to 10 in 6 steps. It is notable, that 
recently the enantioselective synthesis of natural (+)-paeonilide ((ent)-10) was accomplished 
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starting from (ent)-30.32 A similar method was also utilized to construct the core nuclei of 
several spongiane diterpenoids like cheloviolene A and B, norrisolide and macfarlandin C.33  
 
 
Scheme 3. Synthesis of (-)-paeonilide (10) by Harrar and Reiser.31 
 
Compared to mono-cyclopropanated furans, the corresponding double-cyclopropanated 
representatives are less frequently used in organic synthesis. Nevertheless, some interesting 
transformations from tricycles 33, which include a donor-acceptor ring enlargement strategy 
were reported by Werz and co-workers.34–37 Starting materials of type 33 were synthesized by 
a Cu(I) or Rh(II)-catalyzed cyclopropanation of furan 14 with a variety of diazo esters. 
Reducing the ester groups of 33 to aldehydes in 2 steps followed by ring enlargement of 
intermediate 34, gave rise to tricyclic bisacetal 35. A similar approach was used for the 
synthesis of 3,3'-linked dipyrroles 37, that includes imine formation and ring enlargement 
followed by the elimination of water via intermediate 36.  
 
 
Scheme 4. Synthesis of tricyclic bisacetal 35 and 3,3'-linked dipyrroles 37 starting from tricycles 33 by 
Werz and co-workers.34–37   
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3 Applications of cyclopropanated pyrrole derivatives 
 
Just like furans, pyrroles offer a great range of diverse chemistry and have been utilized in 
numerous target-oriented syntheses.38 However, in contrast to furans, the reactivity of pyrroles 
is influenced by the functionality on the nitrogen.39,40 In the reaction with carbenoids, electron-
rich N-H or N-alkyl pyrroles behave more typically like arenes, forming exclusively substitution 
products 38 and 39 via zwitterionic intermediates. The product ratio is dependent on the catalyst 
as well as the size of the alkyl group.41 Due to the conjugation of the carbonyl group with the 
nitrogen lone pair, the aromatic ring of N-acyl pyrroles is not as electron-rich, therefore forming  
predominantly cyclopropanation products of type 41a and 41b in the reaction with 
carbenoids.42-44 The versatile reactivity of these cyclopropanes arising from pyrroles was 
already shown in the pioneering work of Fowler.42 Cyclopropane 41a was transformed to 
pyrrole acetate 42a by heating in the presence of CuBr, whereas subjection of 41a to flash 
vacuum pyrolysis caused rearrangement to 43a. Furthermore, it was demonstrated by Tanny 
and Fowler,45 that 41a is amenable to undergo [5+2] cycloaddition reactions with suitable 
dienophiles forming the corresponding bridged seven-membered rings. In contrast to the 
reaction of acceptor diazo ester 20 with pyrrole 40 (R = Boc), decomposition of 2-(siloxy)vinyl 
diazoacetate (donor-acceptor diazo ester: see chapter B.1.1 for details) in the presence of 40 (R 
= Boc) allowed the asymmetric formation of tropanes via a tandem cyclopropanation/Cope 
rearrangement mechanism.46  
 
 
Scheme 5. Influence on the reactivity of pyrrole 40 by using different N-substituents and transformations 
of 41a using different reaction conditions.39–42,44,45  
 
An approach to utilize cyclopropane 41b without destroying the cyclopropane moiety was 
realized by ozonolytic cleavage of the double bond in 41b analog to furan 21 (scheme 2), 
followed by oxidation and deformylation. This method was successfully applied for the 
construction of conformationally constrained cis- as well as trans-β-aminocyclopropane-
carboxylic acids (β-ACC's).47 The incorporation of this amino acids into peptides enabled the 
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construction of novel secondary structural motifs48 and was successfully utilized for the 
synthesis of organocatalysts49 as well as biologically active ligands toward orexin,50 
neuropeptide Y51 and calcitonin gene-related peptide receptors.52  
 
 
Scheme 6. Possible transformations of cyclopropanated pyrroles 41b and (rac)-41b.53–55  
 
Furthermore, cyclopropane 41b was successfully used as starting point for the enantioselective 
construction of substituted 5-membered N-heterocycles via selective ring opening of the 
exo-cyclic cyclopropane bonds (scheme 6).53–55 In these approaches, the enamine double bond 
in 41b had to be removed first, because otherwise products analog to 38 and 39 resulting from 
rearomatization of the pyrrole moiety were formed. Treatment of 41b with NBS to form the 
corresponding bromohydrin followed by oxidation set the stage for cleavage of the 
cyclopropane bond with Bu3SnH, giving access to 3,4-didehydropyrohomoglutamate 45 via 
intermediate 44. Although a slight epimerization could be obtained during the ring opening 
step, 45 was successfully applied for the enantioselective synthesis of (S)-vigabatrin (9) as well 
as a number of anti-substituted pyrrolidine-2-ones.53 In addition, a multicomponent approach, 
which showed the accessibility of cis-4,5-disubstituted pyrrolidinones 50 by treating (rac)-41b 
with Sc(OTf)3 (5 mol%) under microwave (mw) irradiation, was reported. This cascade 
sequence starts with a [4+2]-cycloaddition (Povarov reaction) of aromatic imines, which can 
be in situ formed from aldehydes 49 and anilines 48, with the double bond of cyclopropane 
(rac)-41b to form the scaffold of the quinoline moiety in 50. Carrying out the reaction at 
ambient temperature allows the isolation of the resulting products at this stage, whereas heating 
causes further transformation to 50 via selective cyclopropane ring opening, followed by 1,4-
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shift of the furan moiety and rearomatization of the quinoline moiety, N-Boc hydrolysis and 
lactamization.54 Recently, the transformation of 41b to homo-β-proline 47, a structurally 
restricted analogue of GABA, was reported by hydrogenation of the double bond in 41b 
followed by acid-catalyzed ring-opening of intermediate 47 (see chapter B.2.2 for details).55  
An elegant protocol for the construction of polycyclic N-heterocycles of type 52 starting from 
hydrazones 51, which can be readily synthesized from the corresponding ketones or aldehydes 
with arenesulfonyl hydrazides, was developed by Zhou, Che and co-workers (scheme 7).56 The 
use of N-hydrazones 51 as carbene precursors gave access to 52 via an intramolecular 
cyclopropanation catalyzed by cobalt(II)-porphyrin complex 55. Moreover, the utility of these 
polycycles as intermediates for the synthesis of N-heterocycles like pyrrolizidine 53 and 
pyrrolizine 54 was shown. It is notable, that an analog transformation was possible with indoles, 
enabling the construction of numerous N-heterocycles having potential biological interest.56 
 
 
Scheme 7. Synthesis of polycyclic N-heterocycles of type 52 starting from hydrazones 51 and further 
transformation to pyrrolizidine 53 and pyrrolizine 54.56 
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4 Applications of cyclopropanated indole derivatives 
 
Due to the great importance of the indole ring, that is present in more than ten thousand 
biologically active compounds, enormous efforts have been devoted to the development of 
synthetic methods for the preparation of this aromatic heterocycle and derivatives thereof.57 
Considering the complexity of several naturally occurring indole derivatives, it is not surprising, 
that the construction, as well as the direct functionalization of this heteroaromatic compound, 
has drawn great attention in organic chemistry.57,58 For this purpose, the [2+1]-addition of 
carbenes represents a powerful and attractive tool, which was already successfully applied as 
inter- as well as intramolecular variant for the construction of natural products.59–61 Additional 
strategies, establishing the indole core structure concurrent or after the formation of the 
cyclopropane ring, have also been described, but will not be covered in here. 
In 2006, Qin and co-workers reported an efficient synthetic route to chiral 3-substituted 
hexahydropyrroloindoline 59 starting from readily available L-tryptophan (scheme 8).62 The 
key step in this synthesis is a Cu(I)-catalyzed one-pot-cascade reaction of oxazolidinone 56, 
which is accessible in three steps starting from readily available L-tryptophan. This cascade is 
initiated by a cyclopropanation reaction of 56 with diazo ester 20 followed by ring opening and 
cyclization via intermediates 57 and 58. Two years later, they were able to transform 59 into 
(-)-ardeemin (60) in 20 additional steps.59  
 
Scheme 8. Synthesis of (-)-ardeemin (60) starting from L-tryptophan by Qin and co-workers.59,62 
An intermolecular cyclopropanation reaction was also a crucial step in the synthesis of 
(-)-desoxyeseroline (12) (scheme 9). The reaction of indole 61 with diazo ester 20 in the 
presence of Cu(OTf) and glucoBox ligand 65 produced cyclopropane 62, which was directly 
transformed into imine 63 via acidic removal of the Boc-group and subsequent ring-opening in 
61% yield. Cleavage of the ester moiety in 63 triggers a cyclization, which gave access to 
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intermediate 64 in 71% yield and 96% ee. A protocol of Ikeda et al. for the racemic synthesis 
of esermethole63 was applied successfully to transform 64 into (-)-desoxyeseroline (12) in 3 
steps.60  
 
Scheme 9. Synthesis of (-)-desoxyeseroline (12) starting from indole 61 by Boysen and co-workers.60 
 
An intramolecular cyclopropanation was utilized as a key step in the synthesis of 
tetrahydro-β-carboline 68 (scheme 10). Treatment of diazo compound 66 with Rh2(cap)4 
(cap = caprolactamate) gave access to intermediate 67, whereby the N-BTMSM 
(bis(trimethylsilyl)methyl) group was crucial to suppress the formation of C-H-insertion 
byproducts via conformational control about the amide moiety. Subsequent acid catalyzed 
rearrangement provided tetrahydro-β-carboline 68 in 84% yield.64  
 
Scheme 10. Synthesis of tetrahydro-β-carboline 68 via intramolecular cyclopropanation as a key step.64 
 
Furthermore, intramolecular cyclopropanation has proven to be a powerful tool to create an all-
carbon quaternary center at the C-3-position of substituted indoles. These strategy was 
successfully applied to the total synthesis of a great number of indole alkaloids (Spino et al: 
(+)-aspidofractinine;65 Nishida et al: lundurine A and B (racemic);66 Qin et al: communesin F 
(racemic), minfiensine (racemic), (-)-kopsine, (-)-isokopsine ,(+)-methyl chanofruticosinate, 
(-)-fruticosine and (-)-kopsanone).61,67 The cyclopropanation as a key step and the following 
ring-opening strategy in the synthesis of (±)-communesin F are depicted in scheme 11 as an 
illustrative example. Reaction of α-aryl-α-diazo ester 69 in the presence of copper(I) triflate led 
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to cyclopropanation product 70 as a mixture of two diastereomers in a 1.6:1 ratio. Reduction of 
the azide group in 70 with PBu3 in aqueous THF and subsequent ring opening followed by ring 
closure with in situ generated aniline, provided the kinetic product 71 as a single diastereomer. 
The resulting pentacyclic substructure 71 was transformed to (±)-communesin F (72) in 17 
additional steps.61  
 
Scheme 11. Synthesis of (±)-communesin F (72) starting from indole 69 by Qin and co-workers.61 
 
The impressive applications of cyclopropanes 7 described here, demonstrate the great potential 
of this building blocks in organic chemistry. Cyclopropanation reactions were used as a key 
step and enabled the installation of key stereocenters in these synthetic strategies and further 
transformation via either rearrangement or ring-opening of the cyclopropanes led to a wide 
portfolio of accessible structures. The last example presented in this chapter utilizes a 
donor/acceptor carbenoid (classification of diazo compounds: see chapter B.1.1 for details) for 
the intramolecular cyclopropanation step in the total synthesis of (±)-communesin F (72). These 
type of carbenoids are stabilized by an additional donor group and thus, capable of undergoing 
highly chemoselective reactions.40 However, in most applications presented here, simple 
acceptor diazo esters were used for the formation of the cyclopropanes. In the present thesis, 
the asymmetric, intermolecular cyclopropanation of aromatic heterocycles with donor-acceptor 
carbenoids was investigated to expand the scope of these useful building blocks. In the 
following, the utility of these cyclopropanes for the construction of natural products derivatives 
was explored.  
A Introduction 
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1 Cyclopropanation of aromatic heterocycles 
1.1 Introduction – Classification of diazo ester 
 
The cyclopropane ring is ubiquitous in nature and can be found in various structural classes of 
natural products including pheromones, fatty acid metabolites, terpenoids and unusual amino 
acids. Naturally occurring cyclopropanes, as well as several synthetic representatives, possess 
a broad spectrum of biological activities and thus, they are popular targets in organic synthesis.1 
Moreover, an impressive array of cyclopropane-based strategies to complex molecules like 
natural products was published.2 Therefore, there is a continuing interest in developing effective 
methods and new catalysts for the chemo-, diastereo- and enantioselective synthesis of 
cyclopropanes. A powerful approach for the construction of highly functionalized 
cyclopropanes represents the reaction of alkenes with carbenoids, which are most readily 
generated by metal-catalyzed decomposition of diazo compounds.3 The reactivity profile of the 
carbenoid is dependent on the metal-ligand system as well as the substitution pattern of the 
applied diazo compound.4–6 According to their adjacent functionalities, metal-carbenes are 
categorized into three major groups: acceptor-acceptor, acceptor and donor-acceptor substituted 
carbenoids, whereby the terms acceptor and donor refer to the ability of the substituents to 
accept or donate electron density at the carbenoid center by resonance (figure 3). 
Electron-withdrawing groups increase the electrophilicity, and thus the reactivity of the 
carbenoid, whereas electron-donating substituents make the carbenoid considerably more stable 
and chemoselective.4–6  
 
 
Figure 3. Classification of metal carbenoids (EWG = electron-withdrawing group; EDG = electron-
donating group).4–6  
 
B Main part 
18 
Although a wide range of chiral catalysts was developed and successfully applied for the 
enantioselective cyclopropanation of electron-rich, electron-neutral and to a lesser extent 
electron-deficient alkenes,7,8 only a few catalytic systems have been employed for the 
asymmetric cyclopropanation of electron-rich heterocycles.9 In the following sections, current 
methods for the enantioselective cyclopropanation of furans, pyrroles, and indoles with 
acceptor diazo esters (scheme 12) and donor-acceptor diazo esters (scheme 13) are presented. 
The reactions of acceptor-acceptor diazo esters with aromatic heterocycles are not covered in 
this thesis since they tend to form substitution products rather than cyclopropanation 
products.10,11  
 
 
Scheme 12. Overview of the currently most successful results regarding enantioselectivity for the 
monocyclopropanation of furans, pyrroles, and indoles with acceptor diazo esters 79, 20 and 80.12–18  
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Copper(I)-complexes with C2-symmetric chiral bis(oxazoline) (box, 73-75), carbohydrate-
based bis(oxazoline) (glucoBox, 65) and aza-bis(oxazoline) (azabox, 76-77) ligands have 
emerged as excellent catalysts for enantioselective cyclopropanation of aromatic heterocycles 
(scheme 12).12–17 Trifluoromethanesulfonate (OTf = triflate) is an exceptionally weak 
coordinating anion19 and therefore, Cu(OTf) or Cu(OTf)2, which is reduced with 
phenylhydrazine in situ, were most commonly used to generate the active copper(I)-species in 
the presence of the chiral ligands. Reiser and co-workers reported that the reaction of furan with 
acceptor diazo esters catalyzed by copper bis(oxazoline) complexes gave only moderate 
enantioselectivities (≤ 51% ee) and very low yields (< 20%).17 The low chemical yields may be 
rationalized by the inherent instability of the resulting adducts, which are prone to undergo 
rearrangement. In contrast, employing these catalytic systems for furans containing an ester 
functionality in 2- or 3-position gave rise to cyclopropanes 21, 30 and 82-84 with excellent 
levels of enantioselectivity (83%-95% ee), albeit with moderate yields (23-63%).15–17 
Noteworthy, these reactions proceeded regioselectively, since only the less hindered double 
bond was cyclopropanated, and moreover, highly diastereoselectively, forming the 
exo-products exclusively.17  
Whereas box, as well as azabox ligands, were successfully applied for the enantioselective 
cyclopropanation of substituted furans, pyrrole turned out to be a more challenging substrate. 
While copper(I)-box complexes were reported to give only moderate enantioselectivities up to 
46% ee for the reaction of N-Boc pyrrole,20 highly increased levels of selectivity were achieved 
with azabox ligands by Reiser and co-workers.12,15 Additionally, it was shown, that the reaction 
temperature and the residue R on the diazo ester have a crucial impact on the selectivity. Best 
results regarding enantioselectivity (93% ee) were obtained using diazo ester 80, bearing a 
sterically demanding tert-butyl group, at -20 °C in the presence of azabox ligand 77.12,15 The 
stereochemical outcome of this reaction was rationalized by a model for the asymmetric 
cyclopropanation of olefins introduced earlier by Pfaltz21 and Andersson.22 It is notable, that 
the cyclopropanation products of substituted furans, as well as N-Boc pyrrole, were accessible 
in the enantiomerically pure form in a multi-gram quantity,12,18 setting the foundation for a 
diverse follow-up chemistry (see chapter A.2 and A.3 for details).  
The first enantioselective cyclopropanation of N-acyl indoles with acceptor diazo ester 20 was 
recently reported by Boysen and co-workers.14 Using copper(I) triflate and glucoBox ligand 65, 
cyclopropanes 85 and 87 were obtained in up to 71% ee, albeit with moderate yields (17% and 
56%). Although the reactions of N-Boc-protected indoles led to higher levels of 
enantioselectivity compared to their acetylated counterparts, it was not feasible to isolate 
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cyclopropanes 86 and 62, since they were not separable from byproducts derived from carbene 
dimerization. Nevertheless, direct transformation of 62 gave rise to hemiaminal ester 64, a key 
intermediate in the synthesis of (-)-desoxyeseroline (12), in 96% ee (see chapter A.4, scheme 9 
for details).14 
Dirhodium(II) tetracarboxylates are known to be remarkably active catalysts for reactions of 
donor-acceptor diazo esters.23–25 Using Rh2(S-DOSP)4,
26 a well-established catalyst for various 
transformations of donor-acceptor diazo esters, Davies and co-workers9,27 have systematically 
investigated the reactions of a variety of heterocycles with diazo ester 91 (scheme 13). This 
study contributed in great measure to improve our understanding of the influence of the 
heterocyclic structure on the enantioinduction in the rhodium-catalyzed reaction with donor-
acceptor carbenoids. However, it also revealed that the construction of monocyclopropanated 
heterocycles is quite challenging since furan (14) and N-Boc pyrrole (90) are prone to form 
products resulting from a second cyclopropanation with donor-acceptor carbenoids.9,27 This 
behavior contrasts with the chemistry of these heterocycles reacting with acceptor carbenoids, 
in which the monocyclopropane products are preferentially formed.18  
 
 
Scheme 13. Overview of the currently most successful results regarding enantioselectivity for the 
monocyclopropanation of furans and pyrroles with donor-acceptor diazo ester 91.27 
 
The tendency to undergo a second cyclopropanation event became especially noticeable with 
the reaction of N-Boc pyrrole (90) and diazo ester 91. Even when 6 equiv of 90 were used, the 
double cyclopropanation product was exclusively formed. In order to obtain monocyclopropane 
93 as the major product, N-Boc pyrrole (90) has to be used in vast excess as solvent. Thus, 93 
could be isolated in 54% yield with 79% ee, albeit with a significant amount of the 
corresponding double cyclopropanation product (34%). Employing the same conditions for the 
reaction of furan (14) with diazo ester 91 gave access to monocyclopropane 92 in 65% yield 
with 91% ee. An interesting feature of these reactions is that cyclopropanes 92 and 93 were 
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formed with opposite sense of asymmetric induction, although the same enantiomer of the 
catalyst was utilized (scheme 13).27 The authors propose that the difference was caused by two 
possible orientations for the asynchronous concerted cyclopropanation.6,28 The initial bond 
formation is supposed to occur at the 2-position of furan, following the expected trend for 
aromatic electrophilic substitution, whereas the steric influence of the N-Boc group and 2,5-
dimethylfuran causes the initial bond formation to take place at the 3-position. Noteworthy, 
Rh2(S-DOSP)4 was reported to be ineffective in catalyzing the reaction of unsubstituted N-Boc 
indole with diazo ester 91, resulting in the recovery of the starting material along with products 
deriving from carbene dimerization.9 The reactions of vinyl diazo acetates and N-Boc pyrroles 
as well as furans proceed via a tandem cyclopropanation/Cope rearrangement and were 
elegantly exploited for the asymmetric synthesis of tropanes29,30 and highly functionalized 
8-oxabicyclo[3.2.1]octene derivatives31–33 by Davies et al. However, no monocyclopropanation 
products were isolated in these reactions.  
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1.2 Chiral rhodium(II) tetracarboxylates catalysts - Synthesis and Application 
 
A central part of the present thesis deals with the asymmetric cyclopropanation of aromatic 
heterocyclic substrates with donor-acceptor carbenoids. Since chiral rhodium(II) 
tetracarboxylates have emerged as very effective catalysts for the cyclopropanation chemistry 
of donor-acceptor carbenoids,23–25,34 the following investigations were predominantly focused 
on the application of this type of catalysts. Figure 4 gives an overview of the catalysts that were 
used in these cyclopropanation studies.8,26,35–42  
 
 
Figure 4. Chiral dirhodium(II) catalysts used in this study.  
 
The currently accepted mechanism for the dirhodium(II)-catalyzed cyclopropanation with 
donor-acceptor diazo compounds is shown in scheme 14.43–45 The reaction is initiated by 
nucleophilic attack of the negatively polarized carbon of the diazo ester on the coordinatively 
unsaturated, axial site of the Rh(II)-catalyst.44 Subsequent extrusion of nitrogen generates a 
rhodium carbenoid that reacts with an alkene in a concerted, non-synchronous manner.43  
B Main part 
23 
 
Scheme 14. Currently accepted mechanism for the cyclopropanation with donor-acceptor diazo 
compounds.43 
 
Chiral rhodium(II) tetracarboxylates, like Rh2(S-TCPTTL)4, which was originally developed 
by Hashimoto and co-workers36 to catalyze aromatic C-H insertion reactions of diazo 
ketoesters, are readily generated by high-temperature ligand exchange46 (scheme 15, eq 2). 
Phthalimide ligands of type 96 are commonly synthesized via dehydrative condensation of 
phthalic anhydrides and chiral primary amines (scheme 15, eq 1).47  
 
 
Scheme 15. Synthesis of Rh2(S-TCPTTL)4.  
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1.3 Asymmetric cyclopropanation of methyl furan-2-carboxylate (19)* 
 
The Cu(I)-catalyzed reactions of methyl furan-2-carboxylate (19) with acceptor diazo esters 
create the foundation for a variety of synthetic approaches aiming at natural products and 
valuable, chiral intermediates (see chapter A.1.2, scheme 2).18 Inspired by these versatile 
applications, it was envisioned that an analog transformation of 19 with donor-acceptor diazo 
esters would provide access to new, highly substituted, chiral monocylclopropanes, which 
could be used as building blocks in stereoselective synthesis. Furthermore, the steric demand 
of the ester group in 19 is supposed to suppress the tendency to undergo a second 
cyclopropanation, which has been observed in earlier studies with donor-acceptor diazo esters 
(see chapter B.1.1). Thus, it was decided to use 19 as the model substrate for an initial catalyst 
screening. 
 
1.3.1 Optimization studies 
 
Rh2(S-DOSP)4
26 shows a quite broad substrate scope in terms of both the trapping agents as 
well as donor groups on the carbenoid in cyclopropanation reactions,48 and thus, it seemed to 
be an ideal catalyst for an initial test reaction. With Rh2(S-DOSP)4 the reaction of methyl 
phenyldiazoacetate 97a with 19 produced a mixture of cyclopropane 98a and the dienone 99 in 
a ratio of 46:54 (table 1, entry 2). This result contrasts with our previous observations aiming 
at the racemic synthesis of 98a, since an almost negligible amount of 99 was formed in the 
Rh2(OPiv)4-catalyzed reaction (entry 1). The formation of ring-opening product 99 is indicative 
that attack of the carbene is occurring at the α-position of 19, resulting in zwitterionic27 
intermediate 102 that can ring open to 99 (scheme 16). An electron-withdrawing substituent in 
2-position was expected to have a destabilizing effect on intermediate 102,27,31–33 and thus, 
reduce the unraveling tendency. However, this was not in line with the observed results. 
Previous studies have shown, that nonpolar solvents can have a beneficial impact on the product 
distribution by limiting the formation of side products derived from zwitterionic 
intermediates.30,49 Changing the reaction solvent from dichloromethane to 
α,α,α-triﬂuorotoluene50 (table 1) gave a worse ratio of 98a:99 (37:63), whereas the use of 
hexanes resulted in a slight improvement of the product ratio (52:48). Lowering the reaction 
temperature to -42 °C led to an additional enhancement of the product ratio (76:24). However, 
                                                 
* This chapter is partially based on Lehner, V.; Davies, H. M. L.; Reiser, O. Rh(II)-Catalyzed Cyclopropanation 
of Furans and Its Application to the Total Synthesis of Natural Product Derivatives. Org. Lett. 2017 (accepted) 
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this approach was not further pursued, since regardless of the applied solvent system and the 
reaction temperature substantial amounts of byproduct 99 were formed in the presence of 
Rh2(S-DOSP)4 and it was not feasible to isolate 98a in pure form.  
 
Table 1. Asymmetric cyclopropanation of furan-2-carboxylate (19) using Rh2(S-DOSP)4. 
 
entrya Rh2L4 solvent temperature (°C) ratio 98a:99c 
1b Rh2(OPiv)4 hexanes 25 > 80:1 
2 Rh2(S-DOSP)4 CH2Cl2 25 46:54 
3 Rh2(S-DOSP)4 CF3C6H5 25 37:63 
4 Rh2(S-DOSP)4 hexanes 25 52:48 
5b Rh2(S-DOSP)4 hexanes -42 76:24 
aStandard reaction conditions: 97a (1.0 equiv) in dry solvent (2 mL) was added to 19 (4.0 equiv) 
in dry solvent (2 mL) and Rh2L4 (1 mol%) over 1 h. 
b2 equiv of 19 was used. cDetermined by 
1H-NMR analysis of the crude mixture. 
 
 
Scheme 16. Possible mechanisms for the formation of cyclopropane 98a and ring-opening product 99. 
 
Obviously, the ligand on the rhodium catalyst has a crucial impact on the product formation 
(table 1, entry 1 vs. 2)30,49 and thus, a systematic study with chiral dirhodium(II) catalysts was 
conducted (table 2). Catalysts, which are less effective at charge stabilization of the zwitterionic 
intermediate 102 were expected to promote the formation of 98a. Indeed, the bulky 
triarylcyclopropane-carboxylate catalyst Rh2(S-BTPCP)4,
8 bearing less electron withdrawing 
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ligands, gave a greatly improved ratio of 98a:99 (93:7) compared to the analog transformations 
with Rh2(S-DOSP)4
26 and Rh2(S-BNP)4
42 (table 2, entry 3 vs. 1 and 2). The use of 
Rh2(S-BTPCP)4 allows the isolation of 98a in high yield (84%), but with a relatively moderate 
level of enantioselectivity (56% ee). Attempts to increase the enantioinduction by modification 
of the reaction conditions as well as extending the substrate scope were not successful.  
 
Table 2. Catalyst screening for the reaction of furan 19 with diazo ester 97a.  
 
entrya Rh2L4 ratio 98a:99b yield 98ac (%) eed (%) 
1e Rh2(S-DOSP)4 55:45 n.d. n.d. 
2f Rh2(S-BNP)4 68:32 n.d. n.d. 
3 Rh2(S-BTPCP)4 93:7 84 56 
4 Rh2(S-NTTL)4 52:48 n.d. 89 
5 Rh2(S-PTAD)4 31:69 n.d. n.d. 
6 Rh2(S-TCPTAD)4 >99:1 54 83 
7 Rh2(S-PTTL)4 30:70 n.d. 48 
8 Rh2(S-TFPTTL)4 80:20 n.d. 46 
9 Rh2(S-TCPTTL)4 >99:1 81 91 
10 Rh2(S-TBPTTL)4 >99:1 79 86 
aStandard reaction conditions: 97a (1.0 equiv) in dry hexanes (2 mL) was added to 19 in dry 
hexanes (2.0 equiv) and Rh2L4 (1 mol%) at rt over 1 h. 
bDetermined by 1H-NMR analysis of 
the crude mixture. cIsolated yield. dDetermined by chiral HPLC analysis. e1.5 equiv of 19 was 
used. fToluene was used as a solvent. 
 
Another generally useful series of catalysts are the phthalimido, and the naphthylimido derived 
catalysts.35–41 Rh2(S-NTTL)4
41 did not have a major influence on the product ratio but did result 
in the formation of 98a in 89% ee (entry 4), whereas the Rh2(S-PTAD)4
40 gave a worse product 
ratio of 31:69 (entry 5). The breakthrough came with the tetrachloro derivative 
Rh2(S-TCPTAD)4
39, which gave an extremely clean reaction, producing 98a in 83% ee with no 
evidence for the formation of the undesired dienone 99 (entry 6). Even better results were 
obtained with the tert-leucine derived catalysts. Rh2(S-PTTL)4
38 gave a mixture and so did the 
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tetrafluoro derivative Rh2(S-TFPTTL)4
37 (entries 7 and 8). However, both the tetrachloro and 
tetrabromo catalysts Rh2(S-TCPTTL)4
36 and Rh2(S-TBPTTL)4
35 gave exceptionally clean 
reactions (entries 9 and 10). The best results were obtained with Rh2(S-TCPTTL)4, which 
generated 98a in 81% yield with 91% ee without any traces of byproduct 99 (entry 9). The 
dramatic change in product distribution with the tetrachloro- and tetrabromophthalimide 
catalysts indicates that these catalysts cause the carbene to react with methyl 2-furoate initially 
at the β-position. 
In order to support this theory, a control experiment should demonstrate, that the formation of 
99 already occurs during the reaction and not afterwards (scheme 17). Therefore, a solution of 
cyclopropane 98a in DCM was refluxed in the presence of Rh2(S-DOSP)4, which was shown 
to promote the ring-opening of the furan moiety in previous experiments (table 1). After six 
hours, no generation of 99, as well as the corresponding epimerization products of 98a were 
detectable from the crude 1H-NMR. This result excludes that the ring opening process takes 
place after initial formation of cyclopropane 98a. 
 
 
Scheme 17. Possible formation of diene 99 and the corresponding epimerization product ((epi)-98a) 
from cyclopropane 98a. 
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1.3.2 Optimization of reaction conditions and catalyst loading 
 
It is well-known that lowering the temperature can have positive effects on selectivity. 
Investigating this concept for the Rh2(S-TCPPTL)4-calalyzed cyclopropanation of furan 19 with 
diazo ester 97a revealed 0 °C as the optimum reaction temperature, generating 98a with slightly 
improved enantioselectivity compared to room temperature (Table 3, entry 1 vs. 2, 91% ee vs. 
96% ee). In contrast, a further decrease of the temperature to -40 °C led to reduced selectivity 
accompanied by a considerably diminished yield (entry 2 vs. 3, 96% ee vs. 93% ee).  
It is well-established, that donor-acceptor carbenoids are capable of operating at low catalyst 
loadings.23,24 Gratifyingly, decreasing the amount of Rh2(S-TCPTTL)4 from 1.0 mol% to 
0.001 mol% did not greatly affect the outcome of the reaction regarding yield and 
enantioselectivity (entry 2 and 4-6) and 98a was obtained in 86% yield (TON = 88000, 
TOF = 24/s) and with 96% ee (entry 6).  
 
Table 3. Optimization of reaction conditions.† 
 
entrya temperature (°C) 
catalyst load 
(mol%) 
yieldb (%) eec (%) 
1 rt 1 81 91 
2 0 1 88 96d,e 
3 -40 1 <48 93 
4 0 0.1 88 96 
5 0 0.01 92 96f 
6 0 0.001 86 96f 
aStandard reaction conditions: 97a (1.0 equiv) in dry hexanes was added to 19 (2.0 equiv) in 
dry hexanes and Rh2(S-TCPTTL)4 over 1 h. 
bIsolated yield. cDetermined by chiral HPLC 
analysis. d>99% ee after recrystallization eAbsolute configuration of 98a was determined by 
X-ray crystallography. fIsolation was carried out by filtration from the crude reaction mixture. 
                                                 
† Entry 5 is taken from the Bachelor thesis of F. Ostler, 2015, Universität Regensburg (supervised by V. Lehner) 
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A notable feature of this reaction is that cyclopropane 98a already precipitates from the reaction 
mixture. Since furan 19, which was used in excess, as well as Rh2(S-TCPTTL)4 are soluble in 
hexanes, purification of 98a can be performed by simple filtration. The high efficiency of 
Rh2(S-TCPTTL)4 in combination with the ease of purification make this reaction a promising 
candidate for up-scaling. Notably, reactions up to 74 mmol were already successfully performed 
(table 3, entry 6) 
A single recrystallization from methanol gave access to enantiopure 98a, and the absolute 
configuration of 98a was unambiguously assigned by X-ray crystallography (figure 5). 
 
 
Figure 5. X-ray structure of cyclopropane 98a.  
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1.3.3. Substrate scope of aryl groups on the carbenoid 
 
Previous reports of Davies and co-workers48 have shown, that the nature of the aryl substituent 
on aryl diazoacetates strongly affect the asymmetric induction imparted by chiral Rh(II)-
catalysts in cyclopropanation reactions with styrene as a model substrate. Due to the promising 
results, that have been obtained in the Rh2(S-TCPTTL)4-catalyzed cyclopropanation reaction of 
furan 19 with diazo ester 97a (see chapter B.1.3.2), the effect of different aryl groups on the 
enantioselectivity for this reaction was investigated. Therefore, several aryl diazo esters (97) 
were synthesized according to a literature-known two-step procedure,51,52 which includes an 
acid catalyzed esterification of starting materials 103 followed by a Regitz diazo-transfer with 
tosyl azide or 4-acetamidobenzenesulfonyl azide (p-ABSA) as diazo-transfer reagents 
(scheme 18).  
 
 
Scheme 18. General method to synthesize diazo esters of type 97.51,52 
 
The cyclopropanation could be applied to a range of aryl diazoacetates as illustrated in table 4. 
Electron-rich aryl groups (entry 2 and 3) performed well, providing the cyclopropanes 98b and 
98c in good yields (81%, 85%) and excellent levels of enantioselectivity (both 95% ee), 
respectively. The best results regarding enantioinduction were obtained by applying halo-
substituted aryl groups (entry 4 and 5), giving access to cyclopropanes 98d and 98e in good 
yields (78%, 81%) and excellent levels of enantioselectivity (both 98%). Employing larger 
(entry 6) or strongly electron-withdrawing groups (entry 7) resulted in a considerable drop in 
yield (65%, 57%), generating cyclopropanes 98f and 98g with slightly diminished levels of 
enantioselectivities (87, 93%). Methyl diazaoacetate (79), with just an acceptor group, gives 
poor results in the cyclopropanation (entry 8). This is routinely the case for diazoacetate 
cyclopropanations with the dirhodium tetracarboxyate catalysts,53 but fortunately, 
copper(I)bis(oxazoline) catalysts give high levels of enantioselectivity (up to 94% ee)17 with 
this reagent (see chapter B.1.1, scheme 12).  
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Table 4. Examination of the influence of substitution on aryl diazoacetate.a  
 
entry diazo ester R product yielda (%) eeb (%) 
1 97a C6H5 98a 88 96 
2 97b 4-CH3OC6H4 98b 81 95 
3 97c 4-CH3C6H4 98c 85 95 
4 97d 4-ClC6H4 98d 81 98 
5 91 4-BrC6H4 98e 78 98 
6 97f 2-Naphthyl 98f 65 93 
7 97g 4-NO2C6H4 98g 57 87 
8 79 H 83 36 8 
aStandard reaction conditions: diazo ester (1.0 mmol, 1.0 equiv) in dry hexanes and DCM 
(2 mL) was added to 19 in dry hexanes (0.5 M, 2.0 mmol, 2.0 equiv) and Rh2(S-TCPTTL)4 
(0.001 mmol, 0.1 mol%) at 0 °C over 1 h.   
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1.4 Asymmetric cyclopropanation of furan derivatives and thiophene‡  
 
Having identified Rh2(S-TCPTTL)4 as an excellent catalyst for the reaction of 19 with a range 
of aryl diazoacetates (see chapter B.1.3.3), the cyclopropanation was then extended to other 
furans to determine if they would also react cleanly without unravelling of the furan moiety 
under previously optimized conditions (table 5).  
 
Table 5. Scope of heterocycles.a,§ 
 
entry heterocycle product yield (%) ee (%) 
1 
  
73 86 
2 
 
 
72 74 
3 
  
91 25 
4 
 
 
0 - 
aStandard reaction conditions: 97a (1.0 mmol, 1.0 equiv) in dry hexanes and DCM (2 mL) was 
added to 19 in dry hexanes (0.5 M, 2.0 mmol, 2.0 equiv) and Rh2(S-TCPTTL)4 (0.001 mmol, 
0.1 mol%) at 0 °C over 1 h.  
                                                 
‡ This chapter is partially based on Lehner, V.; Davies, H. M. L.; Reiser, O. Rh(II)-Catalyzed Cyclopropanation 
of Furans and Its Application to the Total Synthesis of Natural Product Derivatives. Org. Lett. 2017 (accepted) 
§Entry 1 is taken from the Bachelor thesis of F. Ostler, 2015, Universität Regensburg (supervised by V. Lehner)  
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The reaction with 3-methyl furoate (105) gave the cyclopropane 108 in 86% ee, whereas the 
reaction of furan (14) gave the cyclopropane 109 in 74% ee. No evidence of ring opening 
products was observed, indicating that the reaction was not being initiated at the α-position of 
the furan (see chapter B.1.3.1, scheme 16). Recrystallization gave access to enantiopure 108 
and 109, and the absolute configurations were unambiguously assigned by X-ray 
crystallography (figure 6). In contrast, the reaction with benzofuran (8) proceeded with low 
levels of enantioselectivity, suggesting that distinction between α- and β-position is not as 
effective here.  
Thiophene (107) is known as a quite challenging substrate in cyclopropanation reactions.54 
Although Rh2(S-TCPTTL)4 is an excellent catalyst for the reaction of furans with donor-
acceptor diazo esters, attempts to extend the scope of heterocycles to 107 resulted in a complex 
mixture of products, and none of cyclopropane 111 was formed. 
 
                 
Figure 6. X-ray structures of cyclopropanes 108 and 109. 
 
The X-ray crystallographic analysis of monocyclopropanated furans 98a, 108 and 109 revealed 
that all three products had been formed with the same sense of asymmetric induction (figure 5 
and 6). These results are different from what had been reported in the Rh2(S-DOSP)4 catalyzed26 
donor/acceptor carbene reactions,27,31–33 where the sense of asymmetric induction changed, 
depending on the structure of the furan (see chapter B.1.1). 
Both experimental and computational studies have shown that Rh2(S-TCPTTL)4 and 
Rh2(S-TCPTAD)4 cause the reaction of the rhodium bound carbene to occur from the si face of 
the carbene.55–57 Using the same orientation of attack, the observed stereochemistry is consistent 
with attack occurring at the β-position for all three furan derivatives (scheme 19). This means 
that Rh2(S-TCPTTL)4 and Rh2(S-TCPTAD)4 which have a well-defined “chiral bowl”56 do not 
accommodate the approach of the furan at the α-position with the oxygen of the furan pointing 
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towards the catalysts. Therefore, none of the ring opening products were observed with these 
catalysts (see also chapter B.1.3.1). The different behavior illustrates the subtle influences that 
the catalysts can have on the selectivity of donor/acceptor carbene reactions.  
 
 
Scheme 19. Model for Rh2(S-TCPTTL)4 cyclopropanation. 
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1.5 Asymmetric cyclopropanation of pyrroles  
 
In analogy to furans, the cyclopropanation of pyrroles with acceptor diazo esters paved the road 
for a great range of diverse chemistry and was elegantly exploited in several target-oriented 
syntheses (see chapter A.3).18 In contrast to furans, the reactivity of pyrrole is adjustable by 
means of altering the protection group on the nitrogen.9,11 Very electron-rich heteroarenes like 
N-H or N-alkyl pyrroles are expected to favor a zwitterionic pathway since the nitrogen lone 
pair is highly capable of stabilizing the positive charge on the intermediate (analog to zwitterion 
102, see chapter 1.3.1, scheme 16).58 However, incorporation of an electron-withdrawing group 
on the nitrogen atom causes the aromatic ring to be less electron-rich and thus, reduces the 
tendency to form zwitterionic intermediates.9,59 Therefore, electron-withdrawing protection 
groups seemed to be the best choice for the following investigations in order to synthesize 
monocyclopropanes. 
Due to its electron-withdrawing effect and ease of removal, Boc (tert-butoxycarbonyl)60,61 was 
selected as protecting group for an initial test reaction. Under optimized conditions, attempts to 
extend the reaction scope to N-Boc pyrrole (90) were not very successful since almost no 
conversion of 90 was observable and only minor amounts of doublecyclopropanated product 
(< 20%) were obtained (scheme 20). This outcome was rather unexpected due to previously 
reported results, which showed that the reaction of pyrrole 90 in the presence of Rh2(S-DOSP)4 
generates cyclopropanes in high yields and good levels of enantioselectivity (for details see 
chapter B.1.1).27 In regard to the low yield for cyclopropane 112, optimization approaches 
aiming at the synthesis of monocylcopropanes did not promise success, and thus a new synthetic 
strategy was developed.  
 
 
Scheme 20. Asymmetric cyclopropanation of N-Boc pyrrole (90). 
 
Charette and co-workers57 have shown that Rh2(S-TCPTTL)4 adopts an all-up symmetry. In 
this conformation, one axial site is shielded by the four tert-butyl-groups of the ligands, whereas 
the reactive Rh-center is embedded in an ellipsoidal chiral pocket formed by the 
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tetrachlorophthaloyl moieties. It was assumed that the N-Boc-group in 90 might be too bulky 
to fit into the chiral pocket of the catalyst. In order to prove this theory, the influence of the 
protecting group on the nitrogen atom on the outcome of the reaction with regard to steric as 
well as electronic properties was investigated. The synthesis of the starting materials and the 
results of this study are presented in the following chapters. 
 
1.5.1 Synthesis of N-protected pyrroles 
 
Along with the growing interest in pyrrole chemistry due to the abundance of the pyrrolic 
moiety in pharmaceuticals, natural products, and new materials, a great number of protection 
strategies for pyrroles were developed.60 With regard to the planned cyclopropanation study, a 
number of N-protected pyrroles (113a-113e), bearing electron-withdrawing N-sulfonyl or N-
carboxyl protection groups with varying steric demands, were synthesized (figure 7). 
 
 
Figure 7. Overview of all synthesized N-protected pyrroles (113a-113e). 
 
Deprotonation of pyrrole (114) with n-butyl lithium followed by carboxylation gave access to 
pyrrole-1-carboxylic acid (115), which served as starting point for N-carboxyl protected 
pyrroles 113a and 113b (scheme 21). Activation of acid 115 with carbodiimide EDCl‧HCl 
similar to a Steglich esterification and subsequent treatment with the sodium salts of methanol 
or p-cresol afforded N-carboxyl protected pyrroles 113a and 113b in good yields, 
respectively.62  
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Scheme 21. Synthesis of N-protected pyrroles 113a and 113b.62 
 
A quite general approach to introduce sulfonyl groups on the nitrogen of pyrrole represents the 
reaction of the pyrrolyl anion with sulfonyl halides. Applying this method, N-tosyl pyrrole 113c 
has been prepared in 97% yield from 4-toluenesulfonyl chloride and the sodium anion of pyrrole 
(scheme 22).63 
 
 
Scheme 22. Synthesis of N-protected pyrrole 113c.63  
 
Alternatively, condensation of 2,5-dimethoxytetrahydrofuan with a variety of sulfonamides can 
be utilized to synthesize N-sulfonyl pyrroles.64 Thus, pyrroles 113d and 113e were readily 
formed from the corresponding sulfonamides 116 and 118 (scheme 23). The applied 
sulfonamides were either commercially available or synthesized from suitable sulfonylchloride 
precursor (117)65 and liquid ammonia (scheme 23, eq 2) at reflux. 
 
 
Scheme 23. Synthesis of N-protected pyrroles 113d and 113e.64,65  
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1.5.2 Effect of the protecting group 
 
In order to examine, whether the poor yields for the reaction of pyrrole 90 can be traced back 
to the sterical demand of the N-Boc group, the reaction was carried out with pyrrole 113a, 
bearing a less bulky methyl ester at the nitrogen. Indeed, the reaction of pyrrole 113a generated 
cyclopropane 119a at least in low yield (8%), though the corresponding double 
cyclopropanation product 120a was formed in 26% yield (Table 6). Due to the poor solubility 
of N-protected pyrroles 113a-113e in hexanes (optimized condition for furans, see chapter 
B.1.3), toluene was used as solvent for these experiments. The reaction of pyrrole 90 
(scheme 20) was repeated using toluene as solvent, but no significant improvement in yield was 
observed under these modified conditions as judged by crude 1H-NMR analysis. 
 
Table 6. Examination of the influence of pyrrole protecting groups.** 
 
entrya pyrrole 
protecting 
group 
product 
yieldb 
(%) 
eec (%) product 
yieldb 
(%) 
1 113a Methyl ester 119a 8 7 120a 26 (52) 
2 113b p-Tolyl ester 119b 40 57 120b 27 (54) 
3 113c Tosyl 119c 61 93d,e 120c 15 (31) 
4 113d Mesyl 119d n.d. 87 120d n.d. 
5 113e SO2-Cy 119e 40 94 120e 21 (42) 
aStandard reaction conditions: 97a (1.0 equiv) in dry toluene (2 mL) was added to 113a-e in 
dry toluene (2.0 equiv) and Rh2(S-TCPTTL)4 (0.1 mol%) at 0 °C over 1 h. 
bIsolated yield. 
cDetermined by HPLC analysis. d>99% ee after recrystallization. eAbsolute configuration was 
determined by X-ray crystallography. 
 
Since the Rh2(S-TCPTTL)4-catalyzed cyclopropanation of 113a with 97a revealed to be a poor 
reaction in terms of enantioinduction (7% ee), the influence of further protecting groups on the 
outcome of the reaction was examined. Thus, it turned out that pyrroles with sulfonyl protection 
groups provided considerably higher levels of enantioselectivity compared to their ester 
                                                 
** Results are partially taken from the Bachelor thesis of N. Wurzer, 2016, Universität Regensburg (supervised 
by V. Lehner) 
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analogues (entry 3 vs. 2, 93% ee vs. 57% ee; entry 4 vs. 1, 87% ee vs. 7% ee). Furthermore, 
sulfonyl protected pyrroles 113c and 113e favored the formation of the monocyclopropanated 
products 119c and 119e in the presence of Rh2(S-TCPPL)4. X-ray analysis of 119c (figure 8) 
revealed that the four substituents at the sulfur atom are nearly arranged in tetrahedral form, 
orienting the toluene group preferentially on the convex face of the bicyclic framework, and 
thus making a second cyclopropanation unfavorable. However, comparing the yields of 119c 
and 119e (61% vs. 40%), π-stacking interactions of the protecting group and the aromatic 
ligands of the catalyst also seem to have an impact on the product formation.  
 
Figure 8. X-ray structure of cyclopropane 119c. 
 
Determination of the enantiomeric excess of 119a-e necessitated prior synthesis of the analog 
racemic cyclopropanes. In the case of furan derivatives, this was readily achieved by using 
Rh2(OAc)4 or Rh2(OPiv)4. However, pyrroles 113a-e showed a strong tendency towards double 
cyclopropanation under these conditions, and thus, monocylopropanes 119a-e could not be 
observed. 
 
 
Scheme 24. Racemic cyclopropanation of N-protected pyrroles 113a-e.†† 
 
It was shown that pyrroles tend to form the monocylopropanation products with acceptor diazo 
esters by using catalytic amounts of copper(II) triflate, activated by phenylhydrazine.12 
Applying this catalytic system for the reactions of pyrroles 113a-e with diazo ester 97a finally 
                                                 
†† Results are partially taken from the Bachelor thesis of N. Wurzer, 2016, Universität Regensburg (supervised 
by V. Lehner) 
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gave access to monocyclopropanes (rac)-119a-e, albeit in low to moderate yields (5-35%) 
(scheme 24). Nevertheless, sufficient amounts for HPLC were obtained. It is notable that 
attempts to render the reaction of 113c asymmetric under these conditions by addition of chiral 
box-ligand 74 failed. Hence, studies with Rh(II)-catalysts were continued.   
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1.6 Asymmetric cyclopropanation of N-tosyl pyrrole (113c) 
 
1.6.1 Optimization studies 
 
Rhodium catalysts with N-imidyl amino acid ligands were shown to be highly active catalysts 
for cyclopropanation reactions, even at -78 °C.66 In search of optimum conditions for the 
Rh2(S-TCPPTL)4-catalyzed reaction of N-tosyl pyrrole 113c, an examination of the temperature 
profile revealed that lowering the reaction temperature from 0 °C to -10 °C resulted in a slight 
decrease in selectivity accompanied by considerably diminished yield (table 7, entry 1 vs 2). 
Hence, no further efforts were made to study the influence of the temperature on the selectivity.  
 
Table 7. Optimization of reaction conditions.‡‡ 
 
entrya 
temperature 
(°C) 
113c 
(equiv) 
yieldb 
119c (%) 
eec 119c 
(%) 
yieldb 
120c (%) 
Ratiod 
119c/120c 
1 0 2 60 93e,f 15 (31) 4.2/1 
2 -10 2 45 90 11 (22) n.d. 
3 0 4 69 n.d. 8(16) 7.2/1 
4 0 10 39 n.d. - >20/1 
aStandard reaction conditions: 97a (1.0 mmol, 1.0 equiv) in dry toluene was added to 113c in 
dry toluene (2.0 equiv) and Rh2(S-TCPTTL)4 (0.001 mmol, 0.1 mol%) over 1 h. 
bIsolated yield. 
cDetermined by HPLC analysis. dDetermined by 1H-NMR analysis of the crude mixture.e>99% 
ee after recrystallization. fAbsolute configuration was determined by X-ray crystallography. 
 
With the absolute goal of synthesizing monocyclopropanes, it was supposed, that an increasing 
excess of pyrroles could reduce the tendency to form biscyclopropanes. Indeed, by applying a 
two-, four- and ten-fold excess of 113c a clear trend with regard to product distribution was 
observable (table 7, entries 1, 3 and 4). However, increasing the relative amount of 113c caused 
difficulties in purification, and thus led to comparatively diminished isolated yields (entry 4).  
                                                 
‡‡ Results are partially taken from the Bachelor thesis of N. Wurzer, 2016, Universität Regensburg (supervised 
by V. Lehner) 
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1.6.2 Kinetic resolution 
 
During the course of our cyclopropanation studies with pyrrole 113c, an interesting 
phenomenon was observed (scheme 25). While the initial cyclopropanation of 113c with 97a 
in the presence of Rh2(S-TCPTTL)4 provided monocyclopropane 119c in 93% ee, 
biscyclopropane 120c was formed with an unexpectedly low level of enantioselectivity 
(37% ee).  
 
 
Scheme 25. Asymmetric cyclopropanation of N-tosyl pyrrole 113c.  
 
To examine, whether the second cyclopropanation event has an impact on the asymmetric 
induction, monocyclopropane (rac)-119c was subjected to a Rh2(S-TCPTTL)4-catalyzed 
cyclopropanation reaction in the presence of 97a (scheme 26, eq. 1). This experiment revealed 
that kinetic resolution occurred in this reaction since enantioenriched 119c was recovered in 
29% ee and 72% yield and double cyclopropanation product 120c was formed in 88% ee and 
24% yield.  
 
 
Scheme 26. Kinetic resolution experiments.  
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Interestingly, the actually mismatched enantiomer (ent)-119c reacts preferentially in the second 
cyclopropanation event. Considering the model for Rh2(S-TCPTTL)4 catalyzed 
cyclopropanation of furans (see chapter B.1.4, scheme 19), the second cyclopropanation of 
(ent)-119c would be expected to initiate at the β-position, but this is inconsistent with the 
observed stereochemistry in 120c (scheme 27). If the double bond approaches the carbenoid in 
an end-on manner, the initial attack has to occur at the α-position to form the observed 
diastereomer, which is highly unfavorable due to steric as well as electronic grounds. This result 
indicates that a side-on approach26,67 of (ent)-119 is more likely, since (ent)-119 would be the 
matched enantiomer in this case. 
 
 
Scheme 27. Model for Rh2(S-TCPTTL)4 cyclopropanation of (ent)-119c. 
 
If enantiopure 119c was subjected to a second Rh(II)-catalyzed cyclopropanation reaction in 
the presence of 97a (scheme 25, eq. 2), enantiopure (ent)-120c was isolated, regardless of the 
catalysts. This demonstrates that the enantioinduction of the second cyclopropanation event is 
substrate controlled and not influenced by the chiral catalyst. The absolute configuration of 
119c and (ent)-120 was determined by X-ray crystallography (figure 8 and 9).  
 
 
Figure 9. X-ray structures biscyclopropane (ent)-120c.  
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1.7 Asymmetric cyclopropanation of N-tosyl indole 125 
 
The synthesis and functionalization of indole and its derivatives have attracted great attention 
due to their important roles in numerous research areas, like medicinal chemistry and material 
science68. Although a great number of asymmetric metal-based, as well as metal-free 
asymmetric indole functionalization methods have been developed,69 indoles have rarely been 
employed in asymmetric cyclopropanation reactions.9 Recently, the first enantioselective 
intermolecular cyclopropanation of N-protected indoles with acceptor diazo ester 20 was 
reported by Boysen and co-workers14 (for details see chapter B.1.1., scheme 12). However, the 
analog transformation with donor acceptor diazo esters has turned out to be challenging.9 
Rh2(S-DOSP)4, an excellent catalyst for the asymmetric cyclopropanation of several electron-
rich heteroarenes with aryl diazo esters, was shown to be ineffective in catalyzing the reaction 
of unsubstituted N-Boc indole, resulting in recovery of the starting material along with products 
deriving from carbene dimerization.27 Interestingly, the analog transformation of 2- and 
3-substituted indoles 61 and 121 provided biscyclopropanes 122 and 123, arising from double 
cyclopropanation of the benzenoid ring (scheme 28). Studies of Davies and co-workers27 have 
shown, that an initial bond formation at the pyrrole moiety of the indole core is inhibited by the 
sterical clash between the rhodium catalyst and either the N-Boc group or the benzenoid ring. 
  
 
Scheme 28. Rh2(S-DOSP)4-catalyzed cyclopropanation of N-Boc indoles 61 and 121 by Davies et al.27  
 
During the studies with pyrroles (see chapter B.1.5), it became obvious, that the reaction 
outcome is significantly influenced by the catalyst as well as the protecting group. The interplay 
of Rh2(S-TCPTTL)4 and N-tosyl protecting group was shown to be beneficial in the reaction 
with pyrrole. Hence, it was investigated, if the same is true for the cyclopropanation of indole.  
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Starting material 125 was readily prepared in quantitative yield from the potassium salt of 
indole and tosylchloride using tetrabutylammonium hydrogensulfate as phase transfer catalyst 
(scheme 29).70  
 
 
Scheme 29. Synthesis of N-protected indole 125.  
 
Under the optimized reaction conditions, cyclopropane 126 was generated as a single 
diastereomer in 75% yield with 80% ee. It is notable that the heterocyclic ring was exclusively 
cyclopropanated, contrasting to previously reported results27 for the asymmetric 
cyclopropanation of indoles with donor-acceptor diazo esters. The configuration of 
cyclopropane 126 was assigned by X-ray analysis.  
 
 
Scheme 28. Asymmetric cyclopropanation of N-tosyl indole (125).§§ 
 
 
Figure 10. X-ray structure of cyclopropane 126.  
   
                                                 
§§ Experiment is taken from the Bachelor thesis of N. Wurzer, 2016, Universität Regensburg (supervised by V. 
Lehner) 
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1.8 Conclusion and outlook 
 
In summary, Rh2(S-TCPTTL)4 was identified as an exceptionally effective catalyst in terms of 
catalyst loading (TON 88000 and TOF 24 s-1) and enantioinduction (up to 98% ee) for the 
generation of monocyclopropanated aromatic heterocycles. The developed protocol was 
applicable to furans, pyrroles, benzofurans, as well as indoles with a variety of donor-acceptor 
diazoesters. In the case of pyrrole, it was shown that the nature of the protecting group on the 
nitrogen has a great impact on the product formation (mono vs. doublecyclopropanation) and 
the best results were obtained by using the N-tosyl derivative (61%, 93% ee). Current 
experiments in the Davies group by Jiantao Fu are underway to extend the scope of diazoesteres 
for the reaction of N-tosyl pyrrole and to also study the influence of the catalyst on the product 
distribution. Preliminary results indicate that by applying N-tosyl protected pyrrole both 
monocyclopropane, as well as doublecyclopropane, are selectively accessible in good yields 
and excellent levels of enantioselective by simply switching the catalyst. 
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2 Cyclopropane 119c as precursor for the synthesis of a homo-β-proline analogue 
 
2.1 Introduction – Pyrrolidines as catalysts and bioactive compounds  
 
The pyrrolidine ring forms the core of various natural and unnatural compounds endowed with 
a host of biological activities and therapeutical properties.71,72 A prominent synthetic drug 
containing this heterocycle as the central unit is captopril (Capoten™, 127),73 which was 
introduced to the market in the 1980s and has been established as a potent angiotensin 
converting enzyme (ACE) inhibitor (figure 11). Kanoid amino acids74 (e.g. (–)-α-kainic acid 
(130)75, domoic acid (128)76) are conformationally restricted analogues of the neurotransmitter 
glutamic acid and have attracted considerable interest in recent years owing to their 
neuroexcitatory properties, as well as anthelmintic and insecticidal activities. Further examples 
from the about 80 known pyrrolidine alkaloids are (+)-hygrine (129)77 and nicotine (131),78 
which have been the subject of numerous pharmacological and biological studies.79  
 
 
Figure 11. Chemical and biological interesting compounds containing the pyrrolidine ring as a central 
unit.  
 
In catalysis, the pyrrolidine moiety has become ubiquitous, finding use as effective 
organocatalysts as well as ligands in asymmetric transition-metal catalyzed protocols.80–83 In 
the early stage of asymmetric organocatalysis, (S)-proline (133), a non-essential amino acid, 
has played a key role.84 Since then, an array of proline-derived catalysts have been developed 
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(e.g. (R)-β-proline (132),85 Hayashi-Jørgensen catalyst (134)86) and have expanded the scope 
of possible substrates and reactions. Thus, on the one hand, proline and its derivatives were 
demonstrated to be powerful catalysts for diverse transformations, such as epoxidation, aldol, 
Friedel–Crafts, Mannich and Michael reactions, etc.80–83 On the other hand, functionalization 
and derivatization of the native proline moiety have emerged as an important tool to synthesize 
a myriad of naturally occurring molecules ranging from simple to highly complex compounds.79  
A proline derivative that has attracted considerable interest due to its structural analogy to 
γ-aminobutyric acid (GABA, 135)87 (figure 12), the most important inhibitory neurotransmitter 
in the mammalian brain, is (S)-homo-β-proline (47).88 GABA has been estimated to be present 
in 60-70% of all synapses in the central nervous system (CNS) and a number of neurological 
disorders, for instance, epilepsy, anxiety, pain and some forms of schizophrenia are associated 
with a dysfunction of the GABA system.89 Several studies aiming at the evaluation of the 
biological potential of homo-β-proline have shown that this conformationally restricted 
analogue of GABA is capable of interacting with distinct GABAʼergic targets. Racemic 
homo-β-proline was found to be an agonist at postsynaptic GABA receptors. The 
(R)-enantiomer of homo-β-proline binds selective to the GABAA receptor, whereas the 
moderate affinity for GABAB receptor sites is attributed to the (S)-enantiomer (47).
90,91 
Furthermore, homo-β-proline has an inhibitory effect on GABA transport proteins (GAT1), 
which ensure the reuptake of GABA in neuronal and astroglial cells.92 The inhibitory potential 
of 47 was shown to be further increased by adding bulky lipophilic groups to the nitrogen (e.g. 
136), nearly reaching the potency of tiagabine (Gabitril™, 137),92,93 a GABA uptake inhibitor 
used for the treatment of epilepsy. Additionally, the homo-β-proline moiety forms the core 
structure of a number of natural products (e.g. kanoid amino acids 128 and 130, figure 11).74 
Taking into account the remarkable biological properties mentioned above, homo-β-proline and 
its derivatives provide important targets in organic synthesis. 
 
 
Figure 12. Chemical structures of GABA (135), GABA-related molecules (47, 136) and tiagabine (137).  
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2.2 Enantioselective synthesis of homo-ß-proline – State of the art 
 
A number of synthetic strategies yielding either racemic88,94 or enantiopure homo-β-proline 
were developed. However, most of the currently known methods to prepare (S)-47 or (R)-47 in 
enantiopure form are making use of chiral auxiliaries91,95 or starting materials from the chiral 
pool.96 Only three of these are of enantioselective nature (scheme 30).12,97,98  
 
 
Scheme 30. Enantioselective synthesis of homo-β-proline (47) – State of the art.12,97,98  
 
In 2004, the first enantioselective synthesis of both enantiomers of homo-β-proline was reported 
by Felluga and co-workers98 utilizing an enzymatic transformation as key step. 
Desymmetrization of prochiral nitrodiester 138, which was readily synthesized by a Michael 
addition of diethyl glutaconate and nitromethane, was accomplished by selective hydrolysis of 
the pro-(R) ester group of 138 in the presence of porcine pancreatic lipase (PPL). The resulting 
halfester (R)-139 was successfully transformed to (S)-homo-β-proline (47) in 5 additional steps 
(7 steps, 38% overall yield). Alternatively, by using crude pig liver esterase (PLAP, pig liver 
acetone powder) instead of PPL in the desymmetrization step, (R)-homo-β-proline ((R)-47) was 
accessible in 39% overall yield.  
Three years later, Tan and co-workers97 were able to develop an alternative approach to 
(S)-homo-β-proline (47) in which an organocatalyzed Michael reaction was used to control the 
essential stereocenter. Chiral bicyclic guanidine 142 was shown to be an excellent catalyst for 
enantioselective Michael reactions of dithiomalonates and β-keto thioesters with a range of 
acceptors. Starting from N-benzyl maleimide 140 and dithiomalonate 141, this method was 
B Main part 
50 
elegantly exploited for the synthesis of key intermediate 143. Decarboxylation of one of the 
thioesters and functional group transformation led to (S)-homo-β-proline (47) in 6 steps. 
Recently, Reiser and co-workers12 presented a straightforward synthetic route for 
(S)-homo-β-proline (47) making use of an asymmetric Cu(I)-catalyzed cyclopropanation of 
N-Boc-pyrrole (89) to establish the required stereocenter in 47 (see also chapter B.1.1). 
Enantiomerically pure cyclopropane 89, which was accessible in a multigram quantity by 
recrystallization, was transformed to 47 in a two-step sequence in quantitative yield 
(scheme 31). A ring-opening/ deprotection cascade finalized the synthesis of 47 and proceeded 
without loss of enantiopurity at 0 °C. 
 
 
Scheme 31. Synthesis of (S)-homo-β-proline (47) starting from cyclopropane 89 by Reiser et al.12 
 
Inspired by this highly efficient synthetic route reported by Reiser et al. and encouraged by the 
interesting biological properties of homo-β-proline and its derivatives (see chapter B.2.1), an 
analog transformation of cyclopropane 119c aiming at the synthesis of a new, chiral 
homo-β-proline analogue was investigated. 
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2.3 Synthesis of homo-ß-proline analogue 147*** 
 
In the previous section of this work, it was shown that monocyclopropane 119c can be generated 
in good yield (60%) and excellent level of enantioselectivity (93% ee) from simple starting 
materials (scheme 32). The enantiopure material is readily accessible by a single 
recrystallization and low catalyst loading as well as short reaction time are required, making 
monocyclopropane 119c a good starting point for further synthetic efforts. Taking the lead from 
the elegant work of the Reiser group on the employment of donor-acceptor substituted 
cyclopropanes derived from renewable resources,12,18 the utility of cyclopropane 119c was 
investigated with the synthesis of a chiral homo-β-proline analogue. 
 
 
Scheme 32. Enantioselective synthesis of cyclopropane 119c. 
 
In order to circumvent the formation of dimerization products originating from activation of the 
enamine moiety by protonation,12,15 hydrogenation of the double bond in 119c was performed 
under neutral conditions prior to acid-induced ring-opening. Performing the reaction with Pd/C 
at ambient pressure of hydrogen gave rise to adduct 144 in 84% yield (scheme 33). 
 
 
Scheme 33. Hydrogenation of the double bond in cyclopropane 119c.  
 
Utilizing the inherent properties of donor-acceptor cyclopropanes,99 selective opening of the 
weakest bond in the cyclopropane moiety of 144 was achieved by treatment with TFA/ Et3SiH 
                                                 
*** Results are partially taken from the Bachelor thesis of N. Wurzer, 2016, Universität Regensburg (supervised 
by V. Lehner) 
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at room temperature (table 8, entry 2). However, under these conditions the reaction of 
cyclopropane 144 produced a mixture of diastereomers 145 and 146 in a ratio of 85:15, 
indicating that at least one of the two stereocenters is prone to epimerization. A decrease in 
reaction temperature had only little impact on the diastereomeric ratio (87:13 vs. 85:15) and a 
significantly prolonged reaction time was required to accomplish full conversion of the starting 
material (entry 1). Performance of the reaction at slightly elevated temperatures of 40 °C led to 
a decline in diastereoselectivity, forming ring-opening products 145 and 146 in a ratio of 78:22 
(entry 3).  
 
Table 8. Temperature dependence of ring-opening reactions with cyclopropane 144. 
 
entrya 
temperature  
(°C) 
time 
 (h) 
ratio  
145/146b 
ee (145) 
 (%)c 
ee (146) 
 (%)c 
yield  
(%) 
1 0 192 87:13 99 67 n.d. 
2 25 48 85:15 99 37 86d 
3 40 6 78:22 96 0 n.d. 
aStandard reaction conditions: TFA (2.0 equiv), Et3SiH (3.0 equiv). 
bDetermined by 1H-NMR 
analysis of the crude mixture. cDetermined by chiral HPLC analysis. dIsolated yield: 145 
(72%), 146 (14%). 
 
Gratifyingly, separation of the diastereomers was feasible via column chromatography, 
enabling isolation of main diastereomer 145 in 72% yield with 99% ee and minor diastereomer 
146 in 14% yield with 37% ee (entry 2). As can be seen from the absolute configuration of 145 
that was unambiguously assigned by X-ray crystallography (figure 13), ring-opening of 
cyclopropane 144 occurs preferentially with retention of both stereocenters. The corresponding 
minor diastereomer 146 was generated in considerably diminished yields and enantioselectivity 
compared to 145, indicating that each of the two stereocenters is prone to epimerization 
(table 8). Interestingly, while 145 was formed with uniformly high enantiomeric excess 
(96-99% ee) in all experiments, it was found, that lowering the temperature from 40 °C to 0 °C 
led to a significantly improved enantioselectivity of 146 (67% ee vs. 0% ee). These results 
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suggest that predominantly only one of the two stereocenters in 146 is influenced by 
modification of the reaction temperature.  
 
Figure 13. X-ray structure of ring-opening product 145 (main diastereomer). 
 
Aiming at a streamlined synthesis of chiral homo-β-proline analogue 147, cleavage of the two 
protection groups in 145 was envisioned to be accomplished in one step by following a protocol 
reported by Sharpless and co-workers.100 Thus, removal of the N-toluenesulfonyl group and 
hydrolysis of the methyl ester was achieved simultaneously by treating 145 with HBr in acetic 
acid for 16 h at 80 °C (scheme 34). The resulting bromide salt was purified by the use of an 
acidic ion-exchange resin, giving rise to free amino acid 147 in quantitative yield. 
 
 
Scheme 34. Final step in the synthesis of homo-β-proline analogue 147. 
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2.4 Conclusion and Outlook 
 
In summary, the utility of cyclopropane 119c was demonstrated with the synthesis of chiral 
homo-β-proline analogue 147 (scheme 36). Starting from 119c, the targeted pyrrolidine 147 
was accessible in 3 steps and with 60.5% overall yield via hydrogenation, selective ring-
opening and subsequent deprotection of the functional groups. Additionally, 147 can also be 
considered as a pyrrolidine analogue of methylphenidate (150, Ritalin™),101 a dopamine 
reuptake inhibitor used for the treatment of Attention Deficit Hyperactivity Disorder 
(ADHD).102 A slight modification of the synthetic route in the deprotection step by using 
magnesium in methanol, which was reported to be capable of removing N-tosyl groups without 
affecting methyl esters,60 should enable the synthesis of the corresponding methyl ester 
analogue of 147 (structural analogue to 150) without the need for an additional step. Current 
experiments in the Reiser group by Alexander Röther are underway to apply this synthetic route 
to partially unsaturated piperidines aiming at the synthesis of the chiral 3-substituted 
methylphenidate derivative 151. Taking the lead from the work of the Reiser group on the 
application of cyclopropanated pyrroles toward chiral intermediates and natural products (see 
chapter A.1.3 for details),18 it would also be conceivable to transform 119c into 
β-aminocyclopropanecarboxylic acid (β-ACC) derivative 148 or chiral 2-pyrrolidinone 149.  
 
 
Scheme 35. Cyclopropane 119c as precursor and related projects.  
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3 Cyclopropanes 98a/b as precursors for the synthesis of paraconic acid derivatives 
 
3.1 Introduction – γ-Butyrolactone: a privileged motif in natural products and drugs  
 
The γ-butyrolactone ring constitutes the core structure of more than 13000 natural products 
spanning from simple monocycles to highly complex polycyclic scaffolds.103 Along with the 
structural diversity, γ-butyrolactones display an impressive range of biological activities 
including antifungal, anti-inflammatory, antiviral, cytostatic, antitumor as well as antiviral 
properties, making them important lead structures for the development of novel therapeutic 
agents.104 A prominent multi-target drug containing the γ-butyrolactone motif as central unit is 
spironolactone (Aldactone™, 152),105 an aldosterone agonist used for the treatment of high 
blood pressure and heart failure (figure 14). Mycophenolate-mofetil (CellCept™, 153),106 a 
prodrug of mycophenolic acid, is an effective immunosuppressive agent that is commonly used 
in transplant therapy to prevent allograft rejection. 
 
 
Figure 14. Representative examples of γ-butyrolactone natural products and pharmaceuticals. 
 
A particular notable, naturally occurring γ-butyrolactone representative is the farnesyl 
transferase inhibitor Arglabin™ (13),107 which shows promising cytotoxicity against various 
tumor cell lines. The water-soluble hydrochloride salt of the dimethylamino adduct of 
Arglabin™ is already a registered antitumor drug for the treatment of colon, ovarian, breast and 
lung cancers.108 Enterolactone (154), a mammalian lignan that is formed by the metabolization 
of plant lignans in the colon, has been shown to possess protective properties toward breast and 
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prostate cancer.109 Further natural disubstituted γ-butyrolactones are known as sex attractant 
pheromones (e.g. (+)-eldanolide  (155)110 and others are utilized as potential key flavor 
components (e.g. whisky lactone (156) and cognac lactone (157).111 
A group of chiral, trisubstituted γ-butyrolactones that have attracted considerable attention in 
recent years because of their broad biological profile including antitumor, antibiotic, antifungal, 
and antibacterial effects are paraconic acids.112–114 This class of compounds is characterized by 
the presence of a carboxylic functionality at the β-position of the γ-butyrolactone ring. Naturally 
occurring paraconic acid derivatives, which are isolated from various species of lichens, mosses 
and culture filtrates of penicillium sp., also bear an alkyl chain at the γ-carbon atom as well as 
a methyl or a methylene group at the α-position, which is pivotal for the biological activity of 
the molecules.112 Some representative examples are depicted in figure 15. 
 
 
Figure 15. Paraconic acids.112  
 
Inspired by the impressive structural diversity of naturally occurring γ-butyrolactones, synthetic 
chemists have developed various asymmetric strategies for assembling such challenging 
scaﬀolds in the past decades.115 However, due to their broad spectrum of pharmacological and 
biological activities112 the total synthesis of chiral γ-butyrolactones, especially paraconic acids 
and structurally related compounds, is of continuing interest.  
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3.2 Literature syntheses of paraconic acids – Utilization of donor-acceptor 
cyclopropanes 
 
In addition to the various racemic approaches for assembling different members of the 
paraconic acid family that have been reported in the last decades,116 an impressive range of 
strategies for the enantioselective synthesis of these natural products was developed.112 These 
strategies include chiral pool approaches,117 the use of chiral auxiliaries118 or chiral synthons,119 
chemoenzymatic resolution,120 π-face differentiation in chiral olefin-ketene [2 + 2] 
cycloaddition,121 asymmetric dihydroxylation,122 asymmetric epoxidation,123 asymmetric 
reduction,124 chiral conjugate addition,125 as well as asymmetric allylic alkylation.103,126  
 
 
Scheme 36. Enantioselective synthesis of paraconic acids (blue) by Reiser and co-workers.17,127  
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An efficient methodology for the enantioselective construction of anti-4,5-disubstituted 
γ-butyrolactones 158, 161 and 162, which were successfully transformed to a variety of 
paraconic acids, was reported by Reiser and co-workers17,127 (scheme 36). Starting from 
cyclopropane 21 (see chapter B.1.1), cleavage of the double via ozonolysis and subsequent 
reductive work-up gave access to aldehyde cyclopropane 22, which was then subjected to a 
BF3-mediated Hosomi-Sukurai allylation. The resulting adducts 23 that were obtained with 
generally high Felkin-Anh selectivity were transformed to the corresponding γ-butyrolactones 
158 and 161 bearing a free aldehyde moiety at the β-position by a base induced hydrolysis that 
triggers a subsequent retroaldol/lactonization cascade. Alternatively, by using Oteraʼs tin oxide 
catalyst (160) in the presence of ethane-1,2-diol, concomitant acetalization of the aldehyde 
group had taken place, giving access to acetal 162.  
The substitution pattern of γ-butyrolactones 158, 161 and 162 set the foundation for the 
synthesis of several paraconic acids. Thus, (-)-methylenolactocin (159) was accessible from 
158 in 3 steps via hydrogenation of the double bonds, oxidation of the aldehyde and introduction 
of the exo-methylene group. Installation of variable alkyl chains at the γ-carbon atom that are 
present in naturally occurring paraconic acids were accomplished by Reiser and co-workers by 
utilizing crossmetathesis reactions. By applying this method, the syntheses of (-)-roccellaric 
acid (8), (-)-protolichesterinic acid (163), (-)-nephorsteranic acid (164), as well as 
(-)-protopreasorediosic acid (165) were completed within 4-5 steps, respectively, starting from 
γ-butyrolactones 161 and 162.17,127 
Inspired by the protocol that was developed by the Reiser group for the synthesis of 
disubstituted γ-butyrolactones, it was envisioned, that an analog transformation of 
cyclopropanes 98 enable the construction of trisubstituted γ-butyrolactones 166. The synthesis 
of these novel chiral building blocks 166, and their application as precursors for the synthesis 
of paraconic acid derivatives bearing an aryl substituent in the α-position (scheme 37) was 
investigated. 
 
 
Scheme 37. Retrosynthetic analysis for paraconic acid derivatives 167.  
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3.3 Preliminary studies on the synthesis of paraconic acid derivatives 176a and 179a††† 
 
In chapter B.1.3 it was shown that monocyclopropanes 98 are readily generated in good yields 
and high levels of enantioselectivity from simple starting materials (scheme 38). Short reaction 
times and low catalyst loadings were generally required, and purification was realized by simple 
filtration. In the case of cyclopropane 98a (Ar = Ph), reactions up to 74 mmol were already 
successfully performed, and enantiopure material was accessible after single recrystallization. 
Thus, highly functionalized cyclopropanes 98 were envisioned to be good starting points for a 
diverse follow-up chemistry. 
 
Scheme 38. Enantioselective synthesis of cyclopropanes 98. 
 
Following the protocol developed by the Reiser group17,127 (see chapter B.3.2), cyclopropane 
98a was subjected to ozonolysis and subsequent reductive workup (scheme 39). BF3-catalyzed 
allylation of the resulting cyclopropane aldehyde 168a gave access to crude allyl alcohol 169a. 
Unfortunately, it was not feasible to isolate 169a in pure form, since it proved to be unstable 
during chromatographic work-up and recrystallization attempts using different solvents were 
unsuccessful. Thus, the configuration of the newly formed stereocenter in 169a was assigned 
according to the Felkin-Anh-model with the prerequisite that the oxalic ester is the large 
substituent.128 Treatment of crude 169a with triethylamine in methanol generates unmasked 
donor-acceptor cyclopropane 170a that is further transformed to γ-butyrolactone 166a 
(dr = 90:5:5) via ring opening and subsequent lactonization.  
Although 166a was obtained as the main product in this reaction, a number of byproducts 
resulting from elimination of the alcohol moiety, nucleophilic addition of methanol, as well as 
combinations thereof were formed as judged by mass spectrometry and crude 1H-NMR 
analysis. To prevent the formation of byproducts such as 5-methoxy γ-butyrolactone 172a 
which derived from nucleophilic addition of methanol to the aldehyde moiety, a screening of 
different solvents was conducted (scheme 40).  
                                                 
††† Results are partially taken from the Bachelor thesis of F. Ostler, 2015, Universität Regensburg (supervised by 
V. Lehner) 
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Scheme 39. Synthesis of γ-butyrolactone 166a starting from cyclopropane 98a.‡‡‡ 
 
However, only traces of desired product 166a were obtained when 169a was treated with 
triethylamine in aprotic solvent systems. Instead, diene 173a was formed via ring-opening, 
elimination of the alcohol moiety and base-induced isomerization129 of the allyl double bond. 
Using iPrOH as solvent system, applying stoichiometric amounts of MeOH (5 equiv.) in THF, 
decreasing the reaction temperature to -78°C, and employment of Ba(OH)2 as base did not 
improve the situation. Attempts to isolate pure 166a by column chromatography, kugelrohr 
distillation, preparative TLC, as well as recrystallization were unfruitful and led to a 
considerable loss of product. At this point, it was refrained from isolating the product at this 
stage as purification may be more convenient after oxidation of the aldehyde moiety in the last 
step of the planned route to paraconic acid derivatives 167. 
 
 
Scheme 40. Screening of different solvent systems. 
  
                                                 
‡‡‡ The relative configuration of 166a was established by X-ray analysis of downstream product 176a (p. 62). 
The absolute configuration of 166a was tentatively assigned by analogy to the stereochemical results observed 
for the synthesis of related disubstituted γ-butyrolactones. 
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The short-chain paraconic acid derivative 176a was generated by hydrogenation of 166a in the 
presence of Pd/C and a subsequent oxidation (scheme 41). Preliminary studies showed that 
simultaneous to hydrogenation of the double bond in 166a, partial reduction of the aldehyde 
moiety occurred. Therefore, BAIB/ TEMPO130 was used for the oxidation to 176a instead of 
the originally reported NaClO2/ H2O2,
17 since this reagent is able to oxidize aldehydes as well 
as primary alcohol groups.  
 
 
Scheme 41. Preliminary studies on the synthesis of paraconic acid derivatives 176a and 179a. 
 
Utilizing the protocol of Reiser and co-workers,17 installation of the long alkyl chain at the 
γ-carbon position of 177a was achieved by cross metathesis with 1-dodecene applying 
Grubbs II as catalyst and hydrogenation in the presence of Pd/C gave access to intermediate 
178a. In order to increase the overall efficiency of this synthetic route and avoid the use of 
expensive palladium, performance of the elongation and hydrogenation step in a tandem 
sequence was investigated. Applying the metathesis/hydrogenation protocol reported by 
Grubbs and co-workers,131 γ-butyrolactone 166a was efficiently transformed to intermediate 
178a as judged by crude 1H-NMR analysis. Subsequent oxidation using the modified conditions 
afforded paraconic acid derivative 179a. 
Gratifyingly, generation of the acid group in the last step enables the purification and finally 
the isolation of pure compounds 176a and 176b. Thus, it was refrained from purification of the 
intermediates in the following.  
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3.4 Synthesis of novel paraconic acid derivatives§§§ 
 
With the newly optimized reaction conditions at hand (see chapter B.3.3), the consecutive and 
straightforward transformation of cyclopropanes 98a and 98b to paraconic acid derivatives 
176a as well as 179a/b was investigated (scheme 42).  
 
 
Scheme 42. Consecutive synthesis of paraconic acid derivatives 176a and 179a/b. 
 
The key allylation/retroaldol/lactonization cascade of ozonolysis products 168a/b proceeded 
with high diastereoselectivity as judged by crude 1H-NMR, giving rise to intermediates 166a/b. 
Short-chain derivative 176a was readily generated in 18.5% overall yield via hydrogenation of 
the double bond in the presence of Pd/C and oxidation of the aldehyde moiety with BAIB/ 
TEMPO.130 Installation of the tridecyl-substituent in 179a/b, the α-aryl substituted analogues 
of (-)-roccellaric acid (8), was readily achieved by utilizing a metathesis/hydrogenation 
sequence.131 Subsequent oxidation of the aldehyde moiety generated paraconic acid derivatives 
179a/b in 15.2/10.0% overall yields starting from cyclopropanes 98a/b. It is notable that no 
chromatographic work-up of intermediates was required in the course of the sequence since the 
final carboxylic acids can be conveniently purified and isolated in pure form by column 
chromatography and subsequent recrystallization. 
The relative configuration of paraconic acid derivatives 176a and 179a/b was established by 
X-ray analysis of (rac)-176a (figure 16). Since it was not feasible to get suitable crystals from 
                                                 
§§§ This chapter is partially based on Lehner, V.; Davies, H. M. L.; Reiser, O. Rh(II)-Catalyzed Cyclopropanation 
of Furans and Its Application to the Total Synthesis of Natural Product Derivatives. Org. Lett. 2017 (accepted) 
B Main part 
63 
the enantiopure material (determined by chiral HPLC) the absolute configuration of 176a and 
179a was tentatively assigned by analogy to the stereochemical results observed for the 
synthesis of related disubstituted γ-butyrolactones.17 
 
Figure 16. X-ray structure of paraconic acid derivative (rac)-176a. 
 
To broaden the scope of paraconic acids and to analyze the influence of different substituents 
on the biological activities, modification of the different functional groups in 179a and 179b 
was investigated. On the one hand, (rac)-179a was transformed to ester 180a by an acid-
catalyzed esterification to examine the relevance of the acid group (scheme 43). On the other 
hand, demethylation of the aryl methyl ether in 179b was investigated. Preliminary attempt 
using iodocyclohexane as HI source in DMF132 or AlCl3 in DCM,
133 which were shown to be 
suitable reagents to cleave aryl methyl ether without affecting γ-butyrolactone groups, resulted 
in low conversion of starting material. Increasing the temperature as well as prolonged reaction 
times led to the formation of byproducts as judged by crude 1H-NMR analysis. However, the 
transformation of 179b into paraconic acid derivative 181b, bearing a free hydroxyl group, was 
achieved in 88% yield by BBr3-mediated
134 demethylation. 
 
 
Scheme 43. Synthesis of paraconic acid derivatives 180a and 181b. 
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3.5 Biological evaluation  
 
Naturally occurring paraconic acids are endowed with a host of biological activities (see chapter 
B.3.1). Thus, the biological profile of the newly synthesized derivatives was investigated in the 
following.  
Cytotoxicity of the paraconic acid derivatives against HeLa cells was kindly measured by the 
Pharmaceutical Biology department (University of Regensburg) under the direction of Jörg 
Heilmann. A tetrazolium MTT reduction assay was used to evaluate the cell viability.135 The 
IC50 values are reported in table 9.  
 
Table 9. Cytotoxicity of the investigated paraconic acid derivatives against HeLa cells (IC50 in 
μM, means ± SD, n = 8, 72 h) 
Compd HeLA (KB) cells 
(rac)-179a (racemic) 74.4 ± 4.94 
179a (99% ee) 67.0 ± 4.65 
(rac)-176a (racemic) > 600 
176a (99% ee) > 600 
179b (racemic) 70.0 ± 4.87 
181b (racemic) 95.3 ± 5.54 
180a (racemic) 90.0 ± 8.73 
 
Comparison of the IC50 values of the different paraconic acid derivatives revealed that racemic 
and enantiopure compounds exhibit similar cytotoxicity. A significant increase of the toxic 
properties is observed as the length of alkyl chain at the γ-carbon position is increased. The 
ester derivative was slightly less active than the corresponding free acid compound. All of the 
tested compounds exhibited relatively low cytotoxic activities, which may be due to the absence 
of the exo-methylene group,114,136 that is present in cytotoxic, naturally occurring paraconic 
acids. 
Preliminary studies on the antibacterial activities of the derivatives were kindly conducted by 
the Analytical Chemistry department (University of Regensburg) under the direction of Antje 
Bäumner. A disk diffusion method (Müller-Hinton agar plates)137 was utilized to assay the 
paraconic acid derivatives (60 μM) for bactericidal activity against Staphylococcus aureus 
(Staphylococcus aureus crude cell suspension, Sigma-Aldrich Chemie GmbH). After 
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incubation at 35 °C for 18 h, it was shown that compound (rac)-179a, 179a and 181b led to 
poor growth of the bacteria (figure 17). However, further test would be required to evaluate the 
MIC (minimal inhibitory concentration) and to produce comparable results.  
. 
 
Figure 17. Disk diffusion test for bactericidal activity against Staphylococcus aureus (60 μM). 
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3.6 Conclusion  
 
In summary, the utility of monocyclopropanated furans was demonstrated with the synthesis of 
five novel paraconic acid derivatives bearing aryl substituents in γ-position (scheme 44). No 
chromatographic work-up of intermediates was required over the course of the sequence, since 
the final carboxylic acids can be conveniently purified and isolated in pure form by column 
chromatography and subsequent recrystallization. Key steps in this synthetic route were a 
diastereoselective allylation/retroaldol/lactonization cascade to establish the γ-butyrolactone 
framework and a tandem metathesis/ hydrogenation to introduce the C-13 alkyl chain at the 
γ-carbon atom. The applicability of the total sequence for the enantioselective construction of 
γ-butyrolactones was demonstrated with the synthesis of enantiopure 176a and 179a.  
 
 
Scheme 44. Synthesized paraconic acid derivatives starting from cyclopropanes 98a-b. 
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C Summary 
 
Monocyclopropanated aromatic heterocycles have emerged as versatile building blocks in 
organic synthesis as a wide portfolio of natural products and bioactive compounds are 
accessible from these compounds. However, in most reported applications, simple acceptor 
diazo esters were used for the formation of the cyclopropanes (chapter A).  
To expand the scope of these useful building blocks, the intermolecular monocyclopropanation 
of heteroarenes with donor-acceptor carbenoids was investigated in the first part of this thesis 
(chapter B.1). After screening ten Rh(II)-catalysts, Rh2(S-TCPTTL)4 was identified as a highly 
efficient and selective catalyst (up to 98% ee, TON 88000 and TOF 24 s-1) for the 
cyclopropanation of furans, with a variety of aryl diazoesters (scheme 45). In contrast, the 
developed protocol gave only poor results by using simple methyl diazoacetate.  
In the case of pyrrole, it was demonstrated that the nature of the protecting group on the nitrogen 
has a great influence on the product formation (mono vs. doublecyclopropanation). The best 
results were obtained by using the N-tosyl derivative (61%, 93% ee). The interaction of 
Rh2(S-TCPTTL)4 and the N-tosyl protecting group was also shown to be beneficial for the 
reaction of indole. Thus, the first catalytic enantioselective reaction of indole with aryl 
diazoesters was achieved (75%, 80% ee), resulting in cyclopropanation of the heterocyclic ring. 
 
 
Scheme 45. Enantioselective cyclopropanation of aromatic heterocycles with aryl diazoesters. 
 
In the second part of this thesis (chapter B.2 and B.3), the utility of these cyclopropanes as 
starting materials for the enantioselective construction of novel natural product derivatives 
bearing an additional aryl moiety was investigated.  
Starting from cyclopropane 119c, homo-β-proline analog 147 was synthesized in a three-step 
sequence (scheme 46). By utilizing the unique properties of donor-acceptor cyclopropanes in 
the key step, acid-catalyzed ring opening of 144 afforded pyrrolidine 145 as the major 
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diastereomer in 72% yield and 99% ee. Cleavage of the two protection groups in 145 was 
feasible in one step and thus, homo-β-proline analog 147 was accessible in 60.5% overall yield. 
 
 
Scheme 46. Enantioselective synthesis of homo-β-proline analog 147 starting from cyclopropane 119c. 
 
Starting from cyclopropanes 98a-b, five paraconic acid derivatives were synthesized in a 5-6 
step sequence (scheme 47). The key transformation in this synthetic route was a 
diastereoselective allylation/retroaldol/lactonization cascade, which enabled the construction of 
highly functionalized γ-butyrolactones 166a-b. Alkyl chains in the γ-position were introduced 
by simple hydrogenation of the allyl moiety in the presence of Pd/C (R = C3H7) or by a tandem 
Grubbs II catalyzed metathesis/hydrogenation sequence (R = C13H27). Subsequent oxidation of 
the aldehyde moiety with BAIB/ TEMPO allowed for the synthesis of paraconic acid 
derivatives 176a and 179a/b. Two further derivatives were generated by either esterification of 
the carboxylic group or through modification of the aldehyde moiety. The applicability of this 
sequence for the enantioselective construction of γ-butyrolactones was demonstrated with the 
synthesis of enantiopure 176a and 179a 
 
 
Scheme 47. Enantioselective and racemic synthesis of paraconic acid derivatives starting from 
cyclopropanes 98a-b. 
  
D Zusammenfassung 
78 
D Zusammenfassung 
 
Monocyclopropananierte aromatische Heterozyklen haben sich in der organischen Chemie als 
vielseitige Bausteine für die Synthese von Naturstoffen sowie biologisch aktiven Molekülen 
bewährt. Trotzdem ist das Potential dieser Verbindungen noch lange nicht ausgeschöpft, da im 
überwiegenden Teil der Literatur lediglich Akzeptor Diazoester im Cyclopropanierungsschritt 
verwendet werden (Kapitel A).  
Im ersten Teil dieser Arbeit werden Forschungsergebnisse zur Synthese von monocyclo-
propanierten, aromatischen Heterozyklen unter Einsatz von Donor-Akzeptor Diazoestern 
vorgestellt (Kapitel B.1). In einem Screening von zehn Rh(II)-Katalysatoren zeigte sich, dass 
Rh2(S-TCPTTL)4 ein höchst effizienter und selektiver Katalysator (bis zu 98% ee, TON 88000 
und TOF 24 s-1) für die Monoyclopropanierung von Furanen ist (Schema 45). Die entwickelte 
Methodik konnte für eine Vielzahl an Aryldiazoestern angewendet werden, wohingegen eine 
analoge Reaktion mit Methyldiazoacetat mäßige Ergebnissen erzielte. 
Bei der Umsetzung von Pyrrolen wurde neben dem gewünschten monocyclopropanierten 
Produkten auch die entsprechenden doppelcyclopropanierten Produkte erhalten. In einer Studie 
konnte gezeigt werden, dass die Produktverteilung durch die Wahl der Schutzgruppe am 
Stickstoff steuerbar ist. Die besten Ergebnisse wurden hierbei mit dem N-Tosyl Derivat erzielt 
(61%, 93% ee). Die Anwendung dieser Methodik (N-Tosyl Schutzgruppe und 
Rh2(S-TCPTTL)4) ermöglichte schließlich die erste katalytische und enantiselektive 
Umsetzung von Indol mit Aryldiazoestern, in der selektiv die heteroaromatische 
Doppelbindung cyclopropaniert wurde (75%, 80% ee). 
Im zweiten Teil dieser Arbeit (Kapitel B.2 und B.3) wurde die Anwendbarkeit dieser 
Cyclopropane als chirale Bausteine für die Synthese von neuen Naturstoffderivaten mit einer 
zusätzlich Arylgruppe untersucht.  
Ausgehend von Cyclopropan 119c, konnte Homo-β-prolin Analogon 147 in 3 Stufen hergestellt 
werden (Schema 46). Den Schlüsselschritt dieser Sequenz stellte eine säurekatalysierte, 
diasteroselektive Ringöffnung von Donor-Akzeptor Cyclopropan 144 dar, wodurch Pyrrolidin 
145 in 72% Ausbeute und 99% ee synthetisiert werden konnte. Die simultane Eliminierung der 
beiden Schutzgruppen von 145 ermöglichte letztendlich die Darstellung von Homo-β-prolin 
Analog 147 in 60.5% Gesamtausbeute.  
Ausgehend von Cyclopropanen 98a-b konnten fünf Paraconsäurederivate in 5-6 Stufen 
hergestellt werden (Schema 47). Die Darstellung der hoch funktionalisierten γ-Butyrolactone 
166a-b wurde durch eine diasteroselektive Allylierung/Retroaldol/Laktonisierung Sequenz 
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erreicht. Die Einführung der Alkyl Seitenketten in γ-Position gelang durch Hydrierung der 
Allylgruppe mit Pd/C (R = C3H7) beziehungsweise einer Grubbs II katalysierten 
Metathese/Hydrierung Sequenz (R = C13H27). Durch die anschließende Oxidation der 
Aldehydgruppe mit BAIB/ TEMPO war die Darstellung von Paraconsäurederivate 176a and 
179a/b möglich. Zusätzlich wurden noch zwei weitere Derivate durch Veresterung der 
Säuregruppe oder Modifizierung der Arylgruppe synthetisiert. Durch die Synthese der 
enantiomerenreinen Verbindungen 176a und 179a konnte abschließend gezeigt werden, dass 
diese Methode für die enantioselektive Darstellung von substituierten γ-Butyrolactonen 
geeignet ist. 
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E Experimental part 
 
1 General information 
 
1H-NMR and 13C-NMR spectra were recorded on Bruker Avance 300 (300 MHz), Bruker 
Avance 400 (400 MHz) and Bruker Avance III 600 TCI Cryo (600 MHz). NMR spectra were 
recorded in CDCl3 or commercially available deuterated solvents at room temperature unless 
otherwise stated. Chemical shifts are reported as δ, parts per million, relative to the signal of 
the solvent. The coupling constants (J) are reported in Hertz (Hz). Abbreviations for signal 
coupling are as follows: s = singlet, bs = broad singlet, d = doublet, t = triplet, m = multiplet, 
dd = doublet of a doublet, ddd = doublet of a doublet of a doublet, dtd = doublet of a triplet of 
a doublet. Infrared spectroscopy (IR) was carried out on a Cary630 FT-IR spectrometer (Agilent 
Technologies) or a Biorad Excalibur FTS 3000 spectrometer (equipped with a Specac Golden 
Gate Diamond Single Reflection ATR-System). Mass spectrometry was performed in the 
Central Analytic Department on a ThermoQuest Finnigan TSQ 7000, Agilent Q-TOF 6540 
UHD, Finnigan MAT 95 or a MAT SSQ 710 A at the Central Analytical Department 
(University of Regensburg). Melting points were recorded on an OptiMelt MPA 100 
(uncorrected). Optical Rotation was measured in a Perkin Elmer Polarimeter or an ElmerAnton 
Paar MCP500 at 589 nm wavelength (sodium-d-line) in the specific solvent. Column 
chromatography was performed on silica gel 60 (0.063-0.200 nm, Merck) or flash silica gel 60 
(0.040-0.063, Merck). Analytical thin layer chromatography was performed on Merck TLC 
aluminium sheets silica gel 60 F 254 (0.2 mm layer thickness). Eluated plates were visualized 
using a UV lamp (λ = 254 nm or 366 nm) and/ or by staining with vanillin/ sulfuric acid solution 
or bromocresol green solution. X-ray measurements were performed by the crystallographic 
department of the University of Regensburg on Agilent Technologies SuperNova, Agilent 
Technologies Gemini R Ultra or Stoe IPDS I. Analytical HPLC was carried out on a Varian 
920-LC with DAD. Chiralpak AS-H, Phenomenex Lux Cellulose-1 and 2 served as chiral 
stationary phase, and mixtures of n-heptane and iPrOH were used for elution. Reactions with 
moisture and oxygen sensitive reagents were performed in flame-dried, or oven-dried glassware 
under an atmosphere of pre-dried nitrogen or argon. Dry solvents were prepared according to 
standard procedures. Furan (14), furan-2-carboxylate (19) and methyl furan-3-carboxylate 
(105) were distilled prior to use. Unless otherwise stated, all other commercially available 
chemicals were used as received without further purification.   
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2 Synthesis of starting materials and catalysts 
 
Following compounds were synthesized according to literature known procedures or were on 
stock in the laboratories of the Reiser or Davies group:  
Rh2(S-DOSP)4,
1 Rh2(S-BNP)4,
2 Rh2(S-BTPCP)4,
3 Rh2(S-NTTL)4,
4 Rh2(S-PTAD)4,
5 
Rh2(S-TCPTAD)4,
6 Rh2(S-PTTL)4,
7 Rh2(S-TFPTTL)4,
8 Rh2(S-TCPTTL)4,
9 Rh2(S-
TBPTTL)4,
10 Grubbs II,11 methyl 2-diazoacetate (79),12 tert-butyl 1H-pyrrole-1-carboxylate 
(90),13 methyl 2-(4-bromophenyl)-2-diazoacetate (91),14 methyl 2-diazo-2-phenylacetate 
(97a),14 methyl 2-diazo-2-(4-methoxyphenyl)acetate (97b),14 methyl 2-diazo-2-(p-tolyl)acetate 
(97c),14 methyl 2-(4-chlorophenyl)-2-diazoacetate (97d),14 methyl 2-diazo-2-(naphthalen-2-
yl)acetate (97f),14 methyl 2-diazo-2-(4-nitrophenyl)acetate (97g),14 methyl 1H-pyrrole-1-
carboxylate (113a),15 p-tolyl 1H-pyrrole-1-carboxylate (113b),15  1-tosyl-1H-pyrrole (113c),16 
1-(methylsulfonyl)-1H-pyrrole (113d),17 1-tosyl-1H-indole (125).18 
 
1-(cyclohexylsulfonyl)-1H-pyrrole (113e) 
 
 
Cyclohexanesulfonyl chloride (117) (1.50 g, 8.21 mmol, 1.0 equiv) was added to a 32% 
aqueous ammonia solution (30 mL) at rt within 10 minutes. The reaction mixture was allowed 
to stir for 90 min. The solution was acidified with 2 M HCl to pH = 7 and extracted with ethyl 
acetate (4 x 50 mL). The combined organic layers were dried over anhydrous Na2SO4, the solid 
was filtered off, and the filtrate was concentrated to give cyclohexanesulfonamide (118) which 
was directly used in the next step.20  
A solution of cyclohexanesulfonamide (118) (1.03 g, 6.29 mmol, 1.0 equiv) and 2,5-
dimethoxytetrahydrofuran (0.98 mL, 7.22 mmol, 1.2 equiv) in acetic acid (8 mL) was refluxed 
for 4 h. The solvent was evaporated in vacuo and the crude product was purified by flash 
chromatography (SiO2, hexanes/EtOAc, 9:1) to afford pyrrole 113e as a white solid (1.24 mg, 
71% yield over 2 steps).17  
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m.p. 63-64 °C; Rf = 0.60 (hexanes: ethyl acetate = 5:1, Vanillin); IR (neat): 3167, 3122, 3120, 
2945, 2863, 2102, 1610, 1573, 1536, 1454, 1370, 1342, 1271, 1219, 1182, 1156, 1059, 1037, 
891, 850, 824, 749 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.08 – 7.05 (m, 2H), 6.36 – 6.30 (m, 
2H), 3.08 (tt, J = 12.0, 3.5 Hz, 1H), 2.03 – 1.92 (m, 2H), 1.90 – 1.79 (m, 2H), 1.71 – 1.61 (m, 
1H), 1.51 – 1.35 (m, 2H), 1.31 – 1.09 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 121.4, 112.6, 
64.4, 26.2, 24.9,24.8; HRMS (+APCI) calcd. for C10H16NO2S (M+H)
+ 214.0896 found 
214.0901.  
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3 Synthesis of Cyclopropanes 
 
3.1 General procedures 
 
 
 
General procedure (GP-1): Enantioselective cyclopropanation of furans with Rh2(S-TCPTTL)4 
In a flame dried 25-mL round bottom flask equipped with a magnetic stir bar, furan (2.0 equiv) 
and Rh2(S-TCPTTL)4 (0.1 mol%) were dissolved in dry hexanes (2 mL) and cooled to 0 °C. A 
solution of the diazo ester (1.0 mmol, 1.0 equiv) in dry hexanes (1.4-2 mL) and dry 
dichloromethane (0-0.6 mL) was added using a syringe pump for the duration of 1 h. Afterward, 
the reaction mixture was stirred for further 5 min and concentrated under reduced pressure. The 
residue was purified by column chromatography on silica gel using hexanes and ethyl acetate 
as eluents. 
 
General procedure (GP-2): Enantioselective cyclopropanation of pyrroles and indole with 
Rh2(S-TCPTTL)4 
In a flame dried 25-mL round bottom flask equipped with a magnetic stir bar, pyrrole/indole 
(2.0 equiv) and Rh2(S-TCPTTL)4 (0.1 mol%) were dissolved in dry toluene (4 mL) and cooled 
to 0 °C. A solution of the diazo ester (1.0 mmol, 1.0 equiv) in dry toluene (2 mL) was added 
using a syringe pump for the duration of 1 h. Afterward, the reaction mixture was stirred for 
further 5 min and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel using hexanes and ethyl acetate as eluents. 
 
General procedure (GP-3): Racemic cyclopropanation of furans with Rh2(OPiv)4 
In a flame dried 25-mL round bottom flask equipped with a magnetic stir bar, furan (2.0 equiv) 
and Rh2(OPiv)4 (0.5 mol%) were dissolved in dry hexanes (2 mL). A solution of the diazo ester 
(0.5 mmol, 1.0 equiv) in dry hexanes (1.4-2 mL) and dry dichloromethane (0-0.6 mL) was 
added using a syringe pump for the duration of 1 h. Afterward, the reaction mixture was stirred 
for further 5 min and concentrated under reduced pressure. The residue was purified by column 
chromatography on silica gel using hexanes and ethyl acetate as eluents. 
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General procedure (GP-4): Racemic cyclopropanation of pyrroles with Cu(OTf)2 
In a flame dried 25-mL round bottom flask equipped with a magnetic stir bar, pyrrole (2.0 
equiv) and Cu(OTf)2 (6.0 mol%) were dissolved in dry dichloromethane (0.6 mL). 
Phenylhydrazine (0.7 mol%) was added to the reaction mixture. A solution of the diazo ester 
(1.0 mmol, 1.0 equiv) in dry dichloromethane (0.6 mL) was added using a syringe pump for the 
duration of 3 h. The reaction mixture was stirred for further 5 min and afterward filtered through 
basic alumina and washed with DCM (100 mL). The solvent was evaporated in vacuo, and the 
residue was purified by column chromatography on silica gel using hexanes and ethyl acetate 
as eluents. 
 
General procedure (GP-5): Racemic cyclopropanation of indole with Rh2(OAc)4 
In a flame dried 25-mL round bottom flask equipped with a magnetic stir bar, indole (2.0 equiv) 
and Rh2(OAc)4 (0.5 mol%) were dissolved in dry toluene (4 mL). A solution of the diazo ester 
(1.0 mmol, 1.0 equiv) in dry toluene (2 mL) was added using a syringe pump for the duration 
of 1 h. Afterward, the reaction mixture was stirred for further 5 min and then concentrated under 
reduced pressure. The residue was purified by column chromatography on silica gel using 
hexanes and ethyl acetate as eluents. 
 
3.2 Synthesis of cyclopropane 98a with 0.001 mol% Rh2(S-TCPTTL)4 
 
In a flame dried 250-mL round bottom flask equipped with a magnetic stir bar, methyl 
furan-2-carboxylate (19) (17.7 g, 140.4 mmol, 1.9 equiv) and Rh2(S-TCPTTL)4 (1.3 mg, 
0.72 μmol, 0.001 mol%) were dissolved in dry hexanes (45 mL) and cooled to 0 °C. A solution 
of the diazo ester 97a (13.1 g, 74.2 mmol, 1.0 equiv) in dry hexanes (12 mL) was added using 
a syringe pump for the duration of 1 h. Afterward, the reaction mixture was stirred for further 
5 min. The product, which precipitated from the reaction mixture, was filtered off and washed 
with cold hexanes. Thus, cyclopropane 98a (17.5 g, 63.7 mmol, 86%, 96% ee) was obtained as 
a white solid, and a single recrystallization in refluxing methanol provided enantiomerically 
pure 98a (14.5 g, 52.7 mmol, 71%, >99% ee). 
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3.3 Characterization 
 
 
dimethyl (1S,5S,6R)-6-phenyl-2-oxabicyclo[3.1.0]hex-3-ene-3,6-dicarboxylate (98a) 
According to GP-1 methyl furan-2-carboxylate (19) (251 mg, 2.0 mmol, 2.0 equiv) was 
cyclopropanated with diazo ester 97a (178 mg, 1.0 mmol, 1.0 equiv) in 2 mL dry hexanes and 
Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 0.1 mol%). The crude product was purified by flash 
chromatography (SiO2, hexanes/EtOAc, 5:1) to afford cyclopropane 98a as a white solid (245 
mg, 88% yield). 
m.p. 103-104 °C; Rf = 0.25 (hexanes: ethyl acetate = 5: 1, Vanillin); [α]D20 -280.2° (c = 1.0, 
CHCl3); IR (neat): 3142, 3086, 3030, 2952, 2848, 1733, 1707, 1610, 1498, 1439, 1361, 1323, 
1252, 1213, 1148, 1111, 1036, 958, 891, 842, 787 697cm-1; 1H-NMR (300 MHz, CDCl3): δ 
7.30 – 7.17 (m, 5H), 6.11 (d, J = 3.0 Hz, 1H), 5.23 (d, J = 5.4 Hz, 1H), 3.63 (s, 3H), 3.60 (s, 
3H), 3.37 (dd, J = 5.4, 3.0 Hz, 1H); 13C-NMR (75 MHz, CDCl3): δ 173.1, 158.8, 148.9, 132.3, 
129.5, 128.1, 127.7, 114.1, 71.1, 52.9, 52.1, 39.5, 28.5; HRMS (+ESI) calcd. for C13H13O3 
(M+H)+ 275.0914 found 275.0916; HPLC analysis: (Phenomenex Lux Cellulose-1, n-heptane: 
i-Propanol = 95:5, 1.0 mL/min, λ = 215 nm, 30 min, tR = 13.69 min, major; tR = 16.18 min, 
minor). 
 
 
Dimethyl (1S,5S,6R)-6-(4-methoxyphenyl)-2-oxabicyclo[3.1.0]hex-3-ene-3,6-dicarboxylate 
(98b) 
 
According to GP-1 methyl furan-2-carboxylate (19) (251 mg, 2.0 mmol, 2.0 equiv) was 
cyclopropanated with diazo ester 97b (208 mg, 1.0 mmol, 1.0 equiv) in 1.4 mL dry hexanes 
and 0.6 mL dry dichloromethane and Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 0.1 mol%). The 
crude product was purified by flash chromatography (SiO2, hexanes/EtOAc, 5:1) to afford 
cyclopropane 98b as a yellowish solid (248 mg, 80% yield).  
m.p. 115-116 °C; Rf = 0.18 (hexanes: ethyl acetate = 5: 1, Vanillin); [α]D20  -229.0° (c = 1.0, 
CHCl3, 95% ee); IR (neat): 2955, 2839, 1708, 1612, 1516, 1436, 1338, 1245, 1213, 1176, 1147, 
1113, 1034, 958, 913, 884, 848, 799, 731, 633, 538, 500 cm-1; 1H NMR (300 MHz, CDCl3) δ 
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7.16 – 7.06 (m, 2H), 6.83 – 6.74 (m, 2H), 6.10 (d, J = 3.0 Hz, 1H), 5.19 (d, J = 5.4 Hz, 1H), 
3.75 (s, 3H), 3.62 (s, 3H), 3.61 (s, 3H), 3.33 (dd, J = 5.4, 3.0 Hz, 1H); 13C NMR (75 MHz, 
CDCl3) δ 173.5, 158.9, 158.8, 149.0, 133.4, 121.4, 114.1, 113.6, 71.3, 55.1, 52.8, 52.1, 39.7, 
27.8; HRMS (+ESI) calcd. for C16H17O6 (M+H)
+ 305.1020 found 305.1021; HPLC analysis: 
95% ee (Phenomenex Lux Cellulose-1, n-heptane: i-Propanol = 95:5, 1.0 mL/min, λ = 215 nm, 
30 min, tR = 17.23 min, major; tR = 23.71 min, minor). 
 
 
dimethyl (1S,5S,6R)-6-(p-tolyl)-2-oxabicyclo[3.1.0]hex-3-ene-3,6-dicarboxylate (98c) 
 
According to GP-1 methyl furan-2-carboxylate (19) (251 mg, 2.0 mmol, 2.0 equiv) was 
cyclopropanated with diazo ester 97c (191 mg, 1.0 mmol, 1.0 equiv) in 1.8 mL dry hexanes and 
0.2 mL dry dichloromethane and Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 0.1 mol%). The crude 
product was purified by flash chromatography (SiO2, hexanes/EtOAc, 5:1) to afford 
cyclopropane 98c as a white solid (247 mg, 85% yield).  
m.p. 112-115 °C; Rf = 0.28 (hexanes: ethyl acetate = 5: 1, Vanillin); [α]D20 -266.1° (c = 1.0, 
CHCl3, 95% ee); IR (neat): 3027, 2954, 2014, 1720, 1709, 1611, 1519, 1435, 1338, 1253, 1212, 
1146, 1113, 1040, 1004, 958, 913, 884, 847, 820, 794, 758, 731, 623, 553, 528, 499, 455 cm-1; 
1H NMR (300 MHz, CDCl3) δ 7.13 – 7.01 (m, 4H), 6.10 (d, J = 3.0 Hz, 1H), 5.21 (d, J = 5.4 
Hz, 1H), 3.62 (s, 3H), 3.61 (s, 3H), 3.34 (dd, J = 5.4, 3.0 Hz, 1H), 2.28 (s, 3H); 13C NMR (75 
MHz, CDCl3) δ 173.4, 158.9, 148.9, 137.3, 132.1, 128.9, 126.4, 114.2, 71.2, 52.9, 52.1, 39.6, 
28.2, 21.3; HRMS (+ESI) calcd. for C16H17O5 289.1071 (M+H)
+ found 289.1073; HPLC 
analysis: >99% ee, Phenomenex Lux Cellulose-1, n-heptane: i-Propanol = 95:5, 1.0 mL/min, λ 
= 215 nm, 30 min, tR = 11.95 min (15.16 min) 
 
 
Dimethyl (1S,5S,6R)-6-(4-chlorophenyl)-2-oxabicyclo[3.1.0]hex-3-ene-3,6-dicarboxylate 
(98d) 
 
According to GP-1 methyl furan-2-carboxylate (19) (254 mg, 2.0 mmol, 2.0 equiv) was 
cyclopropanated with diazo ester 97d (208 mg, 1.0 mmol, 1.0 equiv) in 2 mL dry hexanes and 
Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 0.1 mol%). The crude product was purified by flash 
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chromatography (SiO2, hexanes/EtOAc, 5:1) to afford cyclopropane 98d as a white solid (249 
mg, 82% yield).  
m.p. 86-87°C; Rf = 0.23 (hexanes: ethyl acetate = 5: 1, Vanillin); [α]D20 -257.5° (c = 1.0, CHCl3, 
98% ee); IR (neat): 2954, 1713, 1611, 1495, 1436, 1401, 1337, 1254, 1213, 1147, 1115, 1091, 
1040, 1016, 958, 911, 885, 848, 796, 758, 739, 633, 591, 529, 493, 452, 419 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 7.26 – 7.20 (m, 2H), 7.19 – 7.09 (m, 2H), 6.11 (d, J = 2.9 Hz, 1H), 5.22 
(d, J = 5.4 Hz, 1H), 3.63 (s, 6H), 3.37 (dd, J = 5.3, 3.0 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 
172.6, 158.7, 149.1, 133.7, 133.6, 128.5, 128.2, 113.8, 71.1, 52.9, 52.2, 39.6, 27.9; HRMS 
(+ESI) calcd. for C15H13ClO5 (M+H)
+ 309.0524 found 309.0527; HPLC analysis: 98% ee (AD-
H, n-hexane: i-Propanol = 99:1, 1.0 mL/min, λ = 230 nm, 60 min, tR = 27.86 min, minor; tR = 
43.01 min, major). 
 
 
Dimethyl (1S,5S,6R)-6-(4-bromophenyl)-2-oxabicyclo[3.1.0]hex-3-ene-3,6-dicarboxylate 
(98e) 
 
According to GP-1 methyl furan-2-carboxylate (19) (253 mg, 2.0 mmol, 2.0 equiv) was 
cyclopropanated with diazo ester 91 (253 mg, 1.0 mmol, 1.0 equiv) in 1.6 mL dry hexanes and 
0.4 mL dry dichloromethane and Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 0.1 mol%). The crude 
product was purified by flash chromatography (SiO2, hexanes/EtOAc, 5:1) to afford 
cyclopropane 98e as a white solid (275 mg, 78% yield). 
m.p. 89-90 °C; Rf = 0.21 (hexanes: ethyl acetate = 5: 1, Vanillin); [α]D20 -° (c = 1.0, CHCl3, 
98% ee); IR (neat): 2955, 1713, 1611, 1490, 1436, 1396, 1337, 1254, 1213, 1147, 1115, 1071, 
1041, 1012, 958, 912, 847, 795, 758 733, 633, 583, 535, 499 cm-1; 1H NMR (300 MHz, CDCl3) 
δ 7.44 – 7.35 (m, 2H), 7.14 – 7.00 (m, 2H), 6.10 (d, J = 2.9 Hz, 1H), 5.22 (d, J = 5.4 Hz, 1H), 
3.64 (s, 3H), 3.63 (s, 3H), 3.37 (dd, J = 5.3, 3.0 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 172.5, 
158.7, 149.2, 133.9, 131.4, 128.7, 122.0, 113.8, 71.1, 53.0, 52.3, 39.6, 27.9; HRMS (+ESI) 
calcd. for C15H13BrO5 (M+H)
+ 353.0019 found 353.0018; HPLC analysis: 98% ee (AD-H, n-
hexane: i-Propanol = 99:1, 1.0 mL/min, λ = 230 nm, 60 min, tR = 29.22 min, minor; tR = 45.86 
min, major). 
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Dimethyl (1S,5S,6R)-6-(naphthalen-2-yl)-2-oxabicyclo[3.1.0]hex-3-ene-3,6-dicarboxylate 
(98f) 
 
According to GP-1 methyl furan-2-carboxylate (19) (250 mg, 2.0 mmol, 2.0 equiv) was 
cyclopropanated with diazo ester 97f (226 mg, 1.0 mmol, 1.0 equiv) in 1.4 mL dry hexanes and 
0.6 mL dry dichloromethane and Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 0.1 mol%). The crude 
product was purified by flash chromatography (SiO2, hexanes/EtOAc, 5:1) to afford 
cyclopropane 98f as a yellowish solid (211 mg, 65% yield). 
m.p. 114-115 °C; Rf = 0.18 (hexanes: ethyl acetate = 5: 1, Vanillin); [α]D20 -234.3° (c = 1.0, 
CHCl3, 94% ee); IR (neat): 3058, 2953, 2848, 1708, 1609, 1507, 1435, 1328, 1255, 1213, 1146, 
1111, 1041, 976, 958, 911, 864, 827, 795, 732, 652, 634, 604, 534, 498 cm-1; 1H NMR (300 
MHz, CDCl3) δ 7.83 – 7.69 (m, 4H), 7.49 – 7.41 (m, 2H), 7.35 – 7.26 (m, 1H), 6.16 (d, J = 3.0 
Hz, 1H), 5.33 (d, J = 5.4 Hz, 1H), 3.63 (s, 3H), 3.51 (s, 3H), 3.45 (dd, J = 5.4, 3.0 Hz, 1H); 13C 
NMR (75 MHz, CDCl3) δ 173.2, 158.8, 149.2, 133.0, 132.8, 131.7, 129.5, 128.0, 127.9, 127.6, 
127.0, 126.1, 125.9, 113.9, 71.5, 52.9, 52.1, 39.8, 28.6; HRMS (+ESI) calcd. for C19H17O5 
(M+H)+ 325.1071 found 325.1075; HPLC analysis: 94% ee (Phenomenex Lux Cellulose-1, n-
heptane: i-Propanol = 95:5, 1.0 mL/min, λ = 215 nm, 30 min, tR = 16.11 min, major; tR = 22.78 
min, minor) 
 
 
dimethyl (1S,5S,6R)-6-(4-nitrophenyl)-2-oxabicyclo[3.1.0]hex-3-ene-3,6-dicarboxylate (98g) 
 
According to GP-1 methyl furan-2-carboxylate (19) (250 mg, 2.0 mmol, 2.0 equiv) in dry 
toluene (2 mL) was cyclopropanated with diazo ester 97g (215 mg, 1.0 mmol, 1.0 equiv) in dry 
toluene (6 mL) and Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 0.1 mol%). The crude product was 
purified by flash chromatography (SiO2, hexanes/EtOAc, 3:1) to afford cyclopropane 98g as a 
yellowish solid (172 mg, 57% yield). 
m.p. 106-107 °C; Rf = 0.28 (hexanes: ethyl acetate = 3: 1, Vanillin); [α]D20 -211.8° (c = 1.0, 
CHCl3, 87% ee); IR (neat): 3105, 3070, 3004, 2956, 1700, 1592, 1495, 1435, 1308, 1246, 1148, 
1061, 1018, 977, 954, 885, 738, 701 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.22 – 8.10 (m, 2H), 
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7.48 – 7.35 (m, 2H), 6.13 (d, J = 3.0 Hz, 1H), 5.30 (d, J = 5.4 Hz, 1H), 3.65 (s, 3H), 3.62 (s, 
3H), 3.46 (dd, J = 5.4, 3.0 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 171.6, 158.5, 149.3, 147.4, 
137.4, 133.3, 123.4, 113.4, 71.1, 53.1, 52.3, 39.7, 28.0; HRMS (+ESI) calcd. for C15H14NO7 
(M+H)+ 320.0765 found 320.0767; HPLC analysis: 87% ee (Phenomenex Lux Cellulose-2, n-
heptane: i-Propanol = 70:30, 0.5 mL/min, λ = 254 nm, 60 min, tR = 24.96 min, major; tR = 36.80 
min, minor). 
 
 
dimethyl (1S,5S,6S)-2-oxabicyclo[3.1.0]hex-3-ene-3,6-dicarboxylate (83)  
 
According to GP-1 methyl furan-2-carboxylate (19) (251 mg, 2.0 mmol, 2.0 equiv) was 
cyclopropanated with diazo ester 79 (290 mg, 35 wt % in pentane, 1.0 mmol, 1.0 equiv) in 
1.8 mL dry hexanes and Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 0.1 mol%). The crude product 
was purified by flash chromatography (SiO2, hexanes/EtOAc, 14:1 → 5:1) to afford 
cyclopropane 83 as a white solid (73 mg, 36% yield).  
Spectroscopic data matched well with those reported in literature.21  
1H NMR (300 MHz, CDCl3) δ 6.38 (d, J = 2.9 Hz, 1H), 4.97 (dd, J = 5.3, 1.0 Hz, 1H), 3.80 (s, 
3H), 3.70 (s, 3H), 2.86 (ddd, J = 5.5, 2.8, 2.8 Hz, 1H), 1.17 (dd, J = 2.7, 1.0 Hz, 1H). HPLC 
analysis: 8% ee (Phenomenex Lux Cellulose-2, n-heptane: i-Propanol = 99:1, 1.0 mL/min, λ = 
254 nm, 70 min, tR = 41.29 min, major; tR = 48.23 min, minor). 
 
 
dimethyl (1S,5S,6R)-6-phenyl-2-oxabicyclo[3.1.0]hex-3-ene-4,6-dicarboxylate (108) 
 
According to GP-1 methyl furan-3-carboxylate (105) (254 mg, 2.0 mmol, 2.0 equiv) was 
cyclopropanated with diazo ester 97a (177 mg, 1.0 mmol, 1.0 equiv) in 2 mL dry hexanes and 
Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 0.1 mol%). The crude product was purified by flash 
chromatography (SiO2, hexanes/EtOAc, 19:1 → 5:1) to afford cyclopropane 108 as a white 
solid (201 mg, 73% yield). The enantioselectivity was enriched to 99% ee by recrystallization 
in refluxing methanol. 
m.p. 100-101 °C; Rf = 0.20 (hexanes: ethyl acetate = 95: 5, Vanillin); [α]D20 -138.5° (c = 1.0, 
CHCl3, 99% ee); IR (neat): 3109, 3030, 2956, 2848, 2363, 1711, 1607, 1498, 1439, 1375, 1331, 
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1286, 1252, 1141 1100, 1006, 969, 910, 850, 794, 753, 701 cm-1; 1H-NMR (300 MHz, CDCl3): 
δ 7.29 – 7.22 (m, 3H), 7.18 – 7.12 (m, 2H), 6.68 (d, J = 0.6 Hz, 1H), 5.29 (dd, J = 5.7, 0.8 Hz, 
1H), 3.69 (s, 3H), 3.60 (s, 3H), 3.54 (d, J = 5.7 Hz, 1H); 13C-NMR (75 MHz, CDCl3): δ 172.9, 
164.1, 156.3, 132.2, 129.6, 128.2, 127.8, 113.8, 72.5, 52.8, 51.5, 36.9, 28.2; HRMS (+ESI) 
calcd. for C15H15O5 (M+H)
+ 275.0914 found 275.0921; HPLC analysis: 99% ee (Phenomenex 
Lux Cellulose-1, n-heptane: i-Propanol = 95:5, 1.0 mL/min, λ = 215 nm, 30 min, tR = 8.46 min, 
major; tR = 10.03 min, minor). 
 
 
methyl (1S,5S,6R)-6-phenyl-2-oxabicyclo[3.1.0]hex-3-ene-6-carboxylate (109) 
 
According to GP-1 furan (14) (136 mg, 2.0 mmol, 2.0 equiv) was cyclopropanated with diazo 
ester 97a (176 mg, 1.0 mmol, 1.0 equiv) in 2 mL dry hexanes and Rh2(S-TCPTTL)4 (1.8 mg, 
1.0 µmol, 0.1 mol%). The crude product was purified by flash chromatography (SiO2, 
hexanes/EtOAc, 5:1) to afford cyclopropane 109 as a white solid (155 mg, 72% yield). The 
enantioselectivity was enriched to 99% ee by recrystallization in refluxing methanol. 
Spectroscopic data matches well with those reported in the literature for (rac)-109.22 
m.p. 72-73 °C; Rf = 0.35 (hexanes: ethyl acetate = 5: 1, Vanillin); [α]D20 -105.1° (c = 0.10, 
CHCl3, 74% ee); IR (neat): 3105, 3004, 2956, 2844, 2102, 1990, 1700, 1592, 1495, 1435, 1308, 
1255, 1148, 1051, 1018, 977, 954, 835, 738, 701 cm-1; 1H-NMR (300 MHz, CDCl3): δ 7.33 – 
7.24 (m, 3H), 7.22 – 7.16 (m, 2H), 5.91 (dd, J = 2.6, 0.6 Hz, 1H), 5.23 (dd, J = 2.6, 2.6 Hz, 1H), 
5.14 (dd, J = 5.6, 0.7 Hz, 1H), 3.62 (s, 3H), 3.31 (dd, J = 5.6, 2.7 Hz, 1H); 13C-NMR (75 MHz, 
CDCl3): δ 173.9, 147.4, 132.7, 130.7, 127.8, 127.3, 104.0, 70.8, 52.6, 39.3, 27.8; HRMS 
(+APCI) calcd. for C13H13O3 (M+H)
+ 217.0859 found 217.0861; HPLC analysis: 74% ee 
(Phenomenex Lux Cellulose-1, n-heptane: i-Propanol = 99:1, 1.0 mL/min, λ = 215 nm, 60 min, 
tR = 8.22 min, major; tR = 9.29 min, minor). 
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Methyl (1R,1aS,6bS)-1-phenyl-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-1-carboxylate 
(110) 
 
According to GP-1 benzofuran (106) (236 mg, 2.0 mmol, 2.0 equiv) was cyclopropanated with 
diazo ester 97a (176 mg, 1.0 mmol, 1.0 equiv) in 2 mL dry hexanes and Rh2(S-TCPTTL)4 (1.8 
mg, 1.0 µmol, 0.1 mol%). The crude product was purified by flash chromatography (SiO2, 
hexanes/EtOAc, 9:1) to afford cyclopropane 110 as a white solid (243 mg, 91% yield). 
m.p. 122 °C; Rf = 0.46 (hexanes: ethyl acetate = 5:1, Vanillin); [α]D20 -119.2° (c = 0.5, CHCl3, 
27% ee); IR (neat): 3053, 2952, 2848, 1703, 1619, 1595, 1465, 1439, 1323, 1260, 1252, 1156, 
1088, 1029, 965, 894, 854, 813, 753, 697 cm-1; 1H-NMR (300 MHz, CDCl3): δ 7.38 (dd, J = 
7.3, 1.4 Hz, 1H), 7.14 – 7.05 (m, 5H), 6.95 – 6.88 (m, 1H), 6.82 (td, J = 7.4, 1.1 Hz, 1H), 6.50 
– 6.46 (m, 1H), 5.40 (d, J = 5.5 Hz, 1H), 3.82 (d, J = 5.5 Hz, 1H), 3.67 (s, 3H); 13C-NMR (75 
MHz, CDCl3): δ 173.4, 159.5, 132.6, 129.6, 128.1, 127.6, 127.2, 126.5, 125.1, 121.2, 109.7, 
70.5, 52.8, 37.4, 30.9; HRMS (+APCI) calcd. for C17H15O3 (M+H)
+ 267.1016 found 267.1017; 
HPLC analysis: 27% ee (Phenomenex Lux Cellulose-1, n-heptane: i-Propanol = 90:10, 1.0 
mL/min, λ = 215 nm, 20 min, tR = 5.86 min, major; tR = 7.23 min, minor) 
 
 
dimethyl (1S,5S,6R)-6-phenyl-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate (119a) 
 
According to GP-2 pyrrole (113a) (250 mg, 2.0 mmol, 2.0 equiv) was cyclopropanated with 
diazo ester 97a (176 mg, 1.0 mmol, 1.0 equiv) and Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 0.1 
mol%). The crude product was purified by flash chromatography (SiO2, hexanes/EtOAc, 5:1) 
to afford cyclopropane 119a as a white solid (26 mg, 8% yield). 
m.p. 113-115°C; Rf = 027 (hexanes : ethyl acetate = 5:1, Vanillin); [α]D20 -47.6° (c = 0.3 
,CHCl3, 7% ee); IR (neat): 3116, 3060, 3030, 2956, 1707, 1592, 1498, 1446, 1398, 1334, 1245, 
1193, 1144, 1059, 1006, 973, 891, 854, 805, 755, 705 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.29 
– 7.22 (m, 3H), 7.14 – 7.02 (m, 2H), 6.19 – 5.97 (m, 1H), 5.27 – 5.15 (m, 1H), 4.78 – 4.61 (m, 
1H), 3.92 – 3.72 (m, 3H), 3.65 – 3.60 (m, 3H), 3.37 – 3.30 (m, 1H); 13C NMR (101 MHz, 
CDCl3) δ 173.9, 173.7, 152.9, 132.6, 132.3, 131.0, 130.9, 130.8, 129.9, 128.1, 127.9, 127.5, 
E Experimental part 
92 
127.4, 108.5, 108.4, 53.3, 53.3, 52.7, 52.6, 49.5, 49.3, 39.2, 38.1, 29.9, 29.6; HRMS (+ESI) 
calcd. for C15H15NO4 (M+H)
+ 274.1074 found 274.1076; HPLC analysis: 7% ee (Phenomenex 
Lux Cellulose-2, n-heptane: i-Propanol = 70:30, 0.5 mL/min, λ = 254 nm, 60 min, tR = 18.05 
min, major; tR = 30.14 min, minor). 
 
 
Trimethyl-rel-(1S,2S,3R,4S,6S,7R)-3,7-diphenyl-5-azatricyclo[4.1.0.02,4]heptane-3,5,7-
tricarboxylate (120a) 
 
Double cyclopropanated pyrrole 120a (111 mg, 26% yield) was obtained as a side product of 
119a following GP-2. The crude mixture was purified by flash chromatography (SiO2, 
hexanes/EtOAc, 5:1) to obtain 120a as a white solid. 
m.p. 203-205 °C; Rf = 0.13 (hexanes : ethyl acetate = 5:1, Vanillin); IR (neat): 3064, 3030, 
2956, 2363, 2255, 1703, 1498, 1454, 1409, 1331, 1323, 1238, 1129, 1077, 1029, 989, 910, 865, 
790, 727, 699 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.44 – 7.32 (m, 6H), 7.29 – 7.17 (m, 4H), 
3.84 – 3.77 (m, 3H), 3.57 – 3.47 (m, 6H), 3.12 – 2.96 (m, 2H), 2.66 – 2.58 (m, 2H); 13C NMR 
(75 MHz, CDCl3) δ 171.7, 171.5, 155.9, 131.6, 131.6, 131.5, 131.3, 128.8, 128.6, 127.9, 127.8, 
53.1, 52.7, 52.7, 48.1, 47.8, 37.7, 37.4, 33.2, 32.1; HRMS (+ESI) calcd. for C24H24NO6 (M+H)
+ 
422.1598 found 422.1608. 
 
 
6-methyl 2-(p-tolyl) (1S,5S,6R)-6-phenyl-2-azabicyclo[3.1.0]hex-3-ene-2,6-dicarboxylate 
(119b) 
 
According to GP-2 pyrrole 113b (402 mg, 2.0 mmol, 2.0 equiv) was cyclopropanated with 
diazo ester 97a (176 mg, 1.0 mmol, 1.0 equiv) and Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 
0.1 mol%). The crude product was purified by flash chromatography (SiO2, hexanes/EtOAc, 
5:1) to afford cyclopropane 119b as a sticky colorless oil (141 mg, 40% yield). 
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Rf = 0.33 (hexanes : ethyl acetate = 5:1, Vanillin); [α]D20 -236.4 (c = 1.0, CHCl3, 57% ee); IR 
(neat): 3034, 2952, 2363, 2255, 1707, 1595, 1510, 1402, 1334, 1245, 1200, 1167, 1118, 1003, 
965, 906, 861, 723 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.27 (m, 3H), 7.25 – 7.11 (m, 
5H), 6.98 – 6.93 (m, 1H), 6.27 – 6.19 (m, 1H), 5.38 – 5.29 (m, 1H), 4.91 – 4.79 (m, 1H), 3.67 
– 3.63 (m, 3H), 3.45 – 3.37 (m, 1H), 2.41 – 2.34 (m, 3H); 13C NMR (101 MHz, CDCl3) δ 173.7, 
173.5, 151.0, 150.9, 148.4, 148.4, 135.7, 135.6, 132.7, 132.4, 130.9, 130.9, 130.8, 130.1, 130.1, 
130.0, 128.2, 128.1, 127.7, 127.6, 121.2, 109.4, 109.3, 52.8, 52.7, 49.5, 49.4, 39.1, 38.1, 30.6, 
30.2, 20.9, 20.9; HRMS (+APCI) calcd. for C21H20NO4 (M+H)
+ 350.1387 found 350.1392; 
HPLC analysis: 57% ee (Phenomenex Lux Cellulose-2, n-heptane: i-Propanol = 70:30, 0.5 
mL/min, λ = 254 nm, 40 min, tR = 16.74 min, major; tR = 23.26 min, minor). 
 
 
3,7-dimethyl 5-(p-tolyl)-rel- (1S,2S,3R,4S,6S,7R)-3,7-diphenyl-5-azatricyclo[4.1.0.02,4] 
heptane-3,5,7-tricarboxylate (120b) 
 
Double cyclopropanated pyrrole 120b (136 mg, 27% yield) was obtained as a side product of 
119b following GP-2. The crude mixture was purified by flash chromatography (SiO2, 
hexanes/EtOAc, 5:1→2:1) to obtain 120b as a white solid. 
m.p. 223-225 °C; Rf = 0.15 (hexanes : ethyl acetate = 5:1, Vanillin); IR (neat): 3407, 3060, 
3034, 2956, 1715, 1603, 1510, 1416, 1323, 1238, 1200, 1167, 1118, 1081, 969, 738, 705 cm-1; 
1H NMR (300 MHz, CDCl3) δ 7.50 – 7.32 (m, 10H), 7.25 – 7.18 (m, 2H), 7.05 – 6.98 (m, 2H), 
3.58 – 3.50 (m, 6H), 3.28 – 3.13 (m, 2H), 2.77 – 2.68 (m, 2H), 2.37 (s, 3H); 13C NMR (75 
MHz, CDCl3) δ 171.6, 171.4, 153.9, 148.54 135.5, 131.7, 131.6, 131.5, 131.4, 130.0, 128.9, 
128.7, 128.1, 128.0, 121.2, 52.8, 52.7, 48.1, 37.9, 37.7, 33.2, 32.3, 20.9; HRMS (+ESI) calcd. 
for C30H28NO6 (M+H)
+ 498.1911 found 498.1917. 
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methyl (1S,5S,6R)-6-phenyl-2-tosyl-2-azabicyclo[3.1.0]hex-3-ene-6-carboxylate (119c) 
 
According to GP-2 pyrrole 113c (442 mg, 2.0 mmol, 2.0 equiv) was cyclopropanated with 
diazo ester 97a (176 mg, 1.0 mmol, 1.0 equiv) and Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 0.1 
mol%). The crude product was purified by flash chromatography (SiO2, hexanes/EtOAc, 5:1) 
to afford cyclopropane 119c as a white solid (226 mg, 61% yield). 
m.p. 120-122 °C; Rf = 0.21 (hexanes : ethyl acetate = 5:1, Vanillin); [α]D20-670.2° (c = 0.10, 
CHCl3); IR (neat): 3109, 3064, 3030, 2952, 2259, 1707, 1584, 1495, 1435, 1357, 1252, 1167, 
1137, 1077, 1051, 989, 910, 813, 727 cm-1; 1H-NMR (300 MHz, CDCl3): δ 7.73 – 7.68 (m, 
2H), 7.37 – 7.31 (m, 2H), 7.29 – 7.16 (m, 5H), 5.95 (dd, J = 3.9, 1.4 Hz, 1H), 5.28 (dd, J = 3.9, 
2.5 Hz, 1H), 4.53 (dd, J = 6.5, 1.4 Hz, 1H), 3.60 (s, 3H), 3.14 (dd, J = 6.5, 2.5 Hz, 1H), 2.45 (s, 
3H); 13C-NMR (75 MHz, CDCl3): δ 173.7, 144.4, 134.8, 132.5, 130.9, 130.4, 130.0, 127.8, 
127.5, 127.2, 111.4, 52.9, 52.2, 38.7, 28.0, 21.7; HRMS (+ESI) calcd. for C20H20NO4S (M+H)
+ 
370.1108 found 370.1112; HPLC analysis: >99% ee (Phenomenex Lux Cellulose-1, n-heptane: 
i-Propanol = 95:5, 0.5 mL/min, λ = 215 nm, 60 min, tR = 35.04 min (tR = 41.66 min)). 
 
 
Dimethyl-rel-(1R,2R,3S,4R,6R,7S)-3,7-diphenyl-5-tosyl-5-azatricyclo[4.1.0.02,4]heptane-3,7-
dicarboxylate (120c) 
Double cyclopropanated pyrrole 120c (80 mg, 15% yield) was obtained as a side product of 
119c following GP-2. The crude mixture was purified by flash chromatography (SiO2, 
hexanes/EtOAc, 5:1 → 2:1) to obtain 120c as a white solid. Analytical data were identical to 
those of its enantiomer and can be found in chapter E.3.4  
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HPLC analysis: 37 % ee (Phenomenex Lux Cellulose-1, n-heptane: i-Propanol = 70:30, 0.5 
mL/min, λ = 215 nm, 40 min, tR = 14.45 min, minor; tR = 19.35 min, major). 
 
              
methyl (1S,5S,6R)-2-(methylsulfonyl)-6-phenyl-2-azabicyclo[3.1.0]hex-3-ene-6-carboxylate 
(119d) 
dimethyl-rel-(1S,2S,3R,4S,6S,7R)-5-(methylsulfonyl)-3,7-diphenyl-5-azatricyclo[4.1.0.02,4] 
heptane-3,7-dicarboxylate (120d) 
 
According to GP-2 pyrrole 113d (290 mg, 2.0 mmol, 2.0 equiv) was cyclopropanated with 
diazo ester 97a (176 mg, 1.0 mmol, 1.0 equiv) and Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 0.1 
mol%). The crude product was purified by flash chromatography (SiO2, hexanes/EtOAc, 5:1) 
to afford a mixture of cyclopropane 119d and side product 120d (87 mg, ratio 119d/120d = 
1/0.85).  
Rf = 0.21 (hexanes : ethyl acetate = 3:1, Vanillin) (119d and 120d) 
HPLC analysis: 87% ee (Chiralpak AS-H, n-heptane: i-Propanol = 70:30, 0.5 mL/min, λ = 215 
nm, 60 min, tR = 24.47 min, minor; tR = 33.12 min, major) (119d) 
HPLC analysis: n.d. (Chiralpak AS-H, n-heptane: i-Propanol = 70:30, 0.5 mL/min, λ = 215 
nm, 60 min, tR = min, minor; tR = min, major) (120d) 
The analytical data of 119d and 120d are in accordance with those described below for 
(rac)-119d and (rac)-120d Because it was not feasible to separate 119d and 120d, 
determination of the enantiomeric excess was performed with a mixture of 119d and 120d. 
 
 
methyl-rel-(1S,5S,6R)-2-(methylsulfonyl)-6-phenyl-2-azabicyclo[3.1.0]hex-3-ene-6-
carboxylate ((rac)-119d) 
 
According to GP-4 pyrrole 113d (290 mg, 2.0 mmol, 2.0 equiv) was cyclopropanated with 
diazo ester 97a (178 mg, 1.0 mmol, 1.0 equiv), Cu(OTf)2 (21 mg, 58 µmol, 6 mol%) and 
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phenylhydrazine (7 µL, 71, µmol, 7 mol%). The crude product was purified by flash 
chromatography (SiO2, hexanes/EtOAc, 3:1) to afford cyclopropane (rac)-119d as a white solid 
(14 mg, 5% yield).  
m.p. 119-120 °C; Rf = 0.16 (hexanes : ethyl acetate = 3:1, Vanillin); IR (neat): 3474, 3064, 
3027, 2956, 2128, 1707, 1584, 1498, 1435, 1342, 1258, 1163, 1081, 1003, 958, 891, 760, 734, 
701 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.38 – 7.14 (m, 5H), 5.87 (dd, J = 3.9, 1.4 Hz, 1H), 
5.43 (dd, J = 3.8, 2.6 Hz, 1H), 4.69 (dd, J = 6.4, 1.3 Hz, 1H), 3.63 (s, 3H), 3.37 (dd, J = 6.4, 
2.5 Hz, 1H), 2.97 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 173.5, 132.5, 130.6, 130.2, 127.9, 
127.6, 111.9, 52.9, 52.3, 38.8, 38.6, 28.2; HRMS (+CI) calcd. for C14H16NO4S (M+H)
+ 
294.07946 found 294.07941. 
 
 
dimethyl-rel-(1S,2S,3R,4S,6S,7R)-5-(methylsulfonyl)-3,7-diphenyl-5-azatricyclo[4.1.0.02,4] 
heptane-3,7-dicarboxylate ((rac)-120d) 
 
According to GP-5 pyrrole 113d (290 mg, 2.0 mmol, 2.0 equiv) was cyclopropanated with 
diazo ester 97a (176 mg, 1.0 mmol, 1.0 equiv) and Rh2(OAc)4 (2.2 mg, 5.0 µmol, 0.5 mol%). 
The crude product was purified by flash chromatography (SiO2, hexanes/EtOAc, 3:1) to afford 
double cyclopropane (rac)-120d as a white solid (137 mg, 31% yield). 
m.p. 216-217 °C; Rf = 0.21 (hexanes : ethyl acetate = 3:1, Vanillin); IR (neat): 3034, 2956, 
2363, 2259, 1707, 1603, 1498, 1435, 1342, 1252, 1219, 1148, 1103, 1006, 962, 910, 857, 760, 
731 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.55 – 7.48 (m, 4H), 7.47 – 7.37 (m, 6H), 3.53 (s, 
6H), 3.22 (d, J = 7.0 Hz, 2H), 2.83 (s, 3H), 2.80 (d, J = 7.0 Hz, 2H); 13C NMR (75 MHz, CDCl3) 
δ 171.5, 132.1, 131.0, 128.6, 128.3, 52.9, 51.0, 42.6, 38.0, 32.7; HRMS (+ESI) calcd. for 
C23H24NO6S (M+H)
+ 442.1319 found 442.1329. 
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Methyl (1S,5S,6R)-2-(cyclohexylsulfonyl)-6-phenyl-2-azabicyclo[3.1.0]hex-3-ene-6-
carboxylate (119e) 
 
According to GP-2 pyrrole 113e (426 mg, 2.0 mmol, 2.0 equiv) was cyclopropanated with 
diazo ester 97a (176 mg, 1.0 mmol, 1.0 equiv) and Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 0.1 
mol%). The crude product was purified by flash chromatography (SiO2, hexanes/EtOAc, 5:1) 
to afford cyclopropane 119e as a sticky oil (147 mg, 41% yield). 
Rf = 0.33 (hexanes : ethyl acetate = 5:1, Vanillin); [α]D20 -388.2° (c = 0.50, CHCl3, 94% ee); 
IR (neat): 3054, 3033, 2937, 2859, 2262, 1707, 1584, 1498, 1455, 1435, 1334, 1252, 1156, 
1081, 999, 910, 783, 727 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.34 – 7.20 (m, 5H), 5.84 (dd, J 
= 3.9, 1.3 Hz, 1H), 5.28 (dd, J = 3.9, 2.6 Hz, 1H), 4.71 (dd, J = 6.7, 1.3 Hz, 1H), 3.61 (s, 3H), 
3.38 (dd, J = 6.7, 2.5 Hz, 1H), 3.09 (tt, J = 12.1, 3.4 Hz, 1H), 2.22 – 2.09 (m, 1H), 2.00 – 1.82 
(m, 3H), 1.76 – 1.66 (m, 1H), 1.61 – 1.45 (m, 2H), 1.36 – 1.17 (m, 3H); 13C NMR (75 MHz, 
CDCl3) δ 173.8, 132.6, 131.7, 130.5, 127.8, 127.5, 109.0, 63.0, 53.0, 52.8, 38.8, 27.7, 26.2, 
25.1, 25.0; HRMS (+ESI) calcd. for C19H24NO4S (M+H)
+ 362.1421 found 362.1426; HPLC 
analysis: 94% ee (Phenomenex Lux Cellulose-2, n-heptane: i-Propanol = 70:30, 0.5 mL/min, λ 
= 215 nm, 40 min, tR = 14.63 min, minor; tR = 17.70 min, major ) 
 
 
Dimethyl-rel-(1S,2S,3R,4S,6S,7R)-5-(cyclohexylsulfonyl)-3,7-diphenyl-5-
azatricyclo[4.1.0.02,4] heptane-3,7-dicarboxylate (120e) 
 
Double cyclopronated pyrrole 120e (106 mg, 21% yield) was obtained as a side product of 119e 
following GP-2. The crude mixture was purified by flash chromatography (SiO2, 
hexanes/EtOAc, 5:1) to obtain 120e as a white solid. 
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m.p. 215-216 °C; Rf = 0.15(hexanes : ethyl acetate = 5:1, Vanillin); IR (neat): 3038, 3008, 
2941, 2855, 1703, 1498, 1435, 1334, 1249, 1211, 1144, 1081, 1010, 962, 895, 857, 764, 731, 
705 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.57 – 7.49 (m, 4H), 7.48 – 7.35 (m, 10H), 3.52 (s, 
6H), 3.25 (d, J = 7.0 Hz, 2H), 2.99 – 2.85 (m, 1H), 2.81 (d, J = 6.9 Hz, 2H), 2.29 – 2.15 (m, 
1H), 1.97 – 1.84 (m, 1H), 1.73 – 1.47 (m, 3H), 1.36 – 1.09 (m, 5H); 13C NMR (75 MHz, CDCl3) 
δ 171.6, 132.0, 131.1, 128.5, 128.1, 64.0, 52.8, 52.4, 38.1, 32.7, 26.1, 26.1, 25.2, 25.0, 24.9; 
HRMS (+ESI) calcd. for C28H32NO6S (M+H)
+ 510.1945 found 510.1960 
 
 
methyl (1R,1aS,6bS)-1-phenyl-2-tosyl-1,1a,2,6b-tetrahydrocyclopropa[b]indole-1-
carboxylate (126) 
 
According to GP-2 indole 125 (542 mg, 2.0 mmol, 2.0 equiv) was cyclopropanated with diazo 
ester 97a (176 mg, 1.0 mmol, 1.0 equiv) and Rh2(S-TCPTTL)4 (1.8 mg, 1.0 µmol, 0.1 mol%). 
The crude product was purified by flash chromatography (SiO2, hexanes/EtOAc, 5:1) to afford 
cyclopropane 126 as a white solid (316 mg, 75% yield). 
m.p. 53-55 °C; Rf = 0.23 (hexanes: ethyl acetate = 5: 1, Vanillin); [α]D20 -82.2° (c = 0.10, 
CHCl3, 80% ee); IR (neat): 3060, 3030, 2952, 2113, 1711, 1599, 1461, 1435, 1361, 1252, 1167, 
1118, 992, 939, 883, 854, 813, 753, 701, 664 cm-1; 1H-NMR (300 MHz, CDCl3): δ 7.68 (d, J 
= 8.3 Hz, 2H), 7.32 (dd, J = 7.3, 1.2 Hz, 1H), 7.25 – 7.17 (m, 3H), 7.14 – 7.04 (m, J = 7.1 Hz, 
5H), 7.01 – 6.87 (m, 2H), 4.94 (d, J = 6.6 Hz, 1H), 3.66 (s, 3H), 3.61 (d, J = 6.6 Hz, 1H), 2.36 
(s, 3H); 13C-NMR (75 MHz, CDCl3): δ 173.3, 144.5, 141.3, 135.3, 132.4, 129.9, 129.5, 129.5, 
127.8, 127.6, 127.3, 126.9, 125.7, 123.6, 114.3, 53.1, 53.0, 35.2, 30.7, 21.6; HRMS (CI+) calcd. 
for C24H22NO4S (M+H)
+ 420.1264 found 420.1268; HPLC analysis: 80% ee (Phenomenex Lux 
Cellulose-1, n-heptane: i-Propanol = 95:5, 0.5 mL/min, λ = 215 nm, 60 min, tR = 24.13 min, 
major; tR = 46.16 min, minor). 
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3.4 Kinetic resolution experiments 
 
 
 
In a flame dried Schlenk flask, (rac)-119c (237 mg, 640 µmol, 1.0 equiv) and Rh2(S-TCPTTL)4 
(1.2 mg, 0.67µmol, 0.1 mol%) were dissolved in dry toluene (2 mL) and cooled to 0 °C. A 
solution of the diazo ester 97a (56 mg, 320 µmol, 0.5 equiv) in dry toluene (1 mL) was added 
using a syringe pump for the duration of 1 h. Afterward, the reaction mixture was stirred for 
further 5 min and concentrated under reduced pressure. The crude product was purified by flash 
chromatography (SiO2, hexanes/EtOAc, 4:1) to afford cyclopropane 119c (170 mg, 72% yield, 
29% ee) and double cyclopropane 120c (81 mg, 24%, 88% ee). 
 
 
 
a) In a flame dried Schlenk flask, 119c (75 mg, 203 µmol, 1.0 equiv, >99% ee) and 
Rh2(S-TCPTTL)4 (7.3 mg, 4.1 µmol, 2.0 mol%) were dissolved in dry toluene (1.5 mL) and 
cooled to 0 °C. A solution of the diazo ester 97a (36 mg, 203 µmol, 1.0 equiv) in dry toluene 
(1 mL) was added using a syringe pump for the duration of 1 h. Afterward, the reaction mixture 
was stirred for further 5 min and concentrated under reduced pressure. The crude product was 
purified by flash chromatography (SiO2, hexanes/EtOAc, 4:1) to afford cyclopropane 119c 
(22 mg, 29% yield, >99% ee) and double cyclopropane (ent)-120c (67 mg, 64%, >99% ee). 
b) a) In a flame dried Schlenk flask, 119c (75 mg, 203 µmol, 1.0 equiv, >99% ee) and 
Rh2(OAc)4 (1.8 mg, 4.1 µmol, 2.0 mol%) were dissolved in dry toluene (1.5 mL) and cooled to 
0 °C. A solution of the diazo ester 97a (36 mg, 203 µmol, 1.0 equiv) in dry toluene (1 mL) was 
added using a syringe pump for the duration of 1 h. Afterward, the reaction mixture was stirred 
for further 5 min and concentrated under reduced pressure. The crude product was purified by 
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flash chromatography (SiO2, hexanes/EtOAc, 4:1) to afford exclusively double cyclopropane 
(ent)-120c (96 mg, 91%, >99% ee). 
Analytical data of compound (ent)-120c: 
m.p. 173 °C decomposition; Rf = 0.09 (hexanes: ethyl acetate = 5:1, Vanillin); [α]D20 -131.6° 
(c = 0.5, CHCl3); IR (neat): 3064, 2997, 2952, 2359, 2113, 1976, 1707, 1599, 1498, 1435, 1349, 
1252, 1215, 1163, 1111, 1077, 1018, 965, 857, 734, 705 cm-1; 1H NMR (300 MHz, CDCl3) δ 
7.72 – 7.62 (m, 2H), 7.40 – 7.34 (m, 2H), 7.32 – 7.25 (m, 2H), 7.23 – 7.15 (m, 4H), 7.12 – 7.05 
(m, 4H), 3.51 (s, 6H), 3.31 (d, J = 7.1 Hz, 2H), 2.69 (d, J = 7.0 Hz, 2H), 2.53 (s, 3H); 13C NMR 
(75 MHz, CDCl3) δ 171.6, 143.8, 138.6, 131.9, 130.7, 130.0, 128.4, 127.8, 127.2, 52.8, 51.3, 
38.0, 32.5, 21.7; HRMS (+ESI) calcd. for C29H28NO6S (M+H)
+ 518.1632 found 518.1636; 
HPLC analysis: >99% ee (Phenomenex Lux Cellulose-1, n-heptane: i-Propanol = 70:30, 
0.5 mL/min, λ = 215 nm, 60 min, tR = 14.75 min) 
Analytical data of compound 119c can be found in chapter E.3.3  
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4 Synthesis of homo-β-proline derivative 147 
 
 
methyl (1S,5S,6R)-6-phenyl-2-tosyl-2-azabicyclo[3.1.0]hexane-6-carboxylate (144) 
 
A Schlenk flask was charged with 119c (211 mg, 571 µmol, 1.0 equiv), methanol (8 mL) and 
Pd/C (10 wt%, 30 mg Pd/C, 29 µmol Pd, 5 mol% Pd). The resulting solution was flushed with 
hydrogen gas for ten times (balloon, 1 atm) and stirred under hydrogen atmosphere at room 
temperature for 2.5 h. After completion the crude mixture was filtered through two consecutive 
folded filter and washed with methanol. The solvent was removed under vacuo and 144 (177 
mg, 84%) was obtained as a white solid. 
m.p. 140 °C; Rf = 0.28 (hexanes: ethyl acetate = 4: 1, Vanillin); [α]D20 -58.8° (c = 0.54, CHCl3); 
IR (neat): 3060, 3030, 2952, 2363, 2121, 1715, 1599, 1495, 1435, 1346, 1252, 1159, 1103, 
1014, 982, 872, 813, 731, 701, 664 cm-1; 1H-NMR (300 MHz, CDCl3): δ 7.75 – 7.70 (m, 2H), 
7.36 – 7.28 (m, 7H), 4.25 (d, J = 6.7 Hz, 1H), 3.57 (s, 3H), 3.24 – 3.13 (m, 1H), 2.49 – 2.45 (m, 
1H), 2.44 (s, 3H), 1.96 – 1.73 (m, 3H); 13C-NMR (75 MHz, CDCl3): δ 171.8, 143.6, 136.4, 
131.5, 131.2, 129.9, 128.6, 127.8, 127.0, 52.7, 51.8, 48.0, 37.1, 30.6, 25.0, 21.6; HRMS (+ESI) 
calcd. for C20H22NO4S (M+H)
+ 372.1264 found 372.1266. 
 
                   
methyl (R)-2-phenyl-2-((S)-1-tosylpyrrolidin-3-yl)acetate (145) 
methyl-rel-(S)-2-phenyl-2-(rel-(S)-1-tosylpyrrolidin-3-yl)acetate (146) 
 
In a round-bottom flask, cyclopropane 144 (131 mg, 351 µmol, 1.0 equiv) was dissolved in 
DCM (7 mL). Triethylsilane (168 µL, 1.1 mmol, 3.0 equiv) and trifluoroacetic acid (54 µL, 703 
µmol, 2.0 equiv) were added, and the solution was stirred at room temperature for 2 d. The 
solvent was evaporated under reduced pressure and the crude product (dr (145/146) = 83/17, 
crude 1H-NMR) was purified by flash chromatography (SiO2, hexanes/EtOAc, 4:1) to give main 
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diastereomer 145 (95 mg, 72%) as a white solid and minor diastereomer 146 (19 mg, 14%) as 
an off-white solid.  
Analytical data of compound 145 
m.p. 140 °C; Rf = 0.30 (hexanes: ethyl acetate = 4: 1, Vanillin); [α]D20 46,3 (c = 1.01, CHCl3, 
99% ee); IR (neat): 3064, 3030, 2952, 2878, 2363, 1733, 1599, 1495, 1454, 1342, 1215, 1122, 
1092, 1033, 824, 745, 709 cm-1; 1H-NMR (400 MHz, CDCl3): δ 7.62 (d, J = 8.2 Hz, 2H), 7.35 
– 7.27 (m, 5H), 7.21 – 7.16 (m, 2H), 3.61 (s, 3H), 3.42 (ddd, J = 9.8, 8.4, 3.9 Hz, 1H), 3.29 (d, 
J = 10.8 Hz, 1H), 3.22 (ddd, J = 9.8, 8.4, 7.5 Hz, 1H), 3.04 (dd, J = 9.7, 6.9 Hz, 1H), 2.84 – 
2.68 (m, 2H), 2.44 (s, 3H), 2.10 (dtd, J = 10.9, 6.9, 3.9 Hz, 1H), 1.59 – 1.48 (m, 1H); 13C-NMR 
(75 MHz, CDCl3): δ 173.1, 143.5, 136.9, 133.5, 129.7, 129.0, 128.0, 127.9, 127.5, 54.9, 52.2, 
51.1, 47.6, 41.7, 30.5, 21.6; HRMS (+ESI) calcd. for C20H24NO4S (M+H)
+ 374.1421 found 
374.1422; HPLC analysis: >99% ee (Phenomenex Lux Cellulose-2, n-heptane: i-Propanol = 
50:50, 0.5 mL/min, λ = 215 nm, 60 min, tR = 33.14 min, major). 
Analytical data of compound 146 
m.p. 122-123°C; Rf = 0.41 (hexanes: ethyl acetate = 4: 1, Vanillin); [α]D20 -17.9 (c = 0.54, 
CHCl3, 37% ee); IR (neat): 3064, 3030, 2952, 2878, 2356, 1730, 1599, 1495, 1454, 1342, 1223, 
1159, 1122, 1092, 1036, 819, 786, 735, 697, 673 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.72 (d, 
J = 8.1 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 7.30 – 7.25 (m, 3H), 7.20 -7.15 (m, 2H), 3.63 (s, 3H), 
3.54 (dd, J = 10.0, 7.5 Hz, 1H), 3.34 (m, 1H), 3.27 (d, J = 11.1 Hz, 1H), 3.03 (m, 2H), 2.82 – 
2.72 (m, 1H), 2.45 (s, 3H), 1.59 – 1.49 (m, 1H + H2O-Peak), 1.38 – 1.28 (m, 1H); 13C NMR 
(101 MHz, CDCl3) δ 173.2, 143.5, 137.1, 133.6, 129.7, 128.9, 128.0, 127.8, 127.6, 55.0, 52.3 
(2 C), 47.3, 41.6, 29.3, 21.6; HRMS (+ESI) calcd. for C20H24NO4S (M+H)
+ 374.1421 found 
374.1426; HPLC analysis: 37% ee (Chiralpak AS-H, n-heptane: i-Propanol = 70:30, 0.5 
mL/min, λ = 215 nm, 60 min, tR = 41.96 min, minor; tR = 49.49 min, major).  
 
 
(R)-2-phenyl-2-((S)-pyrrolidin-3-yl)acetic acid (147) 
Under nitrogen atmosphere a flame dried heavy-wall Schlenk tube was charged with 145 (50 
mg, 134 µmol, 1.0 equiv), phenol (39 mg) and HBr in acetic acid (0.75 mL). The resulting 
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solution was stirred at 80 °C for 16 h. Afterwards, distilled water (0.75 mL) was added and the 
reaction mixture was stirred at 50 °C for 20 min. The solvent was evaporated under reduced 
pressure to yield 147 as TFA salt. To purify the crude product and remove the trifluoroacetate, 
the residue was loaded onto a column with Dowex 50WX8-400 (preactivated with 0.1 M HCl). 
The resin washed with water (300 mL) and subsequently eluted with aqueous ammonia solution 
(15%) to afford 147 (27 mg, quant.) as an off-white solid.  
m.p. >250 °C (limit of detection); Rf = 0.72 (methanol, ninhydrin); [α]D20 40.0° (c = 1.02, H2O); 
IR (neat): 2952, 2714, 2617, 2363, 2113, 1644, 1566, 1491, 1457, 1375, 1245, 1171, 1111, 
1074, 1006, 980, 910, 731, 700 cm-1; 1H NMR (400 MHz, D2O) δ 7.30 – 7.16 (m, 5H), 3.35 – 
3.13 (m, 3H), 3.01 – 2.81 (m, 2H), 2.62 (dd, J = 11.3, 8.7 Hz, 1H), 2.25 – 2.13 (m, 1H), 1.71 – 
1.57 (m, 1H); 13C NMR (101 MHz, D2O) δ 180.1, 139.5, 129.0, 127.8, 127.5, 58.5, 48.3, 45.4, 
40.8, 29.3; HRMS (-ESI) calcd. for C12H14NO2 (M-H)
- 204.1030 found 204.1033. 
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5 Synthesis of paraconic acid derivatives 
 
Trisubstituted γ-butyrolactones 166a/b were synthesized according to a protocol that was 
recently developed by the Reiser group for the synthesis of disubstituted γ-butyrolactones.19 
Starting from cyclopropanes 98a/b, paraconic acid derivatives 176a and 179a/b were 
synthesized in 5 consecutive steps without purification of the intermediates. 
  
5.1 Enantioselective synthesis of paraconic acid derivatives 176a and 179a 
 
 
 
(2S,3R,4S)-5-oxo-4-phenyl-2-propyltetrahydrofuran-3-carboxylic acid (176a) 
 
a) Overview of consecutive steps 
 
 
b) Procedure 
1) A flame dried Schlenk tube was charged with cyclopropane 98a (1.5 g, 5.47 mmol, 1.0 equiv) 
and anhydrous DCM (18 ml). The reaction was cooled to -78 °C and ozone was passed through 
the reaction mixture until a blue color appeared. Excess of ozone was expelled by passing a 
constant stream of oxygen through the solution until it turned colorless. The stream of oxygen 
continued for further 5 min and DMS (2.0 ml, 27.4 mmol, 5.0 equiv) was added. The reaction 
mixture was allowed to warm up to room temperature overnight in an unfreezing cooling bath. 
The solution was washed with sat. NaHCO3 (8 ml) and water (8 ml). After drying over Na2SO4 
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and filtration, the solvent was removed under reduced pressure to afford crude 168a (1.46 g, 
87% crude yield) as a sticky yellow oil.  
2) In a flame dried Schlenk flask crude aldehyde 168a (theoretical: 1.46 g, 4.77 mmol, 1.0 
equiv) was dissolved in dry DCM (30 mL) and the solution was cooled to -78 °C. Boron 
trifluoride diethyl etherate (0.68 mL, 5.48 mmol, 1.15 equiv) was added, and the reaction 
mixture was stirred for 30 min. Subsequently, allyltrimethylsilane (0.98 mL, 6.2 mmol, 1.3 
equiv) was added, and the resulting solution was stirred for 18 h. The reaction was stopped with 
sat. NaHCO3 (10 mL) and allowed to warm up to rt. The phases were separated, and the aqueous 
phase was extracted with DCM (3 x 20 mL). After drying over MgSO4 and filtration, the solvent 
was removed under reduced pressure to afford crude 169a (1.55 g, 93% crude yield) as a sticky 
yellow oil.  
3) A solution of crude allyl 169a (theoretical: 0.29 g, 0.84 mmol, 1.0 equiv) in methanol (5 mL) 
was cooled to 0 °C. Subsequently, triethylamine (0.29 mL, 2.09 mmol, 2.5 equiv) in methanol 
(1.5 mL) was added using a syringe pump for the duration of 2 h, and the solution was stirred 
for 14 h in the unfreezing cooling bath. After removal of the solvent in vacuo, the residue was 
treated with water (5 mL) and DCM (5 mL). The phases were separated, and the aqueous layer 
was extracted with DCM (6x5 mL). After drying over Na2SO4 and filtration, the volatiles were 
removed under reduced pressure (crude yield (166a) > 100%). 
4) A Schlenk flask was charged with crude 166a (theoretical: 192 mg, 0.83 mmol, 1.0 equiv), 
methanol (10 mL) and Pd/C (10 wt %, 18 mg Pd/C, 17 µmol Pd, 2 mol% Pd). The resulting 
solution was flushed with hydrogen gas for ten times (balloon, 1 atm) and stirred under 
hydrogen atmosphere at room temperature for 5 h. After completion, the crude mixture was 
filtered through two consecutive folded filter and washed with methanol, and the solvent was 
removed under reduced pressure. 
5) A round-bottom flask was charged with crude 174a (theoretical: 193 mg, 0.83 mmol, 1.0 
equiv), BAIB (0.59 g, 1.83 mmol, 2.2 equiv), TEMPO (26 mg, 0.17 mmol, 0.2 equiv) and a 
mixture of acetonitrile and water (1:1, 4 mL). The reaction mixture was stirred at rt for 20 h. 
Subsequently, a solution of Na2SO3 (0.13 g) in water (1 mL) was added, and stirring was 
continued for additional 30 min before the reaction mixture was acidified to pH 2 by the 
addition of aqueous HCl (1 M). The mixture was extracted with ethyl acetate (5×10 ml), and 
the combined organic layers were consecutively washed with brine (10 mL) and water (10 mL), 
dried over Na2SO4 and filtered. The solvent was evaporated under reduced pressure, and the 
crude product was purified by flash chromatography (SiO2, hexanes/EtOAc, 2:1 + 1% formic 
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acid) to afford 176a (47 mg, 18.5% yield over 5 steps starting from cyclopropane 98a) as a 
white solid. 
 
c) Characterization of 176a 
m.p. 130-131 °C; Rf = 0.35 (hexanes : ethyl acetate = 2:1 + 1% acetic acid, bromocresol green); 
[α]D20 33.9(c =1.0, CHCl3); IR (neat): 3034, 2960, 2878, 1748, 1722, 1502, 1454, 1394, 1349, 
1312, 1223, 1170, 1122, 1096, 1018, 977, 924, 861, 805, 746, 693 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 10.36 (bs, 1H), 7.41 – 7.30 (m, 3H), 7.28 – 7.21 (m, 2H), 4.57 (td, J = 8.6, 3.9 Hz, 
1H), 4.25 (d, J = 11.4 Hz, 1H), 3.22 (dd, J = 11.4, 9.3 Hz, 1H), 1.96 – 1.75 (m, 2H), 1.69 – 1.44 
(m, 2H), 1.00 (t, J = 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 175.8, 174.6, 134.9, 129.1, 
128.3, 128.3, 79.4, 55.0, 50.6, 37.0, 18.7, 13.7; HRMS (-ESI) calcd. for C14H15O4 (M-H)
- 
247.0976 found 247.0982; HPLC analysis: >99% ee (Chiralpak AS-H, n-heptane: i-Propanol 
= 90:10, 1.0 mL/min, λ = 215 nm, 60 min, tR = 26.94 min) 
 
 
 
(2S,3R,4S)-5-oxo-4-phenyl-2-tridecyltetrahydrofuran-3-carboxylic acid (179a) 
 
a) Overview of consecutive steps: 
 
 
b) Procedure: 
1) A flame dried Schlenk tube was charged with cyclopropane 98a (2.0 g, 7.29 mmol, 1.0 equiv) 
and anhydrous DCM (18 ml). The reaction was cooled to -78 °C and ozone was passed through 
the reaction mixture until a blue color appeared. Excess of ozone was expelled by passing a 
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constant stream of oxygen through the solution until it turned colorless. The stream of oxygen 
continued for further 5 min and DMS (2.7 ml, 36.5 mmol, 5.0 equiv) was added. The reaction 
mixture was allowed to warm up to room temperature overnight in an unfreezing cooling bath. 
The solution was washed with sat. NaHCO3 (10 ml) and water (10 ml). After drying over 
Na2SO4 and filtration, the solvent was removed under reduced pressure to afford crude 168a 
(1.85 g, 83% crude yield) as a sticky yellow oil.  
2) In a flame dried Schlenk flask crude aldehyde 168a (theoretical: 1.85 g, 6.04 mmol, 1.0 
equiv) was dissolved in dry DCM (35 mL) and the solution was cooled to -78 °C. Boron 
trifluoride diethyl etherate (0.86 mL, 6.95 mmol, 1.15 equiv) was added, and the reaction 
mixture was stirred for 30 min. Subsequently, allyltrimethylsilane (1.25 mL, 7.85 mmol, 1.3 
equiv) was added, and the resulting solution was stirred for 18 h. The reaction was stopped with 
sat. NaHCO3 (10 mL) and allowed to warm up to rt. The phases were separated, and the aqueous 
phase was extracted with DCM (3 x 20 mL). After drying over MgSO4 and filtration, the solvent 
was removed under reduced pressure to afford crude 169a (2.03 g, 97% crude yield) as a sticky 
yellow oil.  
3) A solution of crude allyl 169a (theoretical: 2.03 g, 5.82 mmol, 1.0 equiv) in methanol (30 
mL) was cooled to 0 °C. Subsequently, triethylamine (2.03 mL, 14.54 mmol, 2.5 equiv) was 
added using a syringe pump for the duration of 2 h, and the solution was stirred for 14 h in the 
unfreezing cooling bath. After removal of the solvent in vacuo, the residue was treated with 
water (20 mL) and DCM (20 mL). The phases were separated, and the aqueous layer was 
extracted with DCM (6x10 mL). After drying over Na2SO4 and filtration, the volatiles were 
removed under reduced pressure (crude yield (166a) > 100%). 
4) A flame dried Schlenk flask was charged with crude lactone 166a (theoretical: 1.35 g, 5.86 
mmol, 1.0 equiv) and anhydrous DCM (50 mL, bubbling nitrogen through the solvent for 10 
min before use). Afterward, Grubbs II (0.25 g, 0.29 mmol, 5 mol%) and 1-dodecene (7.8 mL, 
35.18 mmol, 6.0 equiv) were added and the solution was refluxed for 16 h. After removal of 
the solvent under reduced pressure the crude mixture was dissolved in methanol (40 mL). The 
reaction mixture was vigorously stirred in an autoclave at rt for 24 h under 20 atm of hydrogen 
gas. The crude mixture was filtered (removal of tetracosane), washed with methanol the solvent 
was removed under reduced pressure. (crude yield (178a) > 100%) 
5) A round-bottom flask was charged with crude 178a (theoretical: 2.18 g, 5.86 mmol, 1.0 
equiv), BAIB (4.15 g, 12.87 mmol, 2.2 equiv), TEMPO (183 mg, 1.17 mmol, 0.2 equiv) and a 
mixture of acetonitrile and water (1:1, 30 mL). The reaction mixture was stirred at rt for 48 h. 
Subsequently, a solution of Na2SO3 (1.5 g) in water (10 mL) was added, and stirring was 
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continued for additional 30 min before the reaction mixture was acidified to pH 2 by the 
addition of aqueous HCl (1 M). The mixture was extracted with ethyl acetate (3×30 ml), and 
the combined organic layers were consecutively washed with brine (15 mL) and water (15 mL), 
dried over Na2SO4 and filtered. The solvent was evaporated under reduced pressure, and the 
crude product was purified by flash chromatography (SiO2, hexanes/EtOAc, 5:1 + 1% formic 
acid) and recrystallized in refluxing methanol to afford 179a (432 mg, 1.11 mmol, 15.2% yield 
over 5 steps starting from cyclopropane 98a) as a white solid. 
c) Characterization of 179a: 
m.p. 75-76 °C; Rf = 0.51 (hexanes : ethyl acetate = 5:1 + 1% formic acid, bromocresol 
green); [α]D20 10.4° (c = 1.0, CHCl3, 99% ee); IR (neat): 3034, 2919, 2851, 2363, 2110, 1744, 
1729, 1498, 1454, 1424, 1364, 1323, 1234, 1170, 1003, 921, 874, 753, 727, 693 cm-1; 1H-
NMR (300 MHz, CDCl3): δ 7.42 – 7.31 (m, 3H), 7.29 – 7.22 (m, 2H), 4.56 (td, J = 8.6, 3.8 
Hz, 1H), 4.25 (d, J = 11.4 Hz, 1H), 3.21 (dd, J = 11.4, 9.3 Hz, 1H), 1.99 – 1.73 (m, 2H), 1.67 
– 1.42 (m, J = 9.5 Hz, 2H), 1.41 – 1.18 (m, 20H), 0.89 (t, J = 6.6 Hz, 3H); 13C-NMR (75 
MHz, CDCl3): δ 175.8, 174.6, 134.8, 129.1, 128.3, 128.3, 79.6, 55.0, 50.6, 35.0, 31.9, 29.7, 
29.7 (2C) 29.6, 29.5, 29.4, 29.4, 29.3, 25.3, 22.7, 14.2; HRMS (-ESI) calcd. for C24H35O4 (M-
H)- 387.2541 found 387.2555 
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5.2 Racemic synthesis of paraconic acid derivatives 179b, 180a and 181b 
 
 
 
rel-(2S,3R,4S)-4-(4-methoxyphenyl)-5-oxo-2-tridecyltetrahydrofuran-3-carboxylic acid 
(179b) 
 
a) Overview of consecutive steps: 
 
 
b) Procedure 
 
1) A flame dried Schlenk tube was charged with (rac)-98b (2.42 g, 7.95 mmol, 1.0 equiv) and 
anhydrous DCM (20 ml). The reaction was cooled to -78 °C and ozone was passed through the 
reaction mixture until a blue color appeared. Excess of ozone was expelled by passing a constant 
stream of oxygen through the solution until it turned colorless. The stream of oxygen continued 
for further 5 min and DMS (2.9 ml, 39.76 mmol, 5.0 equiv) was added. The reaction mixture 
was allowed to warm up to room temperature overnight in an unfreezing cooling bath. The 
solution was washed with sat. NaHCO3 (8 ml) and water (8 ml). After drying over MgSO4 and 
filtration, the solvent was removed under reduced pressure to afford crude 168b (2.36 g, 88% 
crude yield) as a sticky yellow oil  
2) In a flame dried Schlenk flask crude aldehyde 168b (theoretical: 2.36 g, 7.0 mmol, 1.0 equiv) 
was dissolved in dry DCM (50 mL) and the solution was cooled to -78 °C. Boron trifluoride 
diethyl etherate (0.99 mL, 8.0 mmol, 1.15 equiv) was added, and the reaction mixture was 
stirred for 30 min. Subsequently, allyltrimethylsilane (1.4 mL, 9.1 mmol, 1.3 equiv) was added, 
and the resulting solution was stirred for 18 h. The reaction was stopped with sat. NaHCO3 (15 
mL) and allowed to warm up to rt. The phases were separated, and the aqueous phase was 
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extracted with DCM (3 x 20 mL). After drying over Na2SO4 and filtration, the solvent was 
removed under reduced pressure to afford crude 169b (2.48 g, 94% crude yield) as a sticky 
yellow oil.  
3) A solution of crude allyl 169b (theoretical: 2.48 g, 6.6 mmol, 1.0 equiv) in methanol (23 mL) 
was cooled to 0 °C. Subsequently, triethylamine (2.3 mL, 16.4 mmol, 2.5 equiv) was added 
using a syringe pump for the duration of 2 h, and the solution was stirred for 18 h in the 
unfreezing cooling bath. After removal of the solvent in vacuo, the residue was treated with 
water (15 mL) and DCM (15 mL). The phases were separated, and the aqueous layer was 
extracted with DCM (7x12 mL). After drying over MgSO4 and filtration, the volatiles were 
removed under reduced pressure. Attempts were made to purify the residue by flash 
chromatography (SiO2, hexanes/EtOAc, 2:1) and afforded crude 166b (551 mg, 32% crude 
yield) as yellow oil. 
4)A flame dried Schlenk flask was charged with crude lactone 166b (theoretical: 226 mg, 0.87 
mmol, 1.0 equiv), anhydrous DCM (35 mL, bubbling nitrogen through the solvent for 10 min 
before use), Grubbs II (41 mg, 48 µmol, 6 mol%) and 1-dodecene (1.30 mL, 5.76 mmol, 6.6 
equiv). The resulting solution was refluxed for 16 h. After removal of the solvent under reduced 
pressure the crude mixture was dissolved in methanol (8 mL). The reaction mixture was 
vigorously stirred in an autoclave at rt for 24 h under 20 atm of hydrogen gas. The crude mixture 
was filtered (removal of tetracosane) and washed with methanol (crude yield (178b) > 100%).  
5) A round-bottom flask was charged with crude 178b (theoretical: 350 mg, 0.87 mmol, 1.0 
equiv), BAIB (616 mg, 1.91 mmol, 2.2 equiv), TEMPO (27 mg, 0.17 mmol, 0.2 equiv) and a 
mixture of acetonitrile and water (1:1, 30 mL). The reaction mixture was stirred at rt for 48 h. 
Subsequently, a solution of Na2SO3 (1.6 g) in water (2 mL) was added, and stirring was 
continued for additional 30 min before the reaction mixture was acidified to pH 2 by the 
addition of aqueous HCl (1 M). The mixture was extracted with ethyl acetate (3×30 ml), and 
the combined organic layers were consecutively washed with brine (2 mL) and water (2 mL), 
dried over Na2SO4 and filtered. The solvent was evaporated under reduced pressure, and the 
crude product was purified by flash chromatography (SiO2, hexanes/EtOAc, 2:1 + 1% formic 
acid) and recrystallization in refluxing methanol to afford 179b (138 mg, 0.33 mmol, 10.0% 
yield over 5 steps starting from cyclopropane 98b) as a white solid 
 
c) Characterization 
m.p. 107-109 °C; Rf = 0.43 (hexanes : ethyl acetate = 2:1 + 1% formic acid, bromocresol green); 
IR (neat): 3004, 2919, 2851, 1737, 1618, 1521, 1469, 1349, 1290, 1264, 1167, 1029, 977, 865, 
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824, 723, 682 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.19 – 7.13 (m, 2H), 6.93 – 6.87 (m, 2H), 
4.54 (td, J = 8.7, 3.6 Hz, 1H), 4.19 (d, J = 11.4 Hz, 1H), 3.79 (s, 3H), 3.16 (dd, J = 11.1, 9.6 
Hz, 1H), 1.95 – 1.74 (m, 2H), 1.62 – 1.43 (m, 2H), 1.37 – 1.19 (m, 20H), 0.89 (t, J = 6.6 Hz, 
3H); 13C NMR (101 MHz, CDCl3) δ 175.7, 174.9, 159.5, 129.5, 126.9, 114.5, 79.5, 55.3, 55.1, 
50.1, 35.0, 32.0, 29.7, 29.7 (2C), 29.6, 29.5, 29.4, 29.4, 29.3, 25.3, 22.7, 14.1; HRMS (-ESI) 
calcd. for C25H37O5 (M-H)
- 417.2646 found 417.2656. 
 
 
 
Methyl- rel-(2S,3R,4S)-5-oxo-4-phenyl-2-tridecyltetrahydrofuran-3-carboxylate (180a) 
 
A solution of acid (rac)-179 (51 mg, 0.13 mmol, 1.0 equiv) in methanol (3 mL) was treated 
with sulfuric acid (3 drops) and the reaction mixture was stirred for 5 h at room temperature. 
After removal of the solvent under vacuo, the residue was treated with water (6 mL) and diethyl 
ether (10 mL). The phases were separated and the aqueous layer was extracted with diethyl 
ether (3x10 mL). The combined organic layers were washed with aqueous NaHCO3, dried over 
MgSO4, filtered and the solvent was removed under reduced. The crude product was purified 
by flash chromatography (SiO2, hexanes/EtOAc, 95:5) to afford ester 180a as a white solid (48 
mg, 91% yield). 
m.p. 53-54°C; Rf = 0.28 (hexanes : ethyl acetate = 9:1, UV); IR (neat): 3064, 3034, 2915, 2851, 
2363, 2106, 1774, 1733, 1603, 1498, 1457, 1372, 1334, 1279, 1167, 1126, 1003, 969, 861, 749, 
701, 667 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.41 – 7.29 (m, 3H), 7.26 – 7.18 (m, 2H), 4.52 
(ddd, J = 9.3, 7.9, 4.4 Hz, 1H), 4.25 (d, J = 11.6 Hz, 1H), 3.71 (s, 3H), 3.16 (dd, J = 11.5, 9.4 
Hz, 1H), 1.92 – 1.69 (m, 2H), 1.63 – 1.41 (m, 2H), 1.38 – 1.19 (m, 20H), 0.87 (t, J = 6.7 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δ 174.7, 170.9, 135.1, 129.1, 128.3, 128.1, 79.8, 55.4, 52.8, 
51.0, 34.9, 31.9, 29.7, 29.7 (2C), 29.6, 29.5, 29.4, 29.4, 29.3, 25.2, 22.7, 14.2; HRMS (+ESI) 
calcd. for C25H39O4 (M+H)
+ 403.2843 found 403.2837 
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rel-(2S,3R,4S)-4-(4-hydroxyphenyl)-5-oxo-2-tridecyltetrahydrofuran-3-carboxylic acid 
(181b) 
 
A flame dried 2-neck-Schlenk flask equipped with a reflux condenser was charged with acid 
179b (40 mg, 96 µmol, 1.0 equiv) and anhydrous DCM (8 mL). The solution was cooled to 0 
°C and BBr3 (92 µL, 0.96 mmol, 10 equiv) in anhydrous DCM (2 mL) was added within 5 min. 
The reaction mixture was stirred for 4 h in the unfreezing ice bath and subsequently aqueous 
NaOH (0.1 M, 4 mL) was added. The phases were separated and the aqueous phase was 
extracted with ethyl acetate (2x3 mL). After drying over Na2SO4 and filtration, the solvent was 
removed under reduced pressure. The crude product was purified by flash chromatography 
(SiO2, hexanes/EtOAc, 2:1 + 1% formic acid) to afford alcohol 181b as a white solid (33.5 mg, 
87% yield). 
m.p. 119-123 °C; Rf = 0.43(hexanes : ethyl acetate = 2:1 + 1% formic acid, bromocresol green); 
IR (neat): 3269, 2922, 2855, 2363, 1737, 1707, 1618, 1607, 1521, 1489, 1446, 1364, 1174, 
1129, 1006, 977, 876, 828, 723, 690 cm-1; 1H NMR (400 MHz, acetone) δ 7.19 – 7.13 (m, 2H), 
6.86 – 6.81 (m, 2H), 4.57 (ddd, J = 9.1, 8.3, 4.3 Hz, 1H), 4.21 (d, J = 11.7 Hz, 1H), 3.25 (dd, J 
= 11.7, 9.4 Hz, 1H), 1.99 – 1.82 (m, 2H), 1.63 – 1.46 (m, 2H), 1.39 – 1.24 (m, 20H), 0.89 (t, J 
= 6.8 Hz, 3H); 13C NMR (101 MHz, acetone) δ 174.4, 171.2, 156.9, 129.7, 127.1, 115.4, 79.3, 
55.0, 50.2, 34.5, 31.7, 29.5 (hidden under acetone peak), 29.5, 29.5 (2C), 29.4, 29.3, 29.2, 29.2 
(hidden under acetone peak), 25.3, 22.4, 13.5; HRMS (-ESI) calcd. for C24H35O5 (M-H)
- 
403.2490 found 403.2482 
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2 Chiral HPLC data 
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It was not feasible to separate 119d and 120d. Therefore, determination of the enantiomeric 
excess of 120d was performed with a mixture of 119d and 120d and analytical HPLC was 
carried out for racemic 119d as well as racemic 120d.  
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3 X‐ray crystallography data 
 
 
 
Table 1. Crystal data and structure refinement for 98a.  
Identification code  N053  
Empirical formula  C15H14O5  
Formula weight  274.26  
Temperature/K  123.01(10)  
Crystal system  monoclinic  
Space group  P21  
a/Å  9.82867(19)  
b/Å  6.11703(12)  
c/Å  11.6406(2)  
α/°  90.00  
β/°  100.4716(19)  
γ/°  90.00  
Volume/Å3  688.20(2)  
Z  2  
ρcalcmg/mm3  1.324  
m/mm-1  0.836  
F(000)  288.0  
Crystal size/mm3  0.3063 × 0.1966 × 0.0822  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection  7.72 to 128.36°  
Index ranges  -11 ≤ h ≤ 11, -7 ≤ k ≤ 6, -13 ≤ l ≤ 13  
Reflections collected  14187  
Independent reflections  2224 [Rint = 0.0329, Rsigma = 0.0171]  
Data/restraints/parameters  2224/1/183  
Goodness-of-fit on F2  1.151  
Final R indexes [I>=2σ (I)]  R1 = 0.0264, wR2 = 0.0763  
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Final R indexes [all data]  R1 = 0.0268, wR2 = 0.0768  
Largest diff. peak/hole / e Å-3  0.23/-0.26  
Flack parameter -0.07(15) 
 
 
Table 2. Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 98a. Ueq is defined as 1/3 of the trace of the orthogonalized UIJ tensor. 
Atom x y z U(eq) 
O1 9747.2(9) 6201.8(16) 6023.9(8) 23.9(2) 
O3 5667.2(10) 2859.1(18) 6751.6(8) 28.0(3) 
O5 12918.2(10) 5455.7(18) 8012.8(10) 33.2(3) 
O4 11998.5(10) 8580.6(19) 7196.4(9) 29.9(3) 
O2 6438.6(11) 1719(2) 5150.6(9) 34.8(3) 
C5 7939.9(14) 3788(2) 6593.8(12) 21.3(3) 
C10 7994.7(13) 5105(2) 7683.5(11) 20.0(3) 
C11 7486.6(15) 7231(2) 7598.0(13) 24.9(3) 
C15 8514.1(15) 4251(3) 8784.0(12) 24.9(3) 
C13 7969.6(16) 7591(3) 9682.3(14) 34.7(4) 
C1 10776.4(14) 5220(3) 6824.6(12) 22.6(3) 
C8 11933.7(14) 6641(3) 7344.0(12) 22.9(3) 
C12 7462.4(15) 8464(3) 8589.9(14) 30.9(4) 
C2 10556.4(14) 3115(2) 7013.0(12) 23.6(3) 
C14 8497.4(15) 5492(3) 9776.1(13) 32.5(4) 
C3 9208.3(15) 2498(3) 6320.4(12) 24.8(3) 
C9 14147.9(17) 6652(4) 8524.1(18) 47.7(5) 
C4 8741.2(15) 4558(3) 5665.6(12) 24.6(3) 
C6 6623.6(14) 2689(2) 6075.5(12) 24.1(3) 
C7 4347.4(16) 1842(3) 6297.6(15) 35.7(4) 
 
 
Table 3. Anisotropic Displacement Parameters (Å2×103) for 98a. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O1 24.7(5) 25.2(6) 22.6(5) 4.9(4) 6.1(4) -0.7(4) 
O3 23.0(5) 29.7(6) 31.0(5) -4.1(5) 4.5(4) -7.3(5) 
O5 22.7(5) 30.1(7) 44.0(6) 11.6(5) -0.9(4) -1.8(4) 
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O4 34.3(6) 22.3(7) 33.4(6) 0.7(5) 6.9(4) -0.7(4) 
O2 39.6(6) 37.7(7) 26.6(5) -9.3(5) 4.9(4) -10.3(5) 
C5 23.1(7) 21.0(8) 20.2(7) -1.8(6) 5.5(5) -1.3(6) 
C10 17.8(6) 21.6(8) 21.5(7) -1.7(5) 5.9(5) -3.9(5) 
C11 22.0(7) 25.3(9) 27.5(7) -1.4(6) 4.8(6) -2.1(6) 
C15 24.6(7) 26.1(8) 24.1(7) -0.1(6) 4.7(5) -1.7(6) 
C13 32.8(8) 40.1(10) 32.2(8) -17.5(8) 8.7(6) -5.1(7) 
C1 21.9(7) 25.7(8) 22.2(7) 3.5(6) 9.6(5) 3.3(6) 
C8 24.3(7) 24.7(10) 22.1(7) 3.1(6) 10.8(6) 2.6(6) 
C12 25.8(7) 26.0(8) 41.4(9) -9.9(7) 7.2(6) -1.8(6) 
C2 23.9(7) 22.3(9) 26.6(7) 1.4(6) 9.8(5) 4.3(6) 
C14 32.9(8) 43.4(10) 20.7(7) -2.2(6) 3.4(6) -3.7(7) 
C3 28.7(8) 21.5(8) 26.3(7) -2.8(6) 10.7(6) 0.6(6) 
C9 27.0(8) 45.4(11) 65.2(12) 12.7(10) -6.1(8) -7.6(9) 
C4 26.8(7) 27.4(8) 20.4(6) -2.1(6) 6.5(5) -2.6(6) 
C6 29.1(7) 19.7(7) 23.1(7) 1.6(6) 3.9(6) -0.6(6) 
C7 25.1(8) 34.8(9) 45.5(9) -2.5(7) 1.6(7) -10.8(7) 
 
 
Table 4. Bond Lengths for 98a. 
Atom Atom Length/Å  Atom Atom Length/Å 
O1 C1 1.3821(17)  C5 C6 1.4854(19) 
O1 C4 1.4189(18)  C10 C11 1.390(2) 
O3 C6 1.3352(17)  C10 C15 1.391(2) 
O3 C7 1.4490(17)  C11 C12 1.383(2) 
O5 C8 1.3396(18)  C15 C14 1.385(2) 
O5 C9 1.446(2)  C13 C12 1.386(2) 
O4 C8 1.202(2)  C13 C14 1.381(3) 
O2 C6 1.2134(18)  C1 C8 1.472(2) 
C5 C10 1.4954(19)  C1 C2 1.330(2) 
C5 C3 1.5562(19)  C2 C3 1.469(2) 
C5 C4 1.5228(19)  C3 C4 1.500(2) 
 
 
Table 5. Bond Angles for 98a. 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
C1 O1 C4 106.01(11)  C2 C1 C8 129.85(14) 
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C6 O3 C7 115.53(11)  O5 C8 C1 109.97(13) 
C8 O5 C9 115.25(13)  O4 C8 O5 124.47(14) 
C10 C5 C3 122.67(11)  O4 C8 C1 125.56(13) 
C10 C5 C4 119.46(12)  C11 C12 C13 119.88(16) 
C4 C5 C3 58.31(10)  C1 C2 C3 108.38(13) 
C6 C5 C10 118.88(11)  C13 C14 C15 120.31(15) 
C6 C5 C3 111.01(12)  C2 C3 C5 115.70(12) 
C6 C5 C4 112.11(11)  C2 C3 C4 103.03(12) 
C11 C10 C5 119.09(13)  C4 C3 C5 59.73(9) 
C11 C10 C15 118.93(14)  O1 C4 C5 115.67(11) 
C15 C10 C5 121.97(14)  O1 C4 C3 108.25(11) 
C12 C11 C10 120.71(15)  C3 C4 C5 61.96(10) 
C14 C15 C10 120.28(15)  O3 C6 C5 112.31(11) 
C14 C13 C12 119.86(15)  O2 C6 O3 123.58(13) 
O1 C1 C8 115.89(12)  O2 C6 C5 124.10(13) 
C2 C1 O1 114.25(13)      
 
 
Table 6. Torsion Angles for 98a. 
A B C D Angle/˚  A B C D Angle/˚ 
O1 C1 C8 O5 -174.02(11)  C2 C3 C4 C5 -112.36(12) 
O1 C1 C8 O4 5.95(19)  C14 C13 C12 C11 0.0(2) 
O1 C1 C2 C3 -2.44(16)  C3 C5 C10 C11 131.53(14) 
C5 C10 C11 C12 177.05(13)  C3 C5 C10 C15 -49.8(2) 
C5 C10 C15 C14 -177.43(13)  C3 C5 C4 O1 -97.91(13) 
C5 C3 C4 O1 109.94(12)  C3 C5 C6 O3 144.15(12) 
C10 C5 C3 C2 -16.4(2)  C3 C5 C6 O2 -35.0(2) 
C10 C5 C3 C4 -106.90(15)  C9 O5 C8 O4 -3.1(2) 
C10 C5 C4 O1 14.41(19)  C9 O5 C8 C1 176.82(13) 
C10 C5 C4 C3 112.33(14)  C4 O1 C1 C8 -178.70(10) 
C10 C5 C6 O3 -6.56(19)  C4 O1 C1 C2 0.81(15) 
C10 C5 C6 O2 174.33(13)  C4 C5 C10 C11 62.29(17) 
C10 C11 C12 C13 1.1(2)  C4 C5 C10 C15 -119.02(15) 
C10 C15 C14 C13 -0.2(2)  C4 C5 C3 C2 90.50(14) 
C11 C10 C15 C14 1.3(2)  C4 C5 C6 O3 -152.68(12) 
C15 C10 C11 C12 -1.7(2)  C4 C5 C6 O2 28.2(2) 
C1 O1 C4 C5 68.13(14)  C6 C5 C10 C11 -81.33(17) 
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C1 O1 C4 C3 1.13(14)  C6 C5 C10 C15 97.36(16) 
C1 C2 C3 C5 -59.56(16)  C6 C5 C3 C2 -165.80(12) 
C1 C2 C3 C4 2.87(15)  C6 C5 C3 C4 103.69(13) 
C8 C1 C2 C3 176.99(12)  C6 C5 C4 O1 160.32(12) 
C12 C13 C14 C15 -0.4(2)  C6 C5 C4 C3 -101.77(13) 
C2 C1 C8 O5 6.56(19)  C7 O3 C6 O2 -1.5(2) 
C2 C1 C8 O4 -173.47(15)  C7 O3 C6 C5 179.43(14) 
C2 C3 C4 O1 -2.41(14)       
 
 
Table 7. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for 98a. 
Atom x y z U(eq) 
H11 7159 7831 6866 30 
H15 8874 2842 8853 30 
H13 7955 8416 10351 42 
H12 7106 9876 8524 37 
H2 11154 2191 7500 28 
H14 8843 4910 10509 39 
H3 9083 1076 5928 30 
H9A 14534 7346 7917 72 
H9B 14814 5662 8948 72 
H9C 13912 7744 9047 72 
H4 8306 4463 4840 30 
H7A 3896 2631 5622 54 
H7B 3777 1867 6885 54 
H7C 4495 356 6085 54 
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Table 1. Crystal data and structure refinement for 108.  
Identification code  Q072  
Empirical formula  C15H14O5  
Formula weight  274.26  
Temperature/K  123.00(10)  
Crystal system  monoclinic  
Space group  C2  
a/Å  16.4819(2)  
b/Å  5.77330(10)  
c/Å  14.4387(2)  
α/°  90  
β/°  106.4900(10)  
γ/°  90  
Volume/Å3  1317.40(3)  
Z  4  
ρcalcmg/mm3  1.383  
m/mm-1  0.874  
F(000)  576.0  
Crystal size/mm3  0.209 × 0.089 × 0.059  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection  11.198 to 147.04°  
Index ranges  -20 ≤ h ≤ 20, -6 ≤ k ≤ 7, -17 ≤ l ≤ 17  
Reflections collected  19381  
Independent reflections  2593 [Rint = 0.0373, Rsigma = 0.0183]  
Data/restraints/parameters  2593/217/233  
Goodness-of-fit on F2  1.047  
Final R indexes [I>=2σ (I)]  R1 = 0.0287, wR2 = 0.0738  
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Final R indexes [all data]  R1 = 0.0302, wR2 = 0.0751  
Largest diff. peak/hole / e Å-3  0.14/-0.16  
Flack parameter 0.03(8) 
 
 
Table 2. Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 108. Ueq is defined as 1/3 of the trace of the orthogonalized UIJ tensor. 
Atom x y z U(eq) 
O5 8505.1(8) 2891(3) 9218.3(9) 25.8(3) 
O4 8198.8(9) 5857(3) 10077.7(9) 29.6(3) 
O2 7391.5(8) 2988(3) 5573.1(9) 30.4(3) 
O3 7229.1(9) 8871(3) 7299.9(10) 30.8(3) 
O1 6022(8) 2837(13) 5436(8) 29.8(14) 
C14 8174.1(11) 4976(4) 9310.8(13) 21.9(4) 
C13 7484.0(12) 8181(4) 8239.4(14) 26.5(4) 
C3 6816.0(11) 4808(4) 6730.6(13) 23.6(4) 
C2 6789.5(11) 3334(4) 5871.2(13) 27.1(4) 
C4 6015(3) 4772(10) 7059(4) 22.3(11) 
C9 5348(3) 6216(9) 6596(4) 28.5(10) 
C8 4603(3) 6191(10) 6866(4) 31.6(10) 
C7 4525(3) 4723(10) 7598(4) 30.1(11) 
C6 5192(5) 3279(10) 8061(4) 25.7(11) 
C5 5937(4) 3304(11) 7791(5) 21.5(10) 
C12 7799.6(11) 6035(4) 8366.1(13) 22.4(4) 
C11 7727.0(11) 5011(4) 7404.5(13) 22.1(4) 
C10 7353.5(12) 6967(4) 6728.2(14) 26.2(4) 
C15 8905.8(13) 1711(4) 10114.2(14) 30.7(4) 
C1 5918(6) 1582(13) 4535(6) 34.8(15) 
C4A 6077(2) 4988(8) 7130(3) 23.2(10) 
C9A 5530(2) 6870(7) 6911(3) 26.9(9) 
C8A 4806(2) 6909(7) 7222(3) 31.3(9) 
C7A 4629(3) 5066(8) 7754(3) 29.2(9) 
C6A 5176(4) 3184(7) 7973(4) 26.4(10) 
C5A 5900(4) 3145(7) 7662(4) 24.6(10) 
O1A 6016(9) 2133(17) 5492(10) 32.7(18) 
C1A 5949(7) 683(16) 4660(7) 36.0(17) 
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Table 3. Anisotropic Displacement Parameters (Å2×103) for 108. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O5 29.8(6) 23.5(7) 24.0(6) 1.8(6) 7.2(5) 4.5(6) 
O4 40.8(8) 24.3(7) 24.8(7) -2.8(6) 10.9(6) -2.3(6) 
O2 26.9(6) 37.4(8) 30.6(7) -6.3(6) 14.0(5) 1.6(6) 
O3 44.3(8) 22.3(7) 31.5(7) 6.8(6) 19.8(6) 9.2(6) 
O1 25.3(18) 40(4) 25.4(18) -12(3) 8.9(13) -1(3) 
C14 22.4(8) 18.4(9) 25.8(9) -0.5(8) 8.5(6) -2.8(7) 
C13 34.1(9) 21.7(10) 27.8(9) -0.6(8) 15.3(7) 1.6(8) 
C3 22.2(8) 27.8(10) 22.5(9) 3.4(8) 8.9(7) 7.0(8) 
C2 23.7(9) 37.3(12) 20.4(8) 1.3(8) 6.3(7) 4.6(8) 
C4 23.4(18) 26(2) 18.8(18) -3.2(17) 8.2(17) 6.1(17) 
C9 28.6(19) 32(2) 27(2) 5.6(18) 10.7(17) 5.8(17) 
C8 25.8(19) 35(2) 35(2) 0.9(18) 10.4(16) 8.8(17) 
C7 26.8(19) 35(2) 32.4(19) 0.9(18) 14.6(17) 1.5(17) 
C6 29.1(19) 27(2) 23.2(19) -2.8(18) 11.6(17) -2.3(19) 
C5 26.0(18) 20.3(19) 18.4(18) -4.7(16) 6.8(15) 2.5(17) 
C12 25.6(9) 20.3(9) 23.7(9) -0.9(7) 10.9(7) 0.2(7) 
C11 22.4(8) 22.9(9) 22.4(8) -0.2(8) 8.8(6) 3.5(7) 
C10 29.8(9) 26.2(10) 26.4(9) 4.0(8) 13.9(7) 7.3(8) 
C15 32.7(10) 31.3(12) 27.3(9) 8.2(9) 7.2(7) 6.6(9) 
C1 27.6(18) 45(4) 31(2) -16(3) 6.3(17) 2(3) 
C4A 22.5(16) 25.5(18) 21.6(17) 1.0(16) 6.5(15) 2.0(15) 
C9A 25.1(16) 26.6(19) 31.3(19) 6.0(16) 11.6(14) 3.4(14) 
C8A 25.8(17) 31(2) 39(2) 3.6(17) 11.8(15) 7.5(15) 
C7A 26.2(16) 33.9(19) 30.7(17) -2.2(16) 13.3(14) 1.5(15) 
C6A 30.7(17) 26.4(18) 23.6(16) 0.4(16) 10.1(15) -3.5(16) 
C5A 26.3(16) 23.8(17) 22.9(18) -1.4(16) 6.0(14) 3.2(16) 
O1A 22(2) 48(5) 29(3) -20(4) 8.1(17) -8(4) 
C1A 29(2) 50(5) 28(3) -19(3) 8(2) -4(4) 
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Table 4. Bond Lengths for 108. 
Atom Atom Length/Å   Atom Atom Length/Å 
O5 C14 1.344(2)  C4 C9 1.3900 
O5 C15 1.445(2)  C4 C5 1.3900 
O4 C14 1.208(2)  C9 C8 1.3900 
O2 C2 1.205(2)  C8 C7 1.3900 
O3 C13 1.361(2)  C7 C6 1.3900 
O3 C10 1.424(2)  C6 C5 1.3900 
O1 C2 1.275(12)  C12 C11 1.482(2) 
O1 C1 1.456(10)  C11 C10 1.506(3) 
C14 C12 1.462(2)  C4A C9A 1.3900 
C13 C12 1.336(3)  C4A C5A 1.3900 
C3 C2 1.495(3)  C9A C8A 1.3900 
C3 C4 1.524(5)  C8A C7A 1.3900 
C3 C11 1.544(2)  C7A C6A 1.3900 
C3 C10 1.530(3)  C6A C5A 1.3900 
C3 C4A 1.492(4)  O1A C1A 1.443(12) 
C2 O1A 1.418(13)     
  
Table 5. Bond Angles for 108. 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
C14 O5 C15 115.38(15)  C8 C9 C4 120.0 
C13 O3 C10 107.29(15)  C9 C8 C7 120.0 
C2 O1 C1 113.6(8)  C6 C7 C8 120.0 
O5 C14 C12 110.94(15)  C5 C6 C7 120.0 
O4 C14 O5 123.98(18)  C6 C5 C4 120.0 
O4 C14 C12 125.07(19)  C14 C12 C11 127.42(18) 
C12 C13 O3 113.95(17)  C13 C12 C14 124.07(17) 
C2 C3 C4 115.2(3)  C13 C12 C11 108.48(17) 
C2 C3 C11 111.11(15)  C12 C11 C3 115.20(15) 
C2 C3 C10 110.03(16)  C12 C11 C10 102.58(16) 
C4 C3 C11 125.3(2)  C10 C11 C3 60.18(13) 
C4 C3 C10 124.4(3)  O3 C10 C3 116.68(15) 
C10 C3 C11 58.65(12)  O3 C10 C11 107.63(15) 
C4A C3 C2 121.7(2)  C11 C10 C3 61.17(12) 
C4A C3 C11 120.4(2)  C9A C4A C3 120.9(3) 
F Appendix 
177 
C4A C3 C10 118.8(2)  C9A C4A C5A 120.0 
O2 C2 O1 126.1(6)  C5A C4A C3 118.8(3) 
O2 C2 C3 123.90(17)  C4A C9A C8A 120.0 
O2 C2 O1A 121.5(6)  C7A C8A C9A 120.0 
O1 C2 C3 109.1(5)  C8A C7A C6A 120.0 
O1A C2 C3 114.2(6)  C7A C6A C5A 120.0 
C9 C4 C3 118.6(4)  C6A C5A C4A 120.0 
C9 C4 C5 120.0  C2 O1A C1A 116.9(10) 
C5 C4 C3 121.4(4)      
  
Table 6. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for 108. 
Atom x y z U(eq) 
H13 7442.29 9119.07 8747.63 32 
H9 5400.51 7197.89 6105.5 34 
H8 4156.85 7156.59 6556.04 38 
H7 4026.16 4705.96 7779.05 36 
H6 5139.12 2296.59 8551.53 31 
H5 6382.79 2337.84 8101 26 
H11 8183.61 4055.31 7297.4 26 
H10 7567.05 7260.81 6171.13 31 
H15A 9131.84 259.22 9977.81 46 
H15B 8496.12 1435.46 10459.91 46 
H15C 9355.48 2653.67 10500.02 46 
H1A 6038.54 2597.19 4064.47 52 
H1B 5346.39 1031.3 4301.57 52 
H1C 6300.15 290.09 4645.07 52 
H9A 5648.15 8102.56 6555.32 32 
H8A 4439.61 8168.26 7075.45 38 
H7A 4144.3 5092.71 7962.11 35 
H6A 5057.54 1951.47 8328.65 32 
H5A 6266.09 1885.74 7808.54 29 
H1AA 5363.51 454.18 4319.79 54 
H1AB 6209.95 -787.72 4865.91 54 
H1AC 6230.26 1418.26 4239.79 54 
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Table 7. Atomic Occupancy for 108. 
Atom Occupancy  Atom Occupancy  Atom Occupancy 
O1 0.545(7)  C4 0.455(7)  C9 0.455(7) 
H9 0.455(7)  C8 0.455(7)  H8 0.455(7) 
C7 0.455(7)  H7 0.455(7)  C6 0.455(7) 
H6 0.455(7)  C5 0.455(7)  H5 0.455(7) 
C1 0.545(7)  H1A 0.545(7)  H1B 0.545(7) 
H1C 0.545(7)  C4A 0.545(7)  C9A 0.545(7) 
H9A 0.545(7)  C8A 0.545(7)  H8A 0.545(7) 
C7A 0.545(7)  H7A 0.545(7)  C6A 0.545(7) 
H6A 0.545(7)  C5A 0.545(7)  H5A 0.545(7) 
O1A 0.455(7)  C1A 0.455(7)  H1AA 0.455(7) 
H1AB 0.455(7)  H1AC 0.455(7)    
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Table 1. Crystal data and structure refinement for 109.  
Identification code  Q075_1  
Empirical formula  C13H12O3  
Formula weight  216.23  
Temperature/K  122.99(10)  
Crystal system  orthorhombic  
Space group  P212121  
a/Å  8.1779(2)  
b/Å  8.8079(2)  
c/Å  15.2085(3)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  1095.47(4)  
Z  4  
ρcalcmg/mm3  1.311  
m/mm-1  0.763  
F(000)  456.0  
Crystal size/mm3  0.352 × 0.232 × 0.177  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection  11.61 to 133.062°  
Index ranges  -9 ≤ h ≤ 9, -10 ≤ k ≤ 10, -18 ≤ l ≤ 17  
Reflections collected  13735  
Independent reflections  1920 [Rint = 0.0326, Rsigma = 0.0158]  
Data/restraints/parameters  1920/0/194  
Goodness-of-fit on F2  1.078  
Final R indexes [I>=2σ (I)]  R1 = 0.0240, wR2 = 0.0600  
Final R indexes [all data]  R1 = 0.0258, wR2 = 0.0611  
Largest diff. peak/hole / e Å-3  0.13/-0.10  
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Flack parameter -0.10(8) 
 
 
Table 2. Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 109. Ueq is defined as 1/3 of the trace of the orthogonalized UIJ tensor. 
Atom x y z U(eq) 
O1 3317.8(14) 5228.3(14) 6069.1(8) 27.7(3) 
O3 7930.6(15) 7286.3(14) 7452.0(7) 29.1(3) 
O2 2919.3(14) 7464.7(15) 6740.1(8) 30.3(3) 
C2 5645(2) 6689(2) 6399.0(11) 22.0(4) 
C3 6260(2) 7491(2) 7229.7(11) 25.4(4) 
C7 6619.7(19) 5474.4(19) 5955.4(11) 21.3(4) 
C1 3834(2) 6529.1(19) 6425.7(11) 22.3(4) 
C5 7924(2) 8659(2) 6190.0(12) 27.0(4) 
C8 6833(2) 5494(2) 5046.3(11) 25.8(4) 
C4 6177(2) 8387(2) 6394.1(12) 25.4(4) 
C12 7243(2) 4268(2) 6438.1(13) 26.1(4) 
C6 8828(2) 7994(2) 6798.6(12) 28.2(4) 
C10 8255(2) 3102(2) 5114.4(14) 36.4(5) 
C9 7637(2) 4306(2) 4630.9(13) 33.3(5) 
C11 8055(2) 3084(2) 6020.5(14) 33.3(4) 
C13 1557(2) 4998(2) 6089.3(15) 31.3(4) 
  
Table 3. Anisotropic Displacement Parameters (Å2×103) for 109. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O1 17.7(6) 26.5(6) 39.1(7) -5.5(5) 0.9(5) -1.1(5) 
O3 21.2(6) 37.6(7) 28.5(6) -3.2(5) -3.7(5) 1.0(6) 
O2 21.6(6) 34.3(7) 34.9(6) -9.8(6) 1.1(5) 3.3(6) 
C2 20.9(8) 23.0(8) 22.0(8) 0.3(7) -0.4(7) 0.4(7) 
C3 18.6(8) 32.3(9) 25.3(8) -5.4(8) -0.5(7) 2.1(7) 
C7 16.0(8) 22.6(8) 25.3(8) -0.1(7) 1.7(7) -4.6(7) 
C1 23.2(8) 24.2(9) 19.6(7) 1.3(7) -0.2(7) 0.9(7) 
C5 24.6(9) 22.5(9) 34.0(9) -3.0(7) 2.6(8) -1.9(7) 
C8 21.8(9) 28.7(10) 27.0(9) -2.2(7) -0.1(7) -3.4(8) 
C4 22.5(9) 20.9(8) 32.9(9) -1.8(7) -2.2(7) 2.8(7) 
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C12 21.6(8) 24.3(9) 32.2(9) 2.4(8) -1.1(7) -2.8(7) 
C6 21.4(9) 28.4(9) 34.7(9) -8.2(8) 1.1(8) -2.2(7) 
C10 23.4(10) 27.1(10) 58.7(13) -16.4(9) 4.4(9) -2.5(8) 
C9 27.4(10) 40.6(11) 31.9(11) -11.6(8) 5.4(8) -7.7(8) 
C11 23.3(9) 22.4(9) 54.3(12) -1.5(9) -3.3(9) -1.3(7) 
C13 18.2(9) 28.1(10) 47.6(12) -3.3(9) -0.4(8) -1.4(8) 
  
Table 4. Bond Lengths for 109. 
Atom Atom Length/Å  Atom Atom Length/Å 
O1 C1 1.336(2)  C3 C4 1.498(3) 
O1 C13 1.454(2)  C7 C8 1.394(2) 
O3 C3 1.419(2)  C7 C12 1.388(2) 
O3 C6 1.384(2)  C5 C4 1.481(2) 
O2 C1 1.211(2)  C5 C6 1.321(3) 
C2 C3 1.533(2)  C8 C9 1.388(3) 
C2 C7 1.495(2)  C12 C11 1.390(3) 
C2 C1 1.489(2)  C10 C9 1.386(3) 
C2 C4 1.558(2)  C10 C11 1.388(3) 
  
Table 5. Bond Angles for 109. 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
C1 O1 C13 115.07(14)  O1 C1 C2 112.59(14) 
C6 O3 C3 106.38(13)  O2 C1 O1 123.29(16) 
C3 C2 C4 57.96(12)  O2 C1 C2 124.12(16) 
C7 C2 C3 121.79(14)  C6 C5 C4 108.73(16) 
C7 C2 C4 122.41(14)  C9 C8 C7 120.09(18) 
C1 C2 C3 110.36(14)  C3 C4 C2 60.17(12) 
C1 C2 C7 118.38(14)  C5 C4 C2 115.19(15) 
C1 C2 C4 111.64(14)  C5 C4 C3 102.66(14) 
O3 C3 C2 117.00(14)  C7 C12 C11 120.54(18) 
O3 C3 C4 108.24(14)  C5 C6 O3 113.96(16) 
C4 C3 C2 61.88(11)  C9 C10 C11 119.51(18) 
C8 C7 C2 120.37(16)  C10 C9 C8 120.54(18) 
C12 C7 C2 120.31(15)  C10 C11 C12 120.09(18) 
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C12 C7 C8 119.22(16)      
  
Table 6. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for 109. 
Atom x y z U(eq) 
H3 5550(20) 7610(20) 7748(13) 25(5) 
H8 6380(30) 6330(20) 4697(13) 29(5) 
H4 5390(30) 9120(20) 6269(12) 27(5) 
H6 10030(30) 7910(20) 6865(12) 30(5) 
H13A 1030(30) 5740(30) 5709(15) 42(6) 
H13B 1180(20) 5090(20) 6704(14) 29(5) 
H12 7090(30) 4220(20) 7076(14) 32(5) 
H5 8340(30) 9200(20) 5692(14) 32(5) 
H11 8460(30) 2210(30) 6364(14) 44(6) 
H13C 1360(30) 3980(30) 5855(15) 45(6) 
H9 7730(30) 4320(20) 4005(15) 38(6) 
H10 8800(30) 2270(30) 4826(14) 43(6) 
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Table 1. Crystal data and structure refinement for 119c.  
Identification code  P039  
Empirical formula  C20H19NO4S  
Formula weight  369.42  
Temperature/K  123.00(10)  
Crystal system  orthorhombic  
Space group  P212121  
a/Å  8.25344(9)  
b/Å  9.76016(12)  
c/Å  22.2332(2)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  1790.99(4)  
Z  4  
ρcalcmg/mm3  1.370  
m/mm-1  1.825  
F(000)  776.0  
Crystal size/mm3  0.234 × 0.196 × 0.172  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection  7.954 to 146.656°  
Index ranges  -9 ≤ h ≤ 10, -11 ≤ k ≤ 10, -26 ≤ l ≤ 27  
Reflections collected  10156  
Independent reflections  3499 [Rint = 0.0270, Rsigma = 0.0266]  
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Data/restraints/parameters  3499/0/237  
Goodness-of-fit on F2  1.062  
Final R indexes [I>=2σ (I)]  R1 = 0.0315, wR2 = 0.0801  
Final R indexes [all data]  R1 = 0.0327, wR2 = 0.0812  
Largest diff. peak/hole / e Å-3  0.22/-0.41  
Flack parameter 0.006(7) 
 
 
Table 2. Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 119c. Ueq is defined as 1/3 of the trace of the orthogonalized UIJ 
tensor. 
Atom x y z U(eq) 
S1 3264.8(7) 6036.8(6) 6443.6(3) 20.37(15) 
O4 2942(2) 528.9(17) 5169.7(7) 20.4(4) 
O2 2098(2) 6160(2) 5970.5(8) 30.3(4) 
O1 2843(2) 6329.4(19) 7053.5(8) 28.3(4) 
N1 3840(3) 4428(2) 6448.1(9) 20.8(4) 
C4 4976(3) 7762(2) 5714.5(10) 21.0(5) 
O3 4567(4) 2194(3) 4856.0(9) 71.1(10) 
C3 6339(3) 8522(2) 5563(1) 22.2(5) 
C11 2974(3) 403(2) 6626.2(10) 18.8(5) 
C12 1961(3) -126(3) 7063.8(10) 22.5(5) 
C2 7704(3) 8546(2) 5930.9(10) 21.8(5) 
C15 1172(3) 2297(3) 6483.1(11) 22.2(5) 
C6 6301(3) 7060(3) 6634.9(10) 21.8(5) 
C5 4972(3) 7025(2) 6250.7(10) 17.7(5) 
C17 5668(3) 2815(3) 6732.5(12) 26.6(5) 
C18 4745(3) 3846(3) 6926.2(11) 23.5(5) 
C7 7656(3) 7811(3) 6472.9(11) 24.6(5) 
C13 561(3) 572(3) 7223.8(11) 26.1(5) 
C20 3103(3) -79(3) 4577.5(10) 24.5(5) 
C8 4250(3) 3698(3) 5902(1) 24.3(5) 
C10 2585(3) 1619(2) 6330.3(10) 16.7(5) 
C9 3730(3) 2202(3) 5876.3(10) 21.4(5) 
C1 9210(3) 9306(3) 5744.0(12) 32.3(6) 
C16 5461(3) 2619(3) 6079.2(12) 26.6(6) 
C14 174(3) 1780(3) 6935.1(12) 27.2(6) 
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C19 3781(4) 1674(3) 5248.1(11) 29.5(6) 
 
Table 3. Anisotropic Displacement Parameters (Å2×103) for 119c. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
S1 20.6(3) 18.6(3) 21.9(3) -0.6(2) -0.4(2) -3.5(2) 
O4 23.0(9) 16.8(8) 21.5(8) -4.1(6) -1.0(6) -0.8(7) 
O2 23.8(9) 32.3(10) 35(1) 3.8(8) -8.2(7) -4.9(8) 
O1 27.9(9) 28.9(10) 28.1(9) -4.0(7) 8.7(7) -4.8(8) 
N1 32.1(10) 15.6(10) 14.6(8) 0.5(8) -2.2(8) -6.0(8) 
C4 23.9(11) 18.6(12) 20.6(11) -0.8(9) -2.1(9) 3.7(10) 
O3 140(3) 44.0(15) 28.9(11) -13.7(10) 38.3(14) -53.2(17) 
C3 30.2(13) 17.6(13) 18.8(11) 2.6(9) 1.0(9) 0.7(10) 
C11 18.2(11) 15.5(11) 22.8(11) 0.5(9) 1.4(9) 0.2(9) 
C12 25.7(13) 21.2(12) 20.7(11) 4.2(9) 0.0(9) -3.9(10) 
C2 30.7(12) 16.5(12) 18.1(11) -2.1(9) 0.8(9) -6.4(10) 
C15 20.6(11) 15.9(11) 30.1(12) -0.6(10) -6.6(10) -0.5(9) 
C6 28.4(13) 19.0(12) 17.9(10) 2.4(9) -2.0(9) -4.8(10) 
C5 20.9(11) 12.8(11) 19.5(10) -2.1(8) 2.1(9) -0.8(9) 
C17 20.0(12) 26.0(14) 33.8(13) 4.5(11) -4(1) -7.7(11) 
C18 27.8(12) 22.8(12) 19.9(11) 2.4(10) -5.6(9) -10.1(11) 
C7 27.7(12) 27.0(12) 19.1(11) -1.0(11) -4.7(10) -8.5(10) 
C13 24.7(12) 31.8(14) 22.0(11) -2.9(11) 6.2(10) -9.1(11) 
C20 28.2(13) 22.0(12) 23.1(11) -8.2(9) -5.7(10) 3.8(11) 
C8 37.9(14) 17.6(13) 17.3(10) -0.7(9) 3(1) -11.5(11) 
C10 19.8(10) 15.0(11) 15.2(10) -2.2(8) -1.1(8) -4.5(9) 
C9 29.1(13) 16.8(12) 18.2(11) 1.1(9) 2.7(9) -8.6(10) 
C1 36.5(14) 35.6(16) 24.8(12) -0.1(11) 0.1(11) -18.2(12) 
C16 22.9(12) 23.1(14) 33.9(14) -0.9(11) 8.3(10) -8.2(10) 
C14 16.4(11) 29.2(14) 35.9(14) -7.7(11) 3.8(10) -0.3(10) 
C19 48.0(16) 19.3(13) 21.1(12) -1.5(10) 4.6(11) -8.3(12) 
 
 
Table 4. Bond Lengths for 119c. 
Atom Atom Length/Å  Atom Atom Length/Å 
S1 O2 1.4314(18)  C2 C7 1.403(3) 
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S1 O1 1.4287(18)  C2 C1 1.506(3) 
S1 N1 1.641(2)  C15 C10 1.383(3) 
S1 C5 1.761(2)  C15 C14 1.394(4) 
O4 C20 1.450(3)  C6 C5 1.390(3) 
O4 C19 1.326(3)  C6 C7 1.385(3) 
N1 C18 1.418(3)  C17 C18 1.334(4) 
N1 C8 1.448(3)  C17 C16 1.475(4) 
C4 C3 1.388(3)  C13 C14 1.380(4) 
C4 C5 1.392(3)  C8 C9 1.523(3) 
O3 C19 1.200(3)  C8 C16 1.505(4) 
C3 C2 1.393(3)  C10 C9 1.495(3) 
C11 C12 1.383(3)  C9 C16 1.553(3) 
C11 C10 1.394(3)  C9 C19 1.489(3) 
C12 C13 1.388(4)     
 
 
Table 5. Bond Angles for 119c. 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
O2 S1 N1 106.26(11)  C17 C18 N1 111.2(2) 
O2 S1 C5 108.26(11)  C6 C7 C2 121.1(2) 
O1 S1 O2 121.08(12)  C14 C13 C12 119.6(2) 
O1 S1 N1 104.84(11)  N1 C8 C9 115.94(19) 
O1 S1 C5 108.48(11)  N1 C8 C16 106.3(2) 
N1 S1 C5 107.12(11)  C16 C8 C9 61.69(17) 
C19 O4 C20 114.58(19)  C11 C10 C9 119.8(2) 
C18 N1 S1 122.71(17)  C15 C10 C11 119.0(2) 
C18 N1 C8 108.0(2)  C15 C10 C9 121.2(2) 
C8 N1 S1 122.23(16)  C8 C9 C16 58.57(17) 
C3 C4 C5 119.1(2)  C10 C9 C8 121.1(2) 
C4 C3 C2 121.5(2)  C10 C9 C16 119.0(2) 
C12 C11 C10 120.7(2)  C19 C9 C8 111.02(19) 
C11 C12 C13 120.0(2)  C19 C9 C10 121.3(2) 
C3 C2 C7 118.2(2)  C19 C9 C16 109.7(2) 
C3 C2 C1 120.9(2)  C17 C16 C8 104.1(2) 
C7 C2 C1 120.8(2)  C17 C16 C9 115.3(2) 
C10 C15 C14 120.2(2)  C8 C16 C9 59.74(17) 
C7 C6 C5 119.4(2)  C13 C14 C15 120.5(2) 
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C4 C5 S1 119.59(18)  O4 C19 C9 113.6(2) 
C6 C5 S1 119.66(18)  O3 C19 O4 122.9(2) 
C6 C5 C4 120.7(2)  O3 C19 C9 123.4(2) 
C18 C17 C16 110.5(2)      
 
 
Table 6.Torsion Angles for 119c. 
A B C D Angle/˚  A B C D Angle/˚ 
S1 N1 C18 C17 -151.63(19)  C5 S1 N1 C18 77.2(2) 
S1 N1 C8 C9 -142.41(19)  C5 S1 N1 C8 -69.8(2) 
S1 N1 C8 C16 151.63(17)  C5 C4 C3 C2 0.9(4) 
O2 S1 N1 C18 -167.27(19)  C5 C6 C7 C2 0.6(4) 
O2 S1 N1 C8 45.7(2)  C18 N1 C8 C9 66.4(3) 
O2 S1 C5 C4 1.0(2)  C18 N1 C8 C16 0.4(3) 
O2 S1 C5 C6 -178.98(19)  C18 C17 C16 C8 -0.2(3) 
O1 S1 N1 C18 -37.9(2)  C18 C17 C16 C9 -63.1(3) 
O1 S1 N1 C8 175.04(19)  C7 C6 C5 S1 178.30(19) 
O1 S1 C5 C4 -132.14(19)  C7 C6 C5 C4 -1.7(4) 
O1 S1 C5 C6 47.9(2)  C20 O4 C19 O3 2.4(4) 
N1 S1 C5 C4 115.19(19)  C20 O4 C19 C9 -174.2(2) 
N1 S1 C5 C6 -64.8(2)  C8 N1 C18 C17 -0.6(3) 
N1 C8 C9 C10 11.9(3)  C8 C9 C16 C17 92.1(3) 
N1 C8 C9 C16 -95.3(2)  C8 C9 C19 O4 -162.6(2) 
N1 C8 C9 C19 163.9(2)  C8 C9 C19 O3 20.8(4) 
N1 C8 C16 C17 -0.1(3)  C10 C11 C12 C13 -1.7(4) 
N1 C8 C16 C9 111.1(2)  C10 C15 C14 C13 -1.6(4) 
C4 C3 C2 C7 -1.9(4)  C10 C9 C16 C17 -18.6(3) 
C4 C3 C2 C1 176.3(2)  C10 C9 C16 C8 -110.7(2) 
C3 C4 C5 S1 -179.08(18)  C10 C9 C19 O4 -10.7(4) 
C3 C4 C5 C6 0.9(4)  C10 C9 C19 O3 172.7(3) 
C3 C2 C7 C6 1.1(4)  C9 C8 C16 C17 -111.3(2) 
C11 C12 C13 C14 1.3(4)  C1 C2 C7 C6 -177.1(2) 
C11 C10 C9 C8 -129.9(2)  C16 C17 C18 N1 0.5(3) 
C11 C10 C9 C16 -61.1(3)  C16 C8 C9 C10 107.2(2) 
C11 C10 C9 C19 81.0(3)  C16 C8 C9 C19 -100.9(2) 
C12 C11 C10 C15 0.4(3)  C16 C9 C19 O4 134.5(2) 
C12 C11 C10 C9 177.6(2)  C16 C9 C19 O3 -42.1(4) 
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C12 C13 C14 C15 0.3(4)  C14 C15 C10 C11 1.3(3) 
C15 C10 C9 C8 47.2(3)  C14 C15 C10 C9 -175.9(2) 
C15 C10 C9 C16 116.0(3)  C19 C9 C16 C17 -164.7(2) 
C15 C10 C9 C19 -101.9(3)  C19 C9 C16 C8 103.2(2) 
 
 
Table 7. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for 119c. 
Atom x y z U(eq) 
H4 4079 7746 5461 25 
H3 6339 9026 5208 27 
H11 3925 -56 6528 23 
H12 2218 -951 7251 27 
H15 887 3099 6284 27 
H6 6279 6585 6997 26 
H17 6347 2293 6975 32 
H18 4700 4144 7323 28 
H7 8550 7827 6728 29 
H13 -111 229 7524 31 
H20A 2803 581 4277 37 
H20B 2406 -864 4548 37 
H20C 4206 -356 4515 37 
H8 4404 4210 5527 29 
H1A 9694 8854 5405 48 
H1B 9965 9321 6072 48 
H1C 8931 10228 5635 48 
H16 6399 2426 5822 32 
H14 -761 2252 7043 33 
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Table 1. Crystal data and structure refinement for (ent)-120c.  
Identification code  P197  
Empirical formula  C29H27NO6S  
Formula weight  517.57  
Temperature/K  123.04(10)  
Crystal system  triclinic  
Space group  P1  
a/Å  8.8134(2)  
b/Å  11.4422(3)  
c/Å  13.9834(3)  
α/°  106.922(2)  
β/°  103.296(2)  
γ/°  96.903(2)  
Volume/Å3  1286.14(6)  
Z  2  
ρcalcmg/mm3  1.336  
m/mm-1  1.492  
F(000)  544.0  
Crystal size/mm3  0.203 × 0.065 × 0.059  
Radiation  Cu Kα (λ = 1.54184)  
2Θ range for data collection  6.88 to 147.02°  
Index ranges  -10 ≤ h ≤ 10, -14 ≤ k ≤ 14, -17 ≤ l ≤ 17  
Reflections collected  33167  
Independent reflections  9686 [Rint = 0.0326, Rsigma = 0.0280]  
Data/restraints/parameters  9686/3/673  
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Goodness-of-fit on F2  1.037  
Final R indexes [I>=2σ (I)]  R1 = 0.0319, wR2 = 0.0821  
Final R indexes [all data]  R1 = 0.0334, wR2 = 0.0835  
Largest diff. peak/hole / e Å-3  0.22/-0.25  
Flack parameter -0.009(8) 
 
 
Table 2. Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for (ent)-120c. Ueq is defined as 1/3 of the trace of the orthogonalized UIJ 
tensor. 
Atom x y z U(eq) 
S2 4261.5(7) 3280.3(5) 4081.9(4) 22.37(14) 
S1 8643.4(8) 9792.2(6) 8155.1(5) 28.41(15) 
O9 1741(2) 4461.8(18) 524.4(15) 28.0(4) 
O3 7781(2) 6614.4(18) 4297.5(14) 26.0(4) 
O10 3635(3) 3356(2) 248.7(18) 39.3(5) 
O4 5670(3) 7434(2) 3810.4(14) 31.1(4) 
O7 4730(2) 4474.7(17) 3990.8(16) 31.2(5) 
O8 3279(2) 3115(2) 4736.5(15) 34.9(5) 
O5 8272(2) 5615(2) 9311.2(16) 32.9(5) 
O6 5762(2) 5828(2) 8751.4(15) 31.6(4) 
O1 9801(3) 10159(2) 7671.7(19) 41.1(5) 
O2 9096(3) 9765(2) 9196.9(16) 39.7(5) 
O12 2476(2) -1809.8(19) 2476.2(18) 34.4(5) 
N00E 3336(2) 2362.7(18) 2906.8(15) 18.3(4) 
N00F 7704(3) 8380.6(19) 7422.8(16) 21.1(4) 
C21 4721(3) 7666(2) 5579.1(17) 16.8(4) 
O11 203(3) -1142(2) 2188(3) 56.7(8) 
C42 3988(3) -281(2) 1663.8(19) 20.2(5) 
C31 7413(3) 3249(2) 4342.3(19) 23.5(5) 
C22 3361(3) 6807(2) 5444.8(18) 19.5(5) 
C50 644(3) 3253(2) 1699.9(18) 17.3(5) 
C51 836(3) 4236(2) 2614.2(19) 19.6(5) 
C56 2564(3) 3582(2) 636(2) 23.3(5) 
C23 1939(3) 7184(2) 5485(2) 24.1(5) 
C40 2219(3) 1217(2) 2652.9(18) 17.5(5) 
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C33 8676(4) 1656(3) 4815(2) 34.8(7) 
C54 -2213(3) 3031(2) 1353(2) 23.5(5) 
C32 8733(3) 2712(3) 4519(2) 27.6(6) 
C12 9282(3) 6237(3) 7796.9(19) 22.0(5) 
C53 -2009(3) 4041(2) 2244(2) 23.7(5) 
C11 7677(3) 6398(2) 7925.4(18) 21.1(5) 
C39 1472(3) 750(2) 1503.4(18) 18.2(5) 
C52 -478(3) 4631(2) 2880(2) 23.6(5) 
C27 6654(3) 7048(2) 4472.6(18) 20.1(5) 
C9 6967(3) 6431(2) 6067.8(17) 16.7(5) 
C38 2345(3) 1588(2) 1068.2(18) 18.1(5) 
C49 2044(3) 2923(2) 1322.8(18) 18.3(5) 
C18 6914(3) 7511(2) 7807.9(18) 20.6(5) 
C37 3492(3) 2601(2) 1972.9(18) 16.9(5) 
C19 7111(3) 5908(3) 8690(2) 23.8(5) 
C10 6353(3) 6292(2) 6955.0(18) 18.3(5) 
C20 6250(3) 7266(2) 5488.5(17) 16.3(5) 
C13 9428(3) 5075(3) 7188(2) 28.8(6) 
C26 4614(3) 8913(2) 5752(2) 23.0(5) 
C8 7810(3) 7760(2) 6390.1(18) 17.5(5) 
C24 1839(3) 8427(3) 5643(2) 26.9(6) 
C41 2520(3) -24(2) 1989.2(18) 19.1(5) 
C55 -892(3) 2642(2) 1084.2(19) 21.3(5) 
C4 4851(5) 12129(3) 7884(2) 40.8(8) 
C43 5522(4) 395(3) 2163(2) 34.1(6) 
C30 6004(3) 2726(3) 4469.9(19) 24.7(5) 
C47 3786(3) -1303(3) 770(2) 31.0(6) 
C17 10614(3) 7198(3) 8241(2) 30.4(6) 
C14 10881(4) 4863(4) 7043(2) 39.8(8) 
C25 3180(3) 9291(2) 5775(2) 28.3(6) 
C46 5068(4) -1655(3) 432(2) 35.8(7) 
C1 7232(4) 10754(3) 8099(2) 30.3(6) 
C48 1580(3) -1056(2) 2202(2) 23.6(5) 
C44 6806(4) 52(3) 1812(3) 37.5(7) 
C2 7327(5) 11612(3) 7587(3) 39.6(7) 
C58 1685(4) -2805(3) 2747(3) 39.3(7) 
C45 6593(4) -976(3) 958(2) 32.4(6) 
F Appendix 
192 
C15 12195(4) 5817(4) 7480(3) 44.1(9) 
C6 6010(4) 10618(3) 8560(2) 37.3(7) 
C3 6133(5) 12287(3) 7484(3) 43.4(8) 
C5 4833(5) 11301(3) 8440(3) 43.3(8) 
C16 12061(4) 6986(4) 8068(3) 41.8(8) 
C57 2198(4) 5169(3) -108(3) 43.0(8) 
C35 5914(4) 1675(4) 4780(3) 43.5(8) 
C28 6040(5) 7304(4) 2831(3) 49.2(10) 
C34 7243(4) 1152(4) 4939(3) 49.1(10) 
C29 7822(4) 5184(4) 10111(3) 44.9(9) 
C36 10089(4) 1044(4) 4972(3) 48.2(9) 
C7 3519(5) 12822(4) 7720(3) 54.4(10) 
 
 
Table 3. Anisotropic Displacement Parameters (Å2×103) for (ent)-120c. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
S2 18.6(3) 25.2(3) 17.7(3) 0.2(2) 2.4(2) 6.1(2) 
S1 28.7(4) 23.2(3) 23.4(3) -2.1(2) 1.5(3) 4.6(3) 
O9 33.0(11) 31.7(10) 34.9(10) 23.2(9) 18.1(9) 16.9(8) 
O3 23.5(10) 38.3(10) 22.4(9) 11.0(8) 11.4(7) 16.7(8) 
O10 43.0(13) 52.1(13) 50.8(13) 36.1(11) 32.2(11) 28.4(10) 
O4 37.2(12) 48.2(12) 21.4(9) 19.2(8) 14.1(8) 27.6(10) 
O7 24.9(10) 18.3(9) 37.2(11) -2.9(8) -1.1(8) 4.3(8) 
O8 24.6(11) 52.3(13) 21.7(9) 1.8(9) 8.0(8) 8.8(9) 
O5 25.1(10) 57.5(13) 31(1) 30.9(10) 10.7(8) 16.6(9) 
O6 22.7(10) 51.8(12) 31.4(10) 23.3(9) 13.2(8) 13.8(9) 
O1 32.0(12) 29.7(11) 49.6(13) -1.1(9) 11.3(10) -2.8(9) 
O2 44.5(13) 36.2(11) 22.4(10) -3.9(8) -6.8(9) 14(1) 
O12 28.6(11) 32.4(10) 54.0(13) 30.3(10) 11.8(9) 9.3(8) 
N00E 18.8(10) 16.8(9) 17.7(9) 5.0(7) 3.0(8) 3.6(8) 
N00F 22.0(11) 22.3(10) 16.6(9) 3.0(8) 4.3(8) 5.7(8) 
C21 14.7(11) 23.0(11) 13.6(10) 6.5(9) 3.2(8) 7.1(9) 
O11 26.7(12) 52.2(15) 116(2) 59.0(16) 23.6(14) 12.5(10) 
C42 20.2(12) 18.6(11) 25.1(12) 11.4(10) 5.3(10) 7.2(9) 
C31 23.1(13) 25.6(12) 17.8(11) 4.2(9) 2.1(10) 3.8(10) 
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C22 20.1(12) 19.4(11) 18.6(11) 6.4(9) 3.2(9) 5.8(9) 
C50 18.0(12) 16.6(10) 20.5(11) 8.7(9) 7.3(9) 4.9(9) 
C51 20.6(12) 15.3(11) 22.8(11) 6.2(9) 6.4(9) 2.5(9) 
C56 23.9(13) 28.4(13) 25.5(12) 14.4(10) 11.4(10) 11.7(10) 
C23 14.8(12) 30.2(13) 29.1(13) 13.0(11) 5.6(10) 4.7(10) 
C40 15.1(11) 16.6(11) 20.8(11) 5.6(9) 5.2(9) 3.9(9) 
C33 29.2(16) 51.5(18) 35.0(15) 25.6(14) 11.0(12) 17.8(14) 
C54 18.6(12) 24.7(12) 27.7(12) 10.6(10) 5.2(10) 3.7(10) 
C32 23.3(14) 33.3(14) 25.0(12) 9.1(11) 5.4(10) 5.7(11) 
C12 16.3(12) 37.5(14) 17.2(11) 14.9(10) 3.8(9) 10.7(10) 
C53 21.1(13) 26.0(13) 31.8(13) 14.4(11) 13.2(11) 9.9(10) 
C11 17.3(12) 30.1(13) 18.7(11) 10.7(10) 5.3(9) 8.1(10) 
C39 14.9(12) 15.8(11) 22.4(11) 4.9(9) 3.0(9) 5.3(9) 
C52 27.8(14) 19.7(11) 25.1(12) 6.3(10) 11.3(10) 7.2(10) 
C27 20.6(13) 22.2(11) 17.8(11) 7.0(9) 4.9(9) 5.3(10) 
C9 15.5(11) 19.0(11) 15.6(10) 4.4(9) 4.5(9) 6.7(9) 
C38 18.2(12) 17.9(11) 19.1(11) 5.9(9) 5.1(9) 7.5(9) 
C49 20.4(12) 17.9(11) 19.2(11) 7.4(9) 7.2(9) 7.3(9) 
C18 17.3(12) 28.5(12) 17.8(11) 8.1(10) 5.7(9) 8.2(10) 
C37 15.5(12) 17.6(11) 19.3(11) 7.2(9) 5.7(9) 5.9(9) 
C19 22.1(14) 30.7(13) 21.1(12) 10.3(10) 6.5(10) 9.5(10) 
C10 13.2(11) 24.0(12) 18.7(11) 7.5(9) 4.1(9) 7.3(9) 
C20 15.2(11) 18.2(10) 15.2(10) 5.0(9) 3.5(9) 4.3(9) 
C13 24.3(14) 41.8(15) 24.2(13) 13.4(11) 6.0(11) 17.1(12) 
C26 20.0(13) 20.2(11) 29.7(13) 8.1(10) 7.7(10) 6.4(10) 
C8 16.1(12) 19.9(11) 15.8(10) 3.9(9) 4.6(9) 5.8(9) 
C24 18.9(13) 35.3(14) 36.1(14) 16.8(12) 13.6(11) 16.9(11) 
C41 17.9(12) 16.4(11) 22.0(11) 6.5(9) 2.7(9) 4.4(9) 
C55 23.4(13) 19.1(11) 19.9(11) 5.2(9) 4(1) 5.5(10) 
C4 57(2) 29.0(15) 29.0(15) 0.3(12) 3.9(14) 20.4(15) 
C43 24.6(15) 26.1(13) 40.1(16) -4.1(12) 6.8(12) 4.8(11) 
C30 23.1(13) 32.6(14) 16.9(11) 8.1(10) 2.2(10) 7.1(11) 
C47 22.4(14) 38.8(16) 24.7(13) 3.0(11) 3.1(11) 5.2(12) 
C17 21.0(13) 43.6(16) 26.9(13) 16.0(12) 1.3(11) 6.3(12) 
C14 33.5(17) 70(2) 25.4(14) 18.3(14) 10.4(12) 34.1(16) 
C25 28.0(14) 23.5(13) 37.6(15) 11.1(11) 11.9(12) 13.2(11) 
C46 35.7(17) 41.8(16) 25.9(13) 2.6(12) 9.0(12) 13.1(13) 
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C1 40.0(17) 23.4(13) 21.5(12) -0.5(10) 5.0(11) 10.8(12) 
C48 20.1(13) 20.6(11) 28.8(13) 8.8(10) 3.3(10) 3.8(10) 
C44 20.7(14) 34.4(15) 50.0(18) 3.5(13) 9.2(13) 5.1(12) 
C2 48(2) 26.2(14) 40.8(17) 8.0(13) 10.7(14) 4.3(13) 
C58 39.2(18) 36.0(16) 51.6(19) 30.0(15) 11.7(14) 4.2(13) 
C45 26.5(15) 39.3(16) 37.6(15) 15.2(12) 13.1(12) 14.4(12) 
C15 22.9(15) 94(3) 33.1(15) 34.7(17) 15.1(12) 27.6(17) 
C6 53(2) 36.9(16) 29.9(14) 11.9(12) 17.9(14) 24.1(14) 
C3 58(2) 25.9(14) 44.0(17) 11.9(13) 7.8(16) 11.0(14) 
C5 58(2) 42.2(17) 36.4(16) 10.0(13) 21.7(16) 27.1(16) 
C16 16.1(14) 71(2) 39.8(16) 29.1(16) 0.3(12) 3.3(14) 
C57 50(2) 50.8(19) 58(2) 43.6(17) 29.7(17) 26.9(16) 
C35 30.7(17) 66(2) 56(2) 45.2(19) 19.5(15) 17.2(16) 
C28 62(2) 86(3) 27.9(15) 34.5(17) 28.1(16) 50(2) 
C34 41(2) 69(2) 68(2) 57(2) 23.0(18) 22.7(18) 
C29 40.2(19) 74(2) 38.1(17) 39.7(17) 13.9(14) 17.0(17) 
C36 41(2) 63(2) 60(2) 38.8(19) 17.8(17) 26.4(17) 
C7 69(3) 45.0(19) 45.9(19) 8.6(16) 7.9(18) 32.4(19) 
 
 
Table 4. Bond Lengths for (ent)-120c. 
Atom Atom Length/Å  Atom Atom Length/Å 
S2 O7 1.430(2)  C33 C34 1.393(5) 
S2 O8 1.432(2)  C33 C36 1.504(4) 
S2 N00E 1.625(2)  C54 C53 1.389(4) 
S2 C30 1.763(3)  C54 C55 1.386(4) 
S1 O1 1.433(2)  C12 C11 1.492(4) 
S1 O2 1.430(2)  C12 C13 1.394(4) 
S1 N00F 1.634(2)  C12 C17 1.389(4) 
S1 C1 1.760(3)  C53 C52 1.395(4) 
O9 C56 1.333(3)  C11 C18 1.543(4) 
O9 C57 1.449(3)  C11 C19 1.494(3) 
O3 C27 1.205(3)  C11 C10 1.536(3) 
O10 C56 1.209(3)  C39 C38 1.503(3) 
O4 C27 1.329(3)  C39 C41 1.535(3) 
O4 C28 1.450(3)  C27 C20 1.502(3) 
O5 C19 1.325(3)  C9 C10 1.504(3) 
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O5 C29 1.459(3)  C9 C20 1.526(3) 
O6 C19 1.206(3)  C9 C8 1.497(3) 
O12 C48 1.316(3)  C38 C49 1.535(3) 
O12 C58 1.452(3)  C38 C37 1.497(3) 
N00E C40 1.439(3)  C49 C37 1.538(3) 
N00E C37 1.442(3)  C18 C10 1.486(3) 
N00F C18 1.444(3)  C20 C8 1.550(3) 
N00F C8 1.442(3)  C13 C14 1.380(4) 
C21 C22 1.394(3)  C26 C25 1.388(4) 
C21 C20 1.495(3)  C24 C25 1.386(4) 
C21 C26 1.395(3)  C41 C48 1.500(3) 
O11 C48 1.201(4)  C4 C3 1.385(5) 
C42 C41 1.500(4)  C4 C5 1.391(5) 
C42 C43 1.383(4)  C4 C7 1.506(5) 
C42 C47 1.399(4)  C43 C44 1.388(4) 
C31 C32 1.385(4)  C30 C35 1.392(4) 
C31 C30 1.384(4)  C47 C46 1.380(4) 
C22 C23 1.381(4)  C17 C16 1.388(5) 
C50 C51 1.395(3)  C14 C15 1.374(5) 
C50 C49 1.496(3)  C46 C45 1.383(4) 
C50 C55 1.395(3)  C1 C2 1.378(4) 
C51 C52 1.382(4)  C1 C6 1.392(4) 
C56 C49 1.498(3)  C44 C45 1.367(4) 
C23 C24 1.392(4)  C2 C3 1.384(5) 
C40 C39 1.494(3)  C15 C16 1.386(6) 
C40 C41 1.545(3)  C6 C5 1.380(5) 
C33 C32 1.385(4)  C35 C34 1.380(5) 
 
 
Table 5. Bond Angles for (ent)-120c. 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
O7 S2 O8 121.33(14)  C37 C38 C39 107.19(19) 
O7 S2 N00E 105.72(11)  C37 C38 C49 60.95(15) 
O7 S2 C30 107.75(12)  C50 C49 C56 117.5(2) 
O8 S2 N00E 107.32(12)  C50 C49 C38 121.23(19) 
O8 S2 C30 107.56(13)  C50 C49 C37 124.02(19) 
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N00E S2 C30 106.27(12)  C56 C49 C38 112.5(2) 
O1 S1 N00F 106.67(12)  C56 C49 C37 109.7(2) 
O1 S1 C1 107.89(15)  C38 C49 C37 58.32(15) 
O2 S1 O1 121.51(15)  N00F C18 C11 118.2(2) 
O2 S1 N00F 106.16(12)  N00F C18 C10 107.9(2) 
O2 S1 C1 107.26(14)  C10 C18 C11 60.94(16) 
N00F S1 C1 106.49(13)  N00E C37 C38 107.41(18) 
C56 O9 C57 115.9(2)  N00E C37 C49 116.9(2) 
C27 O4 C28 115.2(2)  C38 C37 C49 60.73(15) 
C19 O5 C29 115.3(2)  O5 C19 C11 112.2(2) 
C48 O12 C58 115.7(2)  O6 C19 O5 124.2(2) 
C40 N00E S2 124.84(16)  O6 C19 C11 123.5(2) 
C40 N00E C37 110.57(18)  C9 C10 C11 113.4(2) 
C37 N00E S2 124.58(16)  C18 C10 C11 61.36(17) 
C18 N00F S1 123.26(17)  C18 C10 C9 106.9(2) 
C8 N00F S1 125.04(17)  C21 C20 C27 118.9(2) 
C8 N00F C18 110.65(19)  C21 C20 C9 122.2(2) 
C22 C21 C20 121.4(2)  C21 C20 C8 122.9(2) 
C22 C21 C26 118.6(2)  C27 C20 C9 111.1(2) 
C26 C21 C20 119.9(2)  C27 C20 C8 108.9(2) 
C43 C42 C41 126.3(2)  C9 C20 C8 58.26(14) 
C43 C42 C47 116.9(3)  C14 C13 C12 120.9(3) 
C47 C42 C41 116.9(2)  C25 C26 C21 120.8(2) 
C30 C31 C32 119.5(2)  N00F C8 C9 107.40(19) 
C23 C22 C21 120.7(2)  N00F C8 C20 118.2(2) 
C51 C50 C49 121.1(2)  C9 C8 C20 60.07(15) 
C55 C50 C51 119.0(2)  C25 C24 C23 119.7(3) 
C55 C50 C49 119.6(2)  C42 C41 C40 128.7(2) 
C52 C51 C50 120.2(2)  C42 C41 C39 120.0(2) 
O9 C56 C49 112.3(2)  C39 C41 C40 58.02(15) 
O10 C56 O9 124.2(2)  C48 C41 C42 116.7(2) 
O10 C56 C49 123.4(2)  C48 C41 C40 107.2(2) 
C22 C23 C24 120.3(2)  C48 C41 C39 113.0(2) 
N00E C40 C39 108.08(18)  C54 C55 C50 120.8(2) 
N00E C40 C41 120.1(2)  C3 C4 C5 117.7(3) 
C39 C40 C41 60.68(15)  C3 C4 C7 121.4(3) 
C32 C33 C34 117.7(3)  C5 C4 C7 120.9(4) 
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C32 C33 C36 121.7(3)  C42 C43 C44 121.5(3) 
C34 C33 C36 120.5(3)  C31 C30 S2 119.4(2) 
C55 C54 C53 119.7(2)  C31 C30 C35 120.4(3) 
C33 C32 C31 121.5(3)  C35 C30 S2 119.8(2) 
C13 C12 C11 118.0(2)  C46 C47 C42 121.5(3) 
C17 C12 C11 122.8(3)  C16 C17 C12 119.6(3) 
C17 C12 C13 119.2(3)  C15 C14 C13 119.8(3) 
C54 C53 C52 119.7(2)  C24 C25 C26 119.9(2) 
C12 C11 C18 124.5(2)  C47 C46 C45 120.4(3) 
C12 C11 C19 118.1(2)  C2 C1 S1 120.1(3) 
C12 C11 C10 118.0(2)  C2 C1 C6 120.8(3) 
C19 C11 C18 110.3(2)  C6 C1 S1 119.1(2) 
C19 C11 C10 114.1(2)  O12 C48 C41 111.7(2) 
C10 C11 C18 57.70(16)  O11 C48 O12 123.9(2) 
C40 C39 C38 106.30(19)  O11 C48 C41 124.3(3) 
C40 C39 C41 61.30(16)  C45 C44 C43 120.8(3) 
C38 C39 C41 113.3(2)  C1 C2 C3 118.9(3) 
C51 C52 C53 120.4(2)  C44 C45 C46 118.9(3) 
O3 C27 O4 124.1(2)  C14 C15 C16 120.0(3) 
O3 C27 C20 123.5(2)  C5 C6 C1 118.9(3) 
O4 C27 C20 112.4(2)  C2 C3 C4 122.0(3) 
C10 C9 C20 117.7(2)  C6 C5 C4 121.7(3) 
C8 C9 C10 106.96(19)  C15 C16 C17 120.5(3) 
C8 C9 C20 61.68(15)  C34 C35 C30 118.8(3) 
C39 C38 C49 115.8(2)  C35 C34 C33 122.0(3) 
 
 
Table 6. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for (ent)-120c. 
Atom x y z U(eq) 
H31 7472.81 3954.15 4139.45 28 
H22 3411.35 5971.59 5326.69 23 
H51 1852.08 4627.72 3046.25 24 
H23 1045.12 6604.59 5406.92 29 
H40 1527.15 1179.92 3105.13 21 
H54 -3230.98 2616.4 938.31 28 
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H32 9679.92 3069.29 4437.64 33 
H53 -2889.26 4322.48 2416.43 28 
H39 318.78 446.55 1218.86 22 
H52 -341.22 5293.67 3486.06 28 
H9 7448.85 5770.3 5706.92 20 
H38 2673.38 1220.65 441.11 22 
H18 6208.54 7798.48 8237.07 25 
H37 4555.17 2886.54 1922.56 20 
H10 5288.24 5800.82 6817.51 22 
H13 8535.24 4433.75 6875.47 35 
H26 5514.08 9499.11 5852.23 28 
H8 8818.22 7937.53 6226.24 21 
H24 876.22 8677.2 5658.76 32 
H55 -1030.54 1967.32 486.33 26 
H43 5696.5 1096.26 2746.47 41 
H47 2765.44 -1755.31 395.46 37 
H17 10536.84 7977.45 8651.42 37 
H14 10970.63 4077.6 6650.33 48 
H25 3119.65 10123.13 5880.27 34 
H46 4904.72 -2352.13 -152.55 43 
H44 7822.99 527.21 2161.12 45 
H2 8179.14 11735.77 7315.65 48 
H58A 937.8 -3394.76 2132.97 59 
H58B 1131.32 -2461.52 3245.78 59 
H58C 2461.22 -3217.51 3041.41 59 
H45 7459.71 -1214.67 735.57 39 
H15 13174.38 5677.82 7380.98 53 
H6 5986.35 10076.28 8941.52 45 
H3 6191.95 12864.31 7136.98 52 
H5 4006.64 11204.92 8739.01 52 
H16 12947.99 7633.63 8348.36 50 
H57A 1956.98 4629.47 -815.64 65 
H57B 3319.75 5512.21 151.42 65 
H57C 1621.13 5832.33 -78.08 65 
H35 4974.48 1330.43 4878.04 52 
H28A 5852.07 6435.02 2432.14 74 
H28B 7136.89 7673.74 2964.63 74 
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H28C 5375.03 7715.5 2447.73 74 
H34 7180.63 441.56 5134.21 59 
H29A 6957.89 4475.3 9787.62 67 
H29B 7495.8 5841.15 10573.7 67 
H29C 8716.29 4951.48 10496.81 67 
H36A 9927.85 303.22 4387.14 72 
H36B 10209.07 828.08 5595.4 72 
H36C 11030.64 1610.15 5033.52 72 
H7A 3796.43 13625.84 8251.26 82 
H7B 2563.84 12356.8 7755.29 82 
H7C 3347.32 12926.71 7049.06 82 
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Table 1. Crystal data and structure refinement for 126.  
Identification code  P047  
Empirical formula  C24H21NO4S  
Formula weight  419.48  
Temperature/K  123.01(10)  
Crystal system  orthorhombic  
Space group  P212121  
a/Å  8.61361(8)  
b/Å  12.18576(11)  
c/Å  19.50535(15)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  2047.35(3)  
Z  4  
ρcalcmg/mm3  1.361  
m/mm-1  1.667  
F(000)  880.0  
Crystal size/mm3  0.362 × 0.267 × 0.215  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection  8.556 to 147.946°  
Index ranges  -10 ≤ h ≤ 9, -14 ≤ k ≤ 12, -24 ≤ l ≤ 21  
Reflections collected  12042  
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Independent reflections  4071 [Rint = 0.0238, Rsigma = 0.0206]  
Data/restraints/parameters  4071/0/273  
Goodness-of-fit on F2  1.048  
Final R indexes [I>=2σ (I)]  R1 = 0.0260, wR2 = 0.0677  
Final R indexes [all data]  R1 = 0.0263, wR2 = 0.0678  
Largest diff. peak/hole / e Å-3  0.13/-0.33  
Flack parameter -0.012(6) 
 
 
Table 2. Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 126. Ueq is defined as 1/3 of the trace of the orthogonalized UIJ tensor. 
Atom x y z U(eq) 
S001 4935.0(5) 5917.7(3) 2835.4(2) 21.17(11) 
O1 3717.5(16) 5891.1(12) 2335.1(6) 28.0(3) 
O4 -636.3(15) 3427.3(11) 3836.1(6) 24.5(3) 
O2 5419.9(17) 6935.1(10) 3131.1(7) 29.3(3) 
O3 977.1(18) 2702.7(13) 3056.0(8) 37.3(4) 
N1 4293.2(18) 5152.7(13) 3471.7(7) 21.9(3) 
C5 6582(2) 5257.3(14) 2494.4(8) 20.4(3) 
C4 6388(2) 4346.6(14) 2071.2(9) 22.5(3) 
C13 1553(2) 4826.8(14) 4387.9(9) 20.6(3) 
C14 1208(2) 5912.3(16) 4234.9(9) 26.0(4) 
C8 5160(2) 4921.6(15) 4079.4(8) 22.7(4) 
C9 4708(2) 3903.3(15) 4339.6(9) 24.8(4) 
C3 7682(2) 3861.2(16) 1779.4(9) 26.1(4) 
C17 1127(2) 5206.1(16) 5589.4(9) 26.3(4) 
C10 3537(2) 3398.7(15) 3886.9(9) 24.7(4) 
C6 8045(2) 5661.2(16) 2639.2(9) 26.6(4) 
C18 1511(2) 4481.7(15) 5070.5(9) 23.6(4) 
C12 1969(2) 4023.1(15) 3838.9(9) 22.2(3) 
C15 834(3) 6642.2(16) 4757.4(10) 31.0(4) 
C11 3282(2) 4225.6(15) 3329.9(9) 22.9(4) 
C2 9169(2) 4272.9(16) 1901.0(9) 26.7(4) 
C7 9331(2) 5166.5(17) 2340.1(10) 29.7(4) 
C20 5347(2) 3523.2(17) 4950.1(10) 30.8(4) 
C23 6268(2) 5563.6(17) 4400.7(9) 27.4(4) 
C19 739(2) 3322.3(15) 3529.4(9) 24.3(4) 
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C24 -1841(2) 2719.4(18) 3560.2(10) 30.0(4) 
C16 793(2) 6290.8(16) 5435.8(10) 29.2(4) 
C21 6456(3) 4155(2) 5277.2(10) 36.5(5) 
C22 6919(2) 5152(2) 5004.1(10) 34.1(5) 
C1 10561(3) 3781(2) 1551.0(11) 37.4(5) 
 
 
Table 3. Anisotropic Displacement Parameters (Å2×103) for 126. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
S001 26.4(2) 19.13(19) 17.97(18) 1.70(14) 0.23(15) 2.61(17) 
O1 30.4(7) 32.0(7) 21.6(6) 2.6(5) -3.3(5) 6.8(6) 
O4 23.9(6) 28.6(7) 20.8(6) -2.1(5) 2.6(5) -1.1(5) 
O2 40.5(8) 19.3(6) 28.0(6) -1.5(5) 0.6(6) 2.0(5) 
O3 36.3(8) 38.7(8) 37.1(8) -19.0(6) 12.3(6) -8.7(6) 
N1 23.2(7) 26.4(7) 16.2(6) 0.3(6) 0.0(6) -1.6(6) 
C5 25.0(9) 20.2(8) 16.0(7) 3.2(6) 3.1(6) -0.7(7) 
C4 23.7(8) 24.8(8) 18.9(8) 0.7(6) -1.1(6) -2.6(7) 
C13 21.1(8) 22.3(8) 18.3(7) -2.1(6) 1.5(6) -0.5(7) 
C14 32.7(10) 25.3(9) 20.2(8) -0.3(7) 1.6(7) 1.4(8) 
C8 21.8(9) 28.0(9) 18.4(7) -0.3(6) 1.5(7) 6.3(7) 
C9 24.1(9) 27.2(9) 23.1(8) 1.4(7) 4.6(7) 8.5(7) 
C3 30.1(9) 27.3(9) 20.8(8) -3.0(7) 0.7(7) 0.6(7) 
C17 26.9(9) 33.7(10) 18.4(7) -2.5(7) 0.7(7) -3.3(8) 
C10 26.8(9) 20.7(9) 26.4(8) -1.3(7) 5.8(7) 3.7(7) 
C6 31.6(10) 25.1(9) 23.1(8) -1.6(7) 1.9(7) -8.1(7) 
C18 23.9(9) 25.0(9) 21.7(8) 1.0(7) 1.9(7) 0.2(7) 
C12 24.0(8) 22.4(8) 20.2(7) -1.4(7) 2.9(6) 1.1(7) 
C15 41.9(12) 21.5(9) 29.5(9) -3.1(7) 3.9(8) 3.2(8) 
C11 24.9(8) 24.0(9) 19.7(7) -2.5(7) 3.0(6) -1.0(7) 
C2 27.2(9) 32.5(10) 20.5(8) 4.4(7) 3.3(7) 0.6(8) 
C7 25.9(9) 34.8(10) 28.3(9) 0.6(8) 2.4(8) -7.5(8) 
C20 32.3(11) 32.9(10) 27.0(9) 8.5(8) 6.3(8) 12.2(8) 
C23 26.2(9) 33.2(10) 22.9(8) 0.2(7) -0.1(7) 0.6(8) 
C19 27.7(9) 23.1(8) 22.1(8) -1.0(7) 5.1(7) -0.7(7) 
C24 27(1) 36.1(10) 26.8(9) -0.5(8) -0.4(7) -6.2(8) 
C16 33.1(10) 30.3(10) 24.2(8) -9.2(7) 5.1(8) -2.4(8) 
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C21 34.0(11) 50.4(13) 25.1(9) 7.5(9) -1.6(8) 15.3(10) 
C22 28.1(10) 48.3(12) 26.0(9) -3.2(9) -4.8(8) 3.9(9) 
C1 29.7(10) 53.3(13) 29.3(9) -3.5(9) 5.9(8) 2.7(9) 
 
 
Table 4. Bond Lengths for 126. 
Atom Atom Length/Å  Atom Atom Length/Å 
S001 O1 1.4330(13)  C8 C23 1.384(3) 
S001 O2 1.4296(13)  C9 C10 1.475(3) 
S001 N1 1.6478(15)  C9 C20 1.391(3) 
S001 C5 1.7616(18)  C3 C2 1.396(3) 
O4 C19 1.333(2)  C17 C18 1.383(3) 
O4 C24 1.453(2)  C17 C16 1.385(3) 
O3 C19 1.210(2)  C10 C12 1.553(2) 
N1 C8 1.429(2)  C10 C11 1.498(3) 
N1 C11 1.453(2)  C6 C7 1.389(3) 
C5 C4 1.393(2)  C12 C11 1.525(2) 
C5 C6 1.382(3)  C12 C19 1.489(3) 
C4 C3 1.384(3)  C15 C16 1.391(3) 
C13 C14 1.388(3)  C2 C7 1.392(3) 
C13 C18 1.397(2)  C2 C1 1.504(3) 
C13 C12 1.495(2)  C20 C21 1.383(3) 
C14 C15 1.391(3)  C23 C22 1.397(3) 
C8 C9 1.396(3)  C21 C22 1.385(3) 
 
 
Table 5. Bond Angles for 126. 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
O1 S001 N1 104.75(8)  C9 C10 C11 104.72(15) 
O1 S001 C5 108.78(8)  C11 C10 C12 59.95(12) 
O2 S001 O1 120.54(8)  C5 C6 C7 119.11(17) 
O2 S001 N1 106.55(8)  C17 C18 C13 120.76(17) 
O2 S001 C5 108.25(9)  C13 C12 C10 119.10(15) 
N1 S001 C5 107.23(8)  C13 C12 C11 122.56(16) 
C19 O4 C24 114.30(14)  C11 C12 C10 58.23(12) 
C8 N1 S001 124.12(13)  C19 C12 C13 119.72(15) 
F Appendix 
204 
C8 N1 C11 108.54(14)  C19 C12 C10 111.24(15) 
C11 N1 S001 119.84(11)  C19 C12 C11 110.89(14) 
C4 C5 S001 119.42(14)  C14 C15 C16 120.39(18) 
C6 C5 S001 119.64(14)  N1 C11 C10 107.27(15) 
C6 C5 C4 120.93(17)  N1 C11 C12 116.51(15) 
C3 C4 C5 119.19(17)  C10 C11 C12 61.82(12) 
C14 C13 C18 119.10(16)  C3 C2 C1 120.75(18) 
C14 C13 C12 121.44(16)  C7 C2 C3 118.50(18) 
C18 C13 C12 119.46(16)  C7 C2 C1 120.73(18) 
C13 C14 C15 120.11(17)  C6 C7 C2 121.20(18) 
C9 C8 N1 109.32(16)  C21 C20 C9 118.89(19) 
C23 C8 N1 128.64(17)  C8 C23 C22 117.08(19) 
C23 C8 C9 122.02(16)  O4 C19 C12 113.28(15) 
C8 C9 C10 110.10(15)  O3 C19 O4 123.57(18) 
C20 C9 C8 119.77(19)  O3 C19 C12 123.13(17) 
C20 C9 C10 130.12(18)  C17 C16 C15 119.61(17) 
C4 C3 C2 121.02(17)  C20 C21 C22 120.63(18) 
C18 C17 C16 120.02(17)  C21 C22 C23 121.6(2) 
C9 C10 C12 115.25(15)      
 
 
Table 6. Torsion Angles for 126. 
A B C D Angle/˚  A B C D Angle/˚ 
S001 N1 C8 C9 -151.21(13)  C8 C9 C20 C21 -1.8(3) 
S001 N1 C8 C23 29.9(3)  C8 C23 C22 C21 -1.3(3) 
S001 N1 C11 C10 151.79(12)  C9 C8 C23 C22 -0.3(3) 
S001 N1 C11 C12 -141.63(14)  C9 C10 C12 C13 -19.4(2) 
S001 C5 C4 C3 177.08(13)  C9 C10 C12 C11 92.96(17) 
S001 C5 C6 C7 -176.86(14)  C9 C10 C12 C19 -164.96(15) 
O1 S001 N1 C8 178.08(14)  C9 C10 C11 N1 0.38(18) 
O1 S001 N1 C11 31.82(15)  C9 C10 C11 C12 -110.95(15) 
O1 S001 C5 C4 -35.98(16)  C9 C20 C21 C22 0.3(3) 
O1 S001 C5 C6 142.79(14)  C3 C2 C7 C6 -1.7(3) 
O2 S001 N1 C8 -53.13(16)  C10 C9 C20 C21 179.23(18) 
O2 S001 N1 C11 160.61(14)  C10 C12 C11 N1 -96.27(17) 
O2 S001 C5 C4 -168.61(13)  C10 C12 C19 O4 139.34(15) 
O2 S001 C5 C6 10.16(16)  C10 C12 C19 O3 -39.2(2) 
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N1 S001 C5 C4 76.79(15)  C6 C5 C4 C3 -1.7(3) 
N1 S001 C5 C6 -104.44(15)  C18 C13 C14 C15 0.2(3) 
N1 C8 C9 C10 2.03(19)  C18 C13 C12 C10 -56.3(2) 
N1 C8 C9 C20 -177.15(16)  C18 C13 C12 C11 -125.25(19) 
N1 C8 C23 C22 178.46(18)  C18 C13 C12 C19 86.4(2) 
C5 S001 N1 C8 62.61(16)  C18 C17 C16 C15 0.6(3) 
C5 S001 N1 C11 -83.65(15)  C12 C13 C14 C15 -179.64(18) 
C5 C4 C3 C2 -0.2(3)  C12 C13 C18 C17 -179.84(17) 
C5 C6 C7 C2 -0.2(3)  C12 C10 C11 N1 111.33(16) 
C4 C5 C6 C7 1.9(3)  C11 N1 C8 C9 -1.75(19) 
C4 C3 C2 C7 1.9(3)  C11 N1 C8 C23 179.38(18) 
C4 C3 C2 C1 -176.53(18)  C11 C10 C12 C13 -112.32(18) 
C13 C14 C15 C16 -0.3(3)  C11 C10 C12 C19 102.08(16) 
C13 C12 C11 N1 10.2(2)  C11 C12 C19 O4 -157.81(15) 
C13 C12 C11 C10 106.46(19)  C11 C12 C19 O3 23.7(3) 
C13 C12 C19 O4 -6.0(2)  C20 C9 C10 C12 114.3(2) 
C13 C12 C19 O3 175.49(18)  C20 C9 C10 C11 177.60(18) 
C14 C13 C18 C17 0.3(3)  C20 C21 C22 C23 1.3(3) 
C14 C13 C12 C10 123.57(19)  C23 C8 C9 C10 -179.01(16) 
C14 C13 C12 C11 54.6(3)  C23 C8 C9 C20 1.8(3) 
C14 C13 C12 C19 -93.8(2)  C19 C12 C11 N1 161.04(15) 
C14 C15 C16 C17 -0.1(3)  C19 C12 C11 C10 -102.70(16) 
C8 N1 C11 C10 0.80(19)  C24 O4 C19 O3 0.8(3) 
C8 N1 C11 C12 67.38(19)  C24 O4 C19 C12 -177.71(15) 
C8 C9 C10 C12 -64.82(19)  C16 C17 C18 C13 -0.7(3) 
C8 C9 C10 C11 -1.47(19)  C1 C2 C7 C6 176.75(19) 
 
 
Table 7. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for 126. 
Atom x y z U(eq) 
H4 5402 4068 1986 27 
H14 1228 6152 3782 31 
H3 7559 3251 1498 31 
H17 1092 4965 6042 32 
H10 3589 2615 3778 30 
H6 8167 6256 2933 32 
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H18 1745 3756 5177 28 
H15 609 7370 4653 37 
H11 3165 3972 2856 27 
H7 10317 5437 2435 36 
H20 5034 2855 5135 37 
H23 6565 6240 4223 33 
H24A -1990 2881 3083 45 
H24B -2793 2844 3804 45 
H24C -1536 1966 3611 45 
H16 544 6781 5784 35 
H21 6896 3908 5685 44 
H22 7682 5556 5228 41 
H1A 10521 2996 1589 56 
H1B 11491 4047 1765 56 
H1C 10560 3987 1076 56 
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Table 1. Crystal data and structure refinement for 145. 
Identification code P056 
Empirical formula C20H23NO4S 
Formula weight 373.45 
Temperature/K 123.00(10) 
Crystal system triclinic 
Space group P1 
a/Å 5.7954(2) 
b/Å 8.1636(4) 
c/Å 10.5823(3) 
α/° 78.116(4) 
β/° 87.172(3) 
γ/° 74.207(4) 
Volume/Å3 471.42(4) 
Z 1 
ρcalcmg/mm3 1.315 
m/mm-1 1.733 
F(000) 198.0 
Crystal size/mm3 0.611 × 0.159 × 0.085 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection 8.538 to 153.528° 
Index ranges -7 ≤ h ≤ 7, -10 ≤ k ≤ 10, -13 ≤ l ≤ 13 
Reflections collected 12493 
Independent reflections 3552 [Rint = 0.0297, Rsigma = 0.0241] 
Data/restraints/parameters 3552/3/237 
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Goodness-of-fit on F2 1.127 
Final R indexes [I>=2σ (I)] R1 = 0.0526, wR2 = 0.1464 
Final R indexes [all data] R1 = 0.0530, wR2 = 0.1485 
Largest diff. peak/hole / e Å-3 0.25/-0.48 
Flack parameter 0.02(2) 
 
 
Table 2. Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for 145. Ueq is defined as 1/3 of the trace of the orthogonalized UIJ tensor. 
Atom x y z U(eq) 
S1 1890.3(9) 3042.2(8) 6268.6(6) 24.5(3) 
O4 8893(5) 9014(4) 3573(3) 28.3(6) 
O1 1815(6) 2040(4) 5315(3) 34.8(7) 
O2 -218(5) 3644(5) 6997(3) 34.2(7) 
O3 5171(5) 9863(4) 2744(3) 38.8(8) 
N1 2612(5) 4782(4) 5516(3) 20.8(6) 
C12 7005(6) 6801(5) 3586(3) 21.3(7) 
C19 6847(6) 8743(5) 3250(3) 23.5(7) 
C8 4688(6) 4642(5) 4648(3) 20.2(6) 
C4 4219(7) 2145(6) 8594(3) 28.9(8) 
C16 8574(8) 4746(7) 101(4) 35.0(9) 
C14 9688(7) 4877(5) 2231(4) 26.3(8) 
C5 4242(7) 1843(5) 7350(3) 25.4(8) 
C2 8128(8) 102(5) 9013(4) 28.9(8) 
C6 6204(9) 677(6) 6924(4) 34.5(9) 
C9 4676(6) 6551(5) 4233(3) 19.9(7) 
C15 10215(8) 4214(6) 1111(4) 33.3(9) 
C13 7523(6) 6079(5) 2356(3) 22.2(7) 
C20 9031(8) 10806(6) 3241(4) 33.3(9) 
C11 2393(8) 6220(5) 6205(4) 28.8(8) 
C3 6148(8) 1272(6) 9419(4) 31.8(9) 
C10 4170(7) 7189(5) 5514(4) 26.0(8) 
C7 8121(9) -170(6) 7758(4) 37.7(10) 
C18 5889(7) 6605(7) 1336(4) 36(1) 
C1 10225(9) -808(7) 9898(5) 40.2(10) 
C17 6408(8) 5941(8) 224(4) 41.6(11) 
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Table 3. Anisotropic Displacement Parameters (Å2×103) for 145. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
S1 26.7(4) 31.0(5) 18.3(4) -2.3(3) -2.9(3) -13.1(4) 
O4 25.4(13) 23.0(14) 36.9(14) -6.8(11) -8.5(11) -5.2(11) 
O1 49.4(18) 38.4(17) 23.9(13) -5.2(11) -8.1(12) -23.0(15) 
O2 22.3(13) 50.5(19) 27.4(13) -0.9(12) 1.1(11) -11.2(13) 
O3 24.0(14) 26.4(15) 59(2) 6.4(13) -9.7(13) -3.7(12) 
N1 20.8(14) 21.5(15) 18.4(12) -4.1(11) 1.4(10) -3.3(12) 
C12 15.8(14) 20.4(17) 24.6(17) -2.5(13) -3.1(12) -0.7(13) 
C19 22.3(17) 23.8(18) 23.1(15) -3.3(13) -0.9(13) -4.9(14) 
C8 17.9(15) 22.0(16) 20.3(15) -5.6(12) 0.7(12) -3.7(13) 
C4 22.3(17) 40(2) 18.0(16) -4.5(15) -3.0(13) 1.2(16) 
C16 33(2) 47(3) 26.7(18) -13.6(17) 4.6(16) -10.0(19) 
C14 21.5(17) 28.3(19) 26.0(17) -1.9(14) -1.9(13) -3.5(15) 
C5 33(2) 27.7(19) 19.2(16) -4.3(13) 1.5(13) -15.0(17) 
C2 31(2) 22.1(19) 28.1(19) 2.5(14) -2.8(15) -3.8(16) 
C6 53(3) 24(2) 24.3(18) -10.0(15) -1.4(17) -3.8(19) 
C9 15.7(15) 20.3(17) 20.5(15) -2.1(12) -2.6(12) -0.5(13) 
C15 28.7(19) 34(2) 34(2) -9.2(17) 4.0(16) -1.6(17) 
C13 21.1(16) 23.6(17) 21.1(16) -1.5(13) -0.3(12) -6.9(14) 
C20 36(2) 24(2) 42(2) -8.8(16) -5.8(17) -9.0(17) 
C11 34(2) 29(2) 24.7(17) -11.7(15) 5.9(15) -7.4(16) 
C3 34(2) 40(2) 18.3(16) -4.8(15) -1.9(15) -4.9(18) 
C10 30.1(19) 23.3(19) 26.3(17) -9.9(14) 2.0(14) -6.5(16) 
C7 44(3) 24(2) 35(2) -7.4(16) -3.0(18) 9.0(18) 
C18 19.0(18) 54(3) 28.8(19) -11.6(19) -4.3(15) 3.1(18) 
C1 37(2) 39(2) 36(2) 3.2(18) -6.9(18) -0.6(19) 
C17 27(2) 69(3) 27(2) -17(2) -7.4(16) -2(2) 
 
 
Table 4. Bond Lengths for 145. 
Atom Atom Length/Å  Atom Atom Length/Å 
S1 O1 1.433(3)  C4 C3 1.388(5) 
S1 O2 1.437(3)  C16 C15 1.386(6) 
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S1 N1 1.628(3)  C16 C17 1.384(7) 
S1 C5 1.758(4)  C14 C15 1.389(6) 
O4 C19 1.336(4)  C14 C13 1.386(6) 
O4 C20 1.456(5)  C5 C6 1.393(6) 
O3 C19 1.197(5)  C2 C3 1.392(6) 
N1 C8 1.471(4)  C2 C7 1.391(6) 
N1 C11 1.479(5)  C2 C1 1.497(6) 
C12 C19 1.530(5)  C6 C7 1.386(6) 
C12 C9 1.527(5)  C9 C10 1.537(5) 
C12 C13 1.521(5)  C13 C18 1.391(5) 
C8 C9 1.528(5)  C11 C10 1.533(5) 
C4 C5 1.388(5)  C18 C17 1.381(6) 
 
 
Table 5. Bond Angles for 145. 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
O1 S1 O2 120.12(19)  C4 C5 S1 120.1(3) 
O1 S1 N1 106.63(16)  C4 C5 C6 120.2(4) 
O1 S1 C5 107.64(19)  C6 C5 S1 119.6(3) 
O2 S1 N1 105.74(18)  C3 C2 C1 120.7(4) 
O2 S1 C5 108.78(17)  C7 C2 C3 118.2(4) 
N1 S1 C5 107.29(16)  C7 C2 C1 121.1(4) 
C19 O4 C20 115.7(3)  C7 C6 C5 119.1(4) 
C8 N1 S1 120.3(2)  C12 C9 C8 113.1(3) 
C8 N1 C11 110.4(3)  C12 C9 C10 114.1(3) 
C11 N1 S1 118.8(2)  C8 C9 C10 101.9(3) 
C9 C12 C19 109.0(3)  C16 C15 C14 120.3(4) 
C13 C12 C19 108.4(3)  C14 C13 C12 119.6(3) 
C13 C12 C9 113.0(3)  C14 C13 C18 118.6(4) 
O4 C19 C12 110.0(3)  C18 C13 C12 121.8(3) 
O3 C19 O4 124.4(4)  N1 C11 C10 104.0(3) 
O3 C19 C12 125.6(3)  C4 C3 C2 120.9(4) 
N1 C8 C9 100.7(3)  C11 C10 C9 104.2(3) 
C5 C4 C3 119.9(4)  C6 C7 C2 121.7(4) 
C17 C16 C15 119.1(4)  C17 C18 C13 120.7(4) 
C13 C14 C15 120.7(3)  C18 C17 C16 120.5(4) 
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Table 6. Torsion Angles for 145. 
A B C D Angle/˚  A B C D Angle/˚ 
S1 N1 C8 C9 -178.1(2)  C5 S1 N1 C11 -76.1(3) 
S1 N1 C11 C10 155.6(3)  C5 C4 C3 C2 0.6(6) 
S1 C5 C6 C7 175.5(3)  C5 C6 C7 C2 0.6(7) 
O1 S1 N1 C8 -49.8(3)  C9 C12 C19 O4 135.7(3) 
O1 S1 N1 C11 168.8(3)  C9 C12 C19 O3 -46.0(5) 
O1 S1 C5 C4 -156.4(3)  C9 C12 C13 C14 -124.7(3) 
O1 S1 C5 C6 28.0(4)  C9 C12 C13 C18 56.0(5) 
O2 S1 N1 C8 -178.7(2)  C15 C16 C17 C18 0.4(8) 
O2 S1 N1 C11 39.9(3)  C15 C14 C13 C12 -179.2(4) 
O2 S1 C5 C4 -24.8(4)  C15 C14 C13 C18 0.0(6) 
O2 S1 C5 C6 159.6(3)  C13 C12 C19 O4 -100.9(3) 
N1 S1 C5 C4 89.1(3)  C13 C12 C19 O3 77.4(5) 
N1 S1 C5 C6 -86.4(3)  C13 C12 C9 C8 61.3(4) 
N1 C8 C9 C12 165.5(3)  C13 C12 C9 C10 177.2(3) 
N1 C8 C9 C10 42.5(3)  C13 C14 C15 C16 -0.1(6) 
N1 C11 C10 C9 16.9(4)  C13 C18 C17 C16 -0.4(8) 
C12 C9 C10 C11 -159.3(3)  C20 O4 C19 O3 -1.5(6) 
C12 C13 C18 C17 179.5(4)  C20 O4 C19 C12 176.9(3) 
C19 C12 C9 C8 -178.1(3)  C11 N1 C8 C9 -33.8(3) 
C19 C12 C9 C10 -62.2(4)  C3 C4 C5 S1 -176.1(3) 
C19 C12 C13 C14 114.3(4)  C3 C4 C5 C6 -0.5(6) 
C19 C12 C13 C18 -65.0(4)  C3 C2 C7 C6 -0.5(7) 
C8 N1 C11 C10 10.7(4)  C7 C2 C3 C4 -0.1(7) 
C8 C9 C10 C11 -37.1(4)  C1 C2 C3 C4 178.8(4) 
C4 C5 C6 C7 -0.1(6)  C1 C2 C7 C6 -179.3(4) 
C14 C13 C18 C17 0.2(7)  C17 C16 C15 C14 -0.1(7) 
C5 S1 N1 C8 65.3(3)       
 
 
Table 7. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for 145. 
Atom x y z U(eq) 
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H12 8336 6217 4195 26 
H8A 4462 4151 3918 24 
H8B 6159 3951 5100 24 
H4 2913 2930 8875 35 
H16 8924 4305 -650 42 
H14 10800 4511 2904 32 
H6 6227 469 6091 41 
H9 3332 7156 3635 24 
H15 11675 3410 1039 40 
H20A 8398 11321 2386 50 
H20B 10673 10831 3272 50 
H20C 8111 11449 3846 50 
H11A 2818 5777 7110 35 
H11B 773 6975 6139 35 
H3 6117 1472 10255 38 
H10A 5630 6902 6018 31 
H10B 3470 8436 5360 31 
H7 9439 -941 7472 45 
H18 4431 7414 1403 43 
H1A 10172 -205 10592 60 
H1B 11686 -826 9426 60 
H1C 10161 -1979 10243 60 
H17 5292 6301 -447 50 
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Table 1. Crystal data and structure refinement for (rac)-176a.  
Identification code  P165  
Empirical formula  C14H16O4  
Formula weight  248.27  
Temperature/K  123.00(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  8.22602(16)  
b/Å  15.4712(3)  
c/Å  10.0483(2)  
α/°  90  
β/°  103.364(2)  
γ/°  90  
Volume/Å3  1244.17(4)  
Z  4  
ρcalcmg/mm3  1.325  
m/mm-1  0.799  
F(000)  528.0  
Crystal size/mm3  0.141 × 0.094 × 0.059  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection  10.704 to 146.872°  
Index ranges  -10 ≤ h ≤ 10, -18 ≤ k ≤ 18, -12 ≤ l ≤ 12  
Reflections collected  15266  
Independent reflections  2480 [Rint = 0.0269, Rsigma = 0.0157]  
Data/restraints/parameters  2480/0/228  
Goodness-of-fit on F2  1.040  
Final R indexes [I>=2σ (I)]  R1 = 0.0305, wR2 = 0.0753  
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Final R indexes [all data]  R1 = 0.0350, wR2 = 0.0787  
Largest diff. peak/hole / e Å-3  0.24/-0.16  
 
 
Table 2. Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for (rac)-176a. Ueq is defined as 1/3 of the trace of the orthogonalized 
UIJ tensor. 
Atom x y z U(eq) 
O1 9085.8(9) 5013.7(5) 3192.9(8) 25.2(2) 
O3 5195.2(10) 5984.4(6) 5015.0(8) 27.0(2) 
O2 11040.9(9) 6009.7(6) 3920.8(9) 28.1(2) 
O4 3727.4(10) 5727.1(6) 2881.5(9) 27.1(2) 
C7 8329.4(13) 7232.9(7) 4127.9(11) 21.5(2) 
C14 5133.2(13) 5861.1(7) 3821.5(12) 20.6(2) 
C8 7495.5(14) 7736.4(8) 3033.1(12) 24.0(2) 
C6 8178.2(13) 6259.7(7) 4140.8(11) 21.4(2) 
C4 7269.0(13) 4903.6(7) 3070.1(12) 22.5(2) 
C13 9601.4(13) 5777.1(7) 3749.5(11) 22.5(2) 
C3 6527.1(14) 4462.6(8) 1728.7(12) 24.8(2) 
C12 9344.6(15) 7642.3(8) 5254.0(12) 27.9(3) 
C5 6656.8(13) 5834.3(7) 3215.3(11) 20.8(2) 
C10 8669.0(16) 9030.7(8) 4198.1(13) 29.5(3) 
C9 7668.9(15) 8630.4(8) 3070.6(12) 27.0(3) 
C11 9512.8(16) 8534.0(9) 5288.0(13) 32.5(3) 
C2 7060.4(16) 3520.9(8) 1670.6(13) 28.8(3) 
C1 6247.9(19) 3099.0(9) 310.6(14) 34.8(3) 
 
Table 3. Anisotropic Displacement Parameters (Å2×103) for (rac)-176a. The Anisotropic 
displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O1 15.4(4) 28.0(4) 32.3(4) 0.1(3) 5.6(3) 2.4(3) 
O3 19.4(4) 35.4(5) 26.5(4) -0.4(3) 6.2(3) -1.1(3) 
O2 13.8(4) 37.5(5) 32.3(5) 0.7(4) 4.2(3) 0.4(3) 
O4 13.3(4) 39.0(5) 28.2(4) -0.9(3) 3.1(3) -0.5(3) 
C7 14.3(5) 27.1(6) 24.2(5) 0.1(4) 6.4(4) 0.4(4) 
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C14 15.3(5) 17.9(5) 27.8(6) 2.6(4) 3.2(4) 0.8(4) 
C8 19.0(5) 27.4(6) 23.8(6) -1.6(4) 1.4(4) 0.7(4) 
C6 14.1(5) 27.1(6) 22.5(5) 2.9(4) 3.3(4) 0.8(4) 
C4 14.1(5) 26.1(6) 27.5(6) 3.7(4) 5.3(4) 2.0(4) 
C13 16.4(5) 27.7(6) 22.7(5) 5.0(4) 2.8(4) 2.4(4) 
C3 20.3(5) 26.9(6) 26.7(6) 1.7(5) 4.5(4) 0.8(4) 
C12 23.3(6) 34.9(7) 23.5(6) 2.8(5) 1.5(5) -2.1(5) 
C5 14.9(5) 23.9(5) 22.8(5) 2.1(4) 2.8(4) 0.4(4) 
C10 29.8(6) 26.4(6) 33.5(6) -3.4(5) 10.0(5) -2.7(5) 
C9 24.6(6) 28.4(6) 27.9(6) 1.9(5) 5.6(5) 2.2(5) 
C11 31.0(6) 35.9(7) 29.0(6) -5.7(5) 3.8(5) -8.2(5) 
C2 30.0(6) 25.9(6) 30.8(6) 0.9(5) 7.4(5) 0.7(5) 
C1 38.8(7) 30.7(7) 35.9(7) -5.0(5) 10.9(6) -3.9(5) 
 
 
Table 4. Bond Lengths for (rac)-176a. 
Atom Atom Length/Å  Atom Atom Length/Å 
O1 C4 1.4808(13)  C6 C13 1.5151(15) 
O1 C13 1.3334(14)  C6 C5 1.5252(15) 
O3 C14 1.2038(14)  C4 C3 1.5082(16) 
O2 C13 1.2113(14)  C4 C5 1.5433(15) 
O4 C14 1.3295(14)  C3 C2 1.5266(17) 
C7 C8 1.3923(16)  C12 C11 1.3861(18) 
C7 C6 1.5111(16)  C10 C9 1.3831(18) 
C7 C12 1.3936(16)  C10 C11 1.3858(19) 
C14 C5 1.5154(15)  C2 C1 1.5225(18) 
C8 C9 1.3902(17)     
 
 
Table 5. Bond Angles for (rac)-176a. 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
C13 O1 C4 110.73(8)  C3 C4 C5 115.66(9) 
C8 C7 C6 122.53(10)  O1 C13 C6 110.82(9) 
C8 C7 C12 118.72(11)  O2 C13 O1 121.91(10) 
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C12 C7 C6 118.75(10)  O2 C13 C6 127.26(11) 
O3 C14 O4 124.20(10)  C4 C3 C2 113.92(10) 
O3 C14 C5 123.80(10)  C11 C12 C7 120.67(11) 
O4 C14 C5 112.00(10)  C14 C5 C6 112.42(9) 
C9 C8 C7 120.43(11)  C14 C5 C4 112.44(9) 
C7 C6 C13 114.76(9)  C6 C5 C4 102.74(8) 
C7 C6 C5 118.83(9)  C9 C10 C11 119.57(12) 
C13 C6 C5 101.74(9)  C10 C9 C8 120.37(11) 
O1 C4 C3 108.58(9)  C10 C11 C12 120.23(12) 
O1 C4 C5 103.29(8)  C1 C2 C3 111.90(11) 
 
 
Table 6. Torsion Angles for (rac)-176a. 
A B C D Angle/˚  A B C D Angle/˚ 
O1 C4 C3 C2 69.06(12)  C4 O1 C13 O2 -178.52(10) 
O1 C4 C5 C14 -151.19(9)  C4 O1 C13 C6 2.98(12) 
O1 C4 C5 C6 -30.10(10)  C4 C3 C2 C1 178.67(10) 
O3 C14 C5 C6 -18.63(15)  C13 O1 C4 C3 140.76(9) 
O3 C14 C5 C4 96.74(13)  C13 O1 C4 C5 17.47(11) 
O4 C14 C5 C6 161.75(9)  C13 C6 C5 C14 152.21(9) 
O4 C14 C5 C4 -82.88(11)  C13 C6 C5 C4 31.10(10) 
C7 C8 C9 C10 -0.17(18)  C3 C4 C5 C14 90.34(12) 
C7 C6 C13 O1 -151.93(9)  C3 C4 C5 C6 -148.57(9) 
C7 C6 C13 O2 29.67(16)  C12 C7 C8 C9 -0.35(16) 
C7 C6 C5 C14 -80.73(12)  C12 C7 C6 C13 -81.28(13) 
C7 C6 C5 C4 158.16(9)  C12 C7 C6 C5 158.08(10) 
C7 C12 C11 C10 0.02(19)  C5 C6 C13 O1 -22.27(12) 
C8 C7 C6 C13 98.61(12)  C5 C6 C13 O2 159.33(11) 
C8 C7 C6 C5 -22.03(15)  C5 C4 C3 C2 -175.44(10) 
C8 C7 C12 C11 0.42(17)  C9 C10 C11 C12 -0.54(19) 
C6 C7 C8 C9 179.76(10)  C11 C10 C9 C8 0.62(19) 
C6 C7 C12 C11 -179.68(11)       
 
Table 7. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for (rac)-176a. 
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Atom x y z U(eq) 
H5 6378(16) 6092(8) 2330(14) 21(3) 
H4A 7151(15) 4550(8) 3857(13) 18(3) 
H3A 6831(16) 4786(9) 983(14) 22(3) 
H6 8220(17) 6067(9) 5071(15) 27(3) 
H3B 5302(18) 4496(9) 1609(14) 29(3) 
H8 6781(18) 7481(10) 2232(15) 33(4) 
H10 8773(18) 9664(11) 4209(15) 36(4) 
H2A 6774(19) 3200(10) 2435(16) 35(4) 
H12 9923(19) 7297(10) 6013(16) 36(4) 
H2B 8300(20) 3497(10) 1836(15) 34(4) 
H9 7055(18) 8969(10) 2313(16) 33(4) 
H1A 5000(20) 3099(11) 167(16) 42(4) 
H1B 6530(20) 3426(11) -432(18) 46(4) 
H4 2880(20) 5767(12) 3302(19) 54(5) 
H11 10270(20) 8799(11) 6077(17) 45(4) 
H1C 6630(20) 2496(12) 267(17) 48(5) 
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